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tra t 
~th;lnPr ur) ( 1 Ilg) i a \\cll-knc \\n neurot i ·ant hut the di\er~e mcchanisti · e\ents 
, soci ted \\ i th 1 ' It\ ha\e \et heen lulh 
- -
lucid · ted . In this study. we 
e I I 1r d the me ·halll . Ill l r 1cllg neurc t 1 ' It partt ·ularl} ih r 1Ssihle roles in 
n ur deg ~neratl\ e d1 ea e.., ltke I Mktn on· dt..,ea e (I [ ) u~tng dopaminergic neuronal cells 
and an n-human pnmate mt d l In the ·ell culture m )del. \\e cc mpared effects ){ Mel lg t 
tho T indu cd h: 1-meth: 1-.f-phen: lr: ndtn1um ( 1f P ). a \\ell-e~tahli~hed drug that can 
indu Parkins ni 'm-like : mpt m \ protctmlc appn ach \\as u~ed t identif) and analyl'e 
Mellg afTe ted pr tein and their ht )]c g1cal function and associated pathwa;s in both the 
cellular and marmo. et model . )ur re ulh shO\\Cd that Mellg induced changes of 
gen .. pr tein pr file are imilar to the effects as l 1PP . l· \idence from proteomic results 
·ugg t d M llg au d neurc d generati\ e effecb not on!; as~ociatcd with PD but also other 
neurodegenerati\ di rder , uch a Huntington· . di ea e (} ID ). l;hcimer · s disease ( D). 
and amyotrophic lateral ler i ( L ). \\'e also found brain regional pecific re ponse to 
MeHg timuli. ba d on the protein profile affect d in the following order: cerebellum -> 
occipital lobe (OL) > frontal lob (FL) of the c rebrum. ln the ercbellum. carb h;drate 
derivative m tabolic proc . ynaptic tran mi ion. cell dev lopment and calcium ·ignaling 
are dominant functions and path'v\ay contributing to the motor deficit in Mel lg-treated 
marm et. Mellg a found to electi I target membrane pr t in in the cerebellum 
particularly in ·ynaptic membranes . MeHg af[i cted protein 1nv lved in energ; metaboli ·m 
in both L and F f the cerebrum thr ugh different proteins and biochemical path\\ a) .·. In 
the L, protein were enriched in functions of carbohydrate metabolic proce · . lipid 
.ii 
111 tab li pr 11 ular 111m a id 111 tab li pr c , , . h 111 
and regul ti n f b d\ Ouid l " I. In the l. diffi rentiall; e 1 re ed pre t ins 'v\ere main! 
in" oh d in th 11 \ lc and ell di \ i. i n. gl; cer li p1d met b li pr , . . , ul fur mpound 
m tab li pro e .. . cellular ammc c. cid met b li ' proce"'"'· micr tubule-based pro ess. and 
pr te I) i . ·1 he d) h me ·ta. 1 r \\ ater tran p 1rt and a ~ 1 ' iated path'v\a) s 1bscrved in 0 L 
nd FL \\a fi und t 1 be the under!: mg mechani m f1r brain edema c b. cned in the Mel Ig 
expo. ed mannc :ct. \Ciprottn . u ·ha II 14(P,' P5)inthc 'erebellumand PCl: in 
L \\ "re e'hibited to he · re pr tein. in linking multifunction targeted b; Mel Ig. ·r his study 
pr "ide a ne\\ per. pccti\ e upon under tandtng mechani~ms behind Mellg mediated 
n ur t xt dcfi it ·. nd . ugge:t potential link. bet'v\ecn Mel lg exposure and 
n urod generati\'e di rder. in human 
.iii 
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hapter I. Intr ducti n 
h nerv u . ·. tem i. th main targ t ~ r man metal u h a I ad. aluminum. mangane. e. 
m r ury. ar 111 and lithium in the human h d; . mong them. mer ur (Ji g). speciall y 
m thylmer ur) el lg) i. one f thL: m 1. t neur to . ic metaL ( ' larks n. 1987). and p c a 
p t ntial ri k t h th ec I gi al and human health . Mellg i ~ a non-essential metal that has no 
bioi gi al fun ti n in human bodie:. thu e'\ce. ~i\e Mel lg e. p ure cause adverse effects 
(F rina t al.. _Q l_ ). Me I Ig to · i it) ha. been \\ell d cumented and can he traced back to the 
fir t M Hg p nmg utbreak · in Minamata Ba;. Japan during 1953-195 . A chemical 
fa tory rei a d \\a t containing Mellg (a b;pr )duct of acetaldehyde synthesi s) into 
Minamata Ba) . R ident around the ba; v.ho con. umed the fish and marine products from 
the pollut d \\at r developed ·ymptom · ·uch a. tremor. ataxia. ·ens ry di sturbances. 
dy arthria. and lo of hearing (Clark ·on and train. 200 : llarada. 1995 ). Pathol gical brain 
biop y re ult of Minamata di ea e patient ho\\ed I vated mercury concentrations in the 
cerebellum and cortice in the cerebrum. particular!) in the occipital lob (Eto. 1997). , ince 
then. numerou studie on Hg toxicity and mechani m of it actions have been conducted and 
reviewed ( hapman and han. 2000: lark on. 1972: Clark on and Mago . 2006: Mergler et 
al.. 2007: Mutter et al.. 2007). Th early tudie on the mechani m of 1 Ig t xicit) tarted in 
the 1950 . which identified Hg binding activit with cell pla ma m mbran and it 
involvement in membrane tran port proce es. Later on during the 1960 and 1970 . the toxi 
mechani m involved in di ruption of protein ·ynthe i . nucleic acid metaboli m. and the 
cyto keleton were identified . After 1980. tudic revealed Hg induced di ·ruption to calcium 
h meo tasi (Clark on. 1987). ' ince the 1990's new techniques and ski! I. de\ elopment in the 
1 
fi ld f m 1 ular bi 1 g hav all Vv d re ar h r t identif ' and quantif th pe ifi 
gene r pr tein in term f th me hani ti a ti n of llg. , p i fi all meth lmer ·ury 
(M llg) ha be n e ' len i\ el re\ ie'Aed du it. high!; to,· i prop rt in rganisms (Faro et 
:R 1..- l ~ 0 number of findings point t 1 the abilit f Mel Ig to induce 
high level f xid ti\ e tre, rca tiH~ H} g n ~pccies ( R .' ). disrupti n of mi rotubule and 
intra ellular calcium h me ·t . i. ( t hison and I !arc. I 94: 'cc atclli et a!.. 2007: re1em 
nd eegal. _o 7) . P tential anti- 1 ·idant agents t protect cellular fun tion from Mel lg 
ati n \\ere v.idel; tudicd (Farina et al.. 20 11: Liu et al.. 20 14). dditionally, 
g n t xi it; and a ciated glutamine glutamate c;cling alteration by Mel Ig has been 
b rv din vari u e perimental tudie ( ' re. p -Lope! ct al.. 2007: Yin et al.. 2007) . 
nvir nm ntal p 11 utant uch a mercur; \\ere rep rted to c ntri but t the eti logy of 
neurod gen rative di a e (M nn t-T hudi t al.. 2006) . Mellg iLelf can trigger 
neuropathological condition by affl cting multi-function in target brain region . Farina et al. 
( arina et al.. 2012) de cribed the po ible mechani m for MeJig-induced neurodegeneration 
which involved the binding of M Hg to ulfhydryl group (thiol and eleno) of prot in 
(including neurotransmitter receptors) and oth r non-protein thiol uch as glutathion . Thi 
reaction evoke the redox tate change of thiol group on protein . ub equently I ading to 
cell dy function. MeHg can al o c ntribute to neurodegeneration through calcium 
dy homeo tasis, neurotransmitter alteration and glutathione ( H) depl tion (Ca toldi et al.. 
2001 ). For example. MeHg inhibited dopamine y tern function in ynapto orne of earh 
postnatal rat (Drciem et al.. 2009). The e m chani tic characteri tic are al o common 
featur of several neurodegenerative di ea c . uch a ·. P rkin ·on· Disea ·e ( PD). 
myotrophic lateral sci rosi ( L ) and I Iuntington's di ·case (HD). 
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Rationale 
n th ugh lini al mpt m f mer ur] neur 
due t p t Mellg poi nmg ept de · (Farina et a!.. ..... 0 I l ). the relation bet een these 
ffl ct /b havi ur and intrin ic m bani m cau:ed b; Mcllg i, till n t full under t d. The 
m h ni m r f[i ct: of el Ig. ( articularly it. role · 111 the path gene i f 
n ur deg n rative di ea e · need t) be clarified . I·urthermore. it ts unclear whether the 
m I ular target · of Mellg in different brain rcg1 n are the ·ame. Moreover, 
pid 1111 gi tudi oft n pro\ ide nflicting results (Morken et al., 2005) and no 
ffl tiv treatment ha be n d vel pcd far to mpletel; ab I i ·h Mel Ig t ici ty (Farina et 
al.. 2011 ). mpar d t epid mi I gical . tud;. laboratory in e tigations (in vitro and in vivo) 
larg ly fa ilitat the under tanding f beha\ ioral factor and a. ociated me hani m of 
M Hg neuroto icity in dif[i rent rgani m . and thi v.ill help to rev al the unpredictable 
pattern of toxic outcom ( a toldi tal.. 2008). 
From th context of eco y tem health. thi tud] tem from an environmental health 
perspective. By u ing different re earch models ( dopaminergic n uronal cell . non-human 
primate common marmo et and primary culture ). thi tudy v.a de igned to e plore the 
underlying mechanisn1s of MeHg toxicity and the potential a ociation \\ ith 
neurodegeneration particularly Parkin on· di ea e. and to det n11ine key target protein, that 
can be re pon ible for MeHg neuroto icity . We applied a y tem-ba ed "-omic "approach to 
obtain high throughput gene/protein profile. thi allowed u to ob erve the integrated pi ture 
f respon e to Mel Ig in both in \'ilro and in \'ivo models. The overall goal i to increa ·e our 
under tanding of potential impacts of nvironmental to. ins. Md I g. in human nen OLL ' \stem 
and it r lation to neurodegcnerative condition · uch as I D. 
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Re earch H pothe 1 
Th fir t re r h h; p the i t be t . ted in ' hapter I I I and 1 vva · that Mcllg an d crease 
d pamine r lea in a , imilar me h ni . m t that of 1-Meth; 1-4-Phen lp; ridini um (MPP + ), a 
kn vvn g nt 'O mm nl; u. ed t) induce path gene. i.· or PI , and the tvvo t . ins regulated in a 
imil r manner in t ~rm: r pr tein pr )file in a de paminergic neur nal cell line, M 9I . In the 
ec nd part r thi stud) ( ' hapter and ' hapter I ), a pro tee mic appr ach was used to 
tud) the pattern f differential!) e'<pre'). ed pr )tein~ in Mel lg-treated marmoset brain Ill 
rder to determine the p tential regie nal di{Terence. . ') the open feature of "-omics" 
nd part v.. uld be that some of the identified proteins 
and th ira ciated bi logi al function and path'Aays i: con ·i tent vvith th e reported in the 
lit rature , and ne'v\ pr tein. indentified that can . hed nevv light on the understanding of 
MeHg neur t icity . Th identified enriched functi ns v..ould explain the bserved 
phenotype effect upon M Hg-treated marm et. 
O bj ective and tructure: 
The principle objective of this project wa to explore the mechani m of MeHg intoxication 
y tematicall y using an in ' 'ilro cell model and manno t in ri, ·o mod I and to inve tigate an 
association with neurodegenerative di ea e uch as, Parkin on· di ea e. pecific objective 
included: 
1. To inve tigate the effect of MeHg on a dopaminergic neuronal cell line. M 90 
and compared that to 1-methyl-4-phenyl pyridini um ( MPP+). a \\ell-establi shed 
ag nt associated with the pathogenesi . of PD. 
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2. tu th ffect f Mellg n a d paminergi M 9 ell line u mg a 
T tud J the ffe f ellg p sure in the erebellum f mm n marm J t 
( 'o!ltthrix Jocchu\ usmg a ·h tgun pre teomi ' appr ach with liquid 
hr matograJ h) c up led H ma s ~I e tn metr) . 
4. T mp re the , mprehcn, i \ e pr teo me exprcssi n of the marm )Set brain 
r g1 n. (prefrontal c )I1e'\ )r the fr mtal lobe and the occipital lobe around the 
al arine ·ul u: in cerebrum) expo~ed t Mel Ig using pr te mic techniques. 
ntain e\ en 'haptec and c ne appendix . ·1 he introduction in ' hapter I includes 
th ba kgr und. bjective and ·tructur . rationale and h; p thesi , of thi · re earch . ' hapter Il 
i the literature re\'ie\\,. \\,hich mpri e the general introduction of "mercury life cyc le". 
M Hg in the environm nt and it ocial determination of heath. Chapter I l al o include a 
review of the recent d v lopment of toxic effect and mechani m of Mel I g. particularly on 
the CN . by illu trating ho\\, MeHg embodiment relate to it pathologic proce · and the 
a ociation between these mechani tic proce e . Furthermore. the general review of 
relationship between MeHg expo ure and neurodegen rative di ea e uch a Parkinson· 
disea e will be addres ed. Chapter III-VI comprise th main body f the thesi . the 4 
chapters each containing a manu cript of research paper that aim to achieve each of the 4 
objective described above. A g neral conclu ion along with the potential contribution and 
pi tfall of this the i wil l be given in Chapter VII . Finally. a eparate chapter de cribing the 
proce of method development for a cereb liar a trocyte and neuronal o-culture model i 
included in Appendi l. 
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ha pt r II. it ra tu re Review 
1. Mercur an en ar nm nt 
curot . in · are agent · that c n 'au c t 1 ic cffccL in luding p i. ning or dam ging on the 
ntr l n n u . ; ·tem ( ' ,' ). I he:c \uhstan es <., uch a: mcrcur; (1 !g), mm gancsc (Mn) and 
lead (Pb), al , ' Ur in the natural en\ ir mment. 1 hc ~c metal arc als ~1und in so lid waste, 
h mica! v. a te .. hi I gi al and radic acti\ e materiab. as v.ell as industriaL municipal and 
agricultural \\a, te di:charged intc \\ ~lter (.'iha ct al.. 200() . Mercur; is one of the most we ll 
d urn nted en\'ironmental p )llutant~ and i knO\\ n to he hi gh!; t xic to v.ildlifc and human 
lark n et aL 20 ). There are main!; fc rm . of mcrcur; : elemental mercury or 
qui k ilver (Hg0 ), in rganic m r ur; or i nic mercury (Ji g· and I Ig2 · ) and organic mercury 
uch a methylmercur; (M Hg) and thylmercur; ( ' arocci et al., 2014 ). 
There are tv.o main ource of Hg emi ion : natural!; occurring emi sion and em is ion from 
human activitie . Anthropogenic contribute to the majority of mercury mi s ion. Selin et al. 
( elin taL 20 10) u ed -Chem. a global three-dimensional atmo ph ric chemi tr; 
transport model to estimate atmo pheric mercury depo ition from it emi ion ource 111 .. . 
This tudy reported 68°/o of Hg emi ion are from anth ropogenic ources ( 59° o from North 
America and 9°/o from out ide N011h America), 16o/o were natural and the re t of the 16° o 
were from historical anthropogen ic Hg. 
Mercury producti on, emi ion, atmo ph ri c tran port and di tr ihuti on in the en\'ironment are 
a complex proces . Elemental mercury (Hg0 ) or 1I g2+ in the atmosphere can be transported to 
remote areas by wind , then depos ited into ocean, ·oi l and land, and thi , represent · the 
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mi i n. b th natural and anthr p g mc ur e f I lg. F 11 ing I lg meth lation 
tn rt 111 ana r bi ba t ria. i ni I lg an be c 11\ rted t Mellg. the mo t l fonn f 
m r ury . Mel Ig nl r th ~ d chain thr ugh hi m gnifi ati n , and hiomagnifications 111 
predat r fi h and ther m nn mammaL . J luman, nd vvildlife that n 'Ume Mellg 
ntamin nt d cean or t rre. trial rgam . m \\ere \entuall affect d (f ri c 11 el aL 201 ). 
In term f mer ur) life ) cle bar cter.. mercury i able tc travel gl ball y carried by wind 
and rain . Ther ~ r . m rcur) pc lluti n ism 1r, than a simple en\ ironmental health iss ue. The 
in r a ing p ial i1 ti n and am unt r re. earch ha\ e led to further efforts to under 'land the 
f[i ct f mer ur; in the n\ innment. and health impacts n I iving 1rganisms. 
Th mam our f human expo. ure t 1 mercur; is fish and mammals' c nsumption. ' hina is 
con ider d n f the large t ource. of anthropogenic I Ig emi ·sions. ""hich is generated 
mo tl; by c al combu ti n and m tal melting. Intriguingly. Mel Ig con entration in fish 
ti u in hina are v ry lovv. even in the heavily Hg ontaminated area . The rea on may be 
due to the hort aquatic food chain . and the fact that mo t of the fi h are pr duced b; 
aquaculture. which are not favoured Hg bioaccumulation proce according to Li · revie"" 
(Li et aL 201 0). Low fish Hg concentration ha re ulted in lo"" hair Hg levels in the fi h 
eating population in hina. Rice on the other hand \\Ia reported to contain high level of 
Mellg from Hg polluted Qingzhen area and th Wan han mining area in uizhou Province. 
hina (Horvat el aL 2003 ). A signifi cant relationship \\a found bet\\-een the area v. here 
there was high level of MeHg in the rice and hair MeHg level (r= 0.65. P< 0.001) (Li eta!.. 
201 0). Therefore, it appear the source for human e. po ure to Hg differ depending on 
g ographic location , and thi is as ociated v.ith particular characteri ' tic , of local 
environment and I i fe style. 
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In the h 11 I l n nutriti n h rt tud . 'Aith 12 moth r- hild a1r the p si ti 
rr l ti n w [i und b t 'A n bl d I I ( d ahc n 1c acid) in prcnat Mcllg 
c p ur fi h c n umpti n and language d \ cl pmcnt 1f child. and PlJ F (n-
p l un tur ted fatt a id. \\Crc [! und t be an impc rtant nutriti n fa t r t modify the 
pr natal e. po ure \\ith ell g and P. )- ·h 1111 t1r [ e\cl pmcntal Indc . th ugh the rc ult did 
n t find maternal c. p urc to 1el lg rr 1111 fish con. umption associat d with 
n ur d \ elopmcnt ut m n ·hi ldrcn ( ab 1ut ~Omonth~) (. ' train ct a!.. 2015 ). ·r his cohort 
tud ' indi ated ial en\ ir nmental fact r ~uch a. diet. especial! in high fish eating 
p pulati n (m·er g . fi h meal \\Cck). are important in modif;ing Mcllg to ic effect. 
Th fact r. h uld be n ider d in ri k a .. c. sment and pol ic; determination . Recent 
ep1g n tic-ba d tudie al cmpha i7e genetic pol; morphi sms In prediction of 
nvironmentally n itiv gene in MeHg exp ed population . This is valuable in estimating 
biomarker uncertainty and health outc me ( ee i ladri Ba u revie\\) ( Basu et al.. 2014 ). 
oodrich et al. ( oodrich t al.. 2011 ) found 5 p lymorphi ms ( '. 'TT 1 deletion. GSTP 1-1 05. 
TPl-114. 5' and PP 1 ') · TR) to be a ociated with mercury accumulation in urine 
and hair levels in a population of dental profe~ sional . indicating change of glutathione 
yntheta e ( ) and selenoproteins EPP1 affect MeHg limination which r ulted from 
the polymorphism modification of S and S EPP 1 gene . The re ul t illu trate that 
environmental factors are able to modify th epigenome and ingle nucleotid polymorphi ·m. 
pigenetic tudies have dire t role to monitor biomarker and MeHg xpo ure source like 
fi h con umption (Basu et al., 2014). uch tudie will benefit m rcury ri k a e sment and 
policy deci ion-making on improving management on u ceptible population \\ith i\1eHg 
po ure. 
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2. To ac ffect and Mechani m of Meth lm r ury 
2.1 arget ite ymptom and path I gical chang 
M Hg th m t t '\I ~ rm f m r ur) that hie a umulate. in aq mtic s tcms, au ·mg 
high e p ·ure in human · \\he on~ume large amount~ 1f fi sh and ea mammal s (,' himsha k 
and Ward) ( ' e catelli et al.. ~0 I 0: .'anfcliu et al.. ~00 ). Man)' studies have shown 
in rea ing le\ el f I Ig and cl Ig in the hair and hlo d of people in cultures vvith high fi sh 
n umption ( iez et al.. 20 9: Jochfeld. ~003: Pa~~o~ et aL 2008), for ~ ample, maternal 
n umpti n f large i I; fi ·h has been . h '" n , igni fie anti 1 correlated with total mercury in 
n \\b rn ' hair in pani h ( iez et al.. 2009) . 
M Hg t xicit) extr m 1; damaging t the nen u y tern m the early devel pmental 
tage a it I ad to alteration of th ·tructure and functionality of the ncr u ·y tern 
( rand jean t aL 201 0). \'en m l \\ do e , prenatal expo ure to MeHg can di srupt brain 
d velopment in the fetu ( arpenter, 2001 ). nimal tudie have hown that e po ure to low 
dose of MeHg (0.02mg/kg/day for 7 week ) reduced birth weight of mou e pups, and 
induced neurobehavioral defect (locomotor activity, motor equilibrium impairment and 
auditory dy function). The e anatomical and phy iological effect were matched by change 
in lipid peroxidation, Na+ /K+ -A TPase and nitric o. ide ignalling (Huang et aL 201 0). 
Mat rna] nutrients change may alter the phy i logical et point and rai the \'Uinerahilit; of 
the off pring to the low level of MeHg in the environment ( Fo. et al.. 2013 ). Th re i. lear 
electivity of Mel Ig for pecific cell t pe and brain tructure (Sanfeliu et aL 2003 ). MeHg 
preferentially accumulate in a trocyte di abling the capacity for a trocyte to pro\'ide 
metabo li and antioxidant upport to neuron . Thi inevitably leads to neuronal damag ~ and 
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th a umul ti n f llg 111 neur n ( hn r et aL 20 7). The me hani m of thi 
pr ~ rred umulati n re n t yet full under t d. 
IIi t h mi al r , ult from autop~ie of Minamata di s a. e p tients revealed that I Ig were 
d p ited in alm , t all the ti , ue and organ~ in human h d;. 1f ~hich kidney. brain. liver, 
thyr id \\ler th m , t ·tained rgans ( hi ghe ~ t le\ el: of I Ig accumulati n) ( Fto. 1997: ( kabe 
and Takeuchi. 1 0) . In th ~ nen U'> s_ ~tem. I Ig accumulati n ~as highest in the cerebellum 
and er brum r the a ute phase 111 1inamata disease case~. 'I he pathological changes of 
c rebrum ·h wed that damage pred )minantl) 1ccurred in the calcarine regiOn , the 
po t entral and pre entral g; ri. and the temp )raJ trans\ erse gyrus. The to icity in the 
c r b llum \\a hara teri1ed b) I s · c f granu le neurons hut a relative ~ell maintained 
purkinj c II ( ~ to . 1997). indicating that granule neurons are specific tartgeted cells for 
Mel-lg toxicity. Brain ed rna and ub equent i chemic changes were observed in the early 
tage of acute ca e . In chroni ca e . Hg accumulation ~a . lower in brain ti . ue than the 
other organ ( kabe and Takeuchi. 1980). A neur logical study of 77 autopsy ca es from 
Minamata di ea e found 80.5 o/o patient with n ory impairment. 35.8°/o of patient had lo~er 
e tr mity coordination. patients ~ith con triction of vi ual field ccupied 28.8°/o. and 
retrocochlear hearing lo was in 15.3°/o ( chino tal.. 1995). Another evere occurrence of 
MeHg poi oning occuned in Iraq in 1971-1972s with mortality rate of 459 ca e from 6530 
record d ho pita! ca e (Bakir et al.. 1980). Patient exhibited imilar ymptom (muscle 
weakne s. ataxia. dy arthria and tremor, ev r ca e appear visual and hearing impairment) 
found in Minamata di ea e. Notably, neurological deficits such a un teadine · and frequent 
fa ll , early sign for Mel lg poisoning. were ob erved in the Iraqi patient . There are 3 major 
fa tor reported to contribute to cause thi tragedy : people ~ ho consumed bread that \\as 
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tr t d ith M Hg fungi id , br eding r ut fr m ed m ther. nd prenatal e p ur . 
c rding t thi tud; ( Bakir et a!.. 198 al o th prin ipl targ t rgan f Mel Ig 
ning ba d n th ) mpt m and hi t path gi al alt ration . . The brain path 1 gical 
hang v. r par II I v. ith the degree r p is ming nd bloc d mercur le cl. 
2.2 Mechani m f McHg acti n 
including Mel lg enter the hod) and c crt their t ), ic ciTe ts in 4 general pha e · 
a rding t Mar 111 arc ni and I arhicri. 1 8 ) and Philbert (Philbert ct al., 2000): ( 1) 
d liv ry pha . entr) into orgam ·m and di trihution to the regton )[ action; (2) 
re ept r/m tab li ph e. bind and rea t \\ith spe iiic cellular targets: ( ) to icodynamic 
pha e, initiati n fbi h mica] hange : and ( 4) lead to the alteration of cellular structure 
and functi n in (clinical pha e). ince the initial identification of l lg poi oning in 1956, 
the clinical n urology and the effect of neur toxicit; of Mel lg have been v.idely studied. 
How ver. the mechani m re p n ible [! r MeHg induced change in neurobehavioral effect 
and function are till enthu ia tically debat d. number of ·tudie have shov.n that Mel Ig 
di rupt a number of cellular function including inhibition of prot in ynthe i . microtubule 
di ruption. and increase of cyto olic and mitochondrial vel and di rupt of 
neurotran mitter function in the brain, uch a catecholamine (Ro i. et al.. 1997: Fit anaki 
and Aschner. 2005a: Johan on et al.. 2007: anfeliu et al.. 2003 ). llere. I pre nt a mini 
review on the mo t commonly proposed m chani m [! r MeHg neurotoxic it) . 
2. 2. 1 Oxidal ive stress and Ani ioxidanl defense 
xidative tre s is a condition of fom1ation of total free radical in a cell that exceeded the 
anti-ox idant capabi I i ty that triggers variet of pathological condition ( Smcyne and Sme\ ne. 
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201 ). Tr nit in r a f r a tive gcn p 1e ( R , ) are mm nl e i t d in n rmal 
ellul r pr I ignall in g. nd ntio. id nt n/) m in b d; uld rapid! r m e R t 
t th red . b ian . I ligh n ntrati n f R , ' may cau e o idati e modi f and 
damag f macr m le ule n rau. tad llir ct al.. ~0 1 ~ ). ' mentioned abo c. 1n the first 
d li f\' ph c. llg enter. the ell. h) binding Jig mL pre. cnt in membrane. whi h include 
thi I gr up. el n gr up. amino. phc sphak and car be x; I. Mcllg can bind t -, ,I I nd - 'e lI 
ligand in th ) t ine amino acid resulting in the r m1ation of a Mel Ig stcinc c mplc 
( ar i t a!.. ~ 14: ' lark on. 19 7 . I hi · is al. o the major c, cretion route for Mel I g. for 
e. ample. Mellg i tran ported th li\er canalicular membrane · into bile in the form of 
H-Me g c mpl x ( utczak and Ballatori . 1994 ). , 'elen proteins ( ie .Glutathione p roxidasc 
1. PX 1) and non-pr t in abundant in -,, 1 I (membrane transporter . I i poic acid) are more 
·u ceptible target f MeHg . .'elenopr tein like ' PXI are also important anti xidative 
protein again t MeHg toxicity. In addition. previous tudy ha sho-wn that Mel Ig 
preferentially bind to high molecular w ight prot in (> 200Kda) uch a ·keletal mu cl 
myo in heavy chain. which ha. been proved in tuna fi sh mu cle by metallomic approach 
(Kutscher et al.. 2012). 
xc ss1ve RO generation 1s a well-document d mechanism of MeHg neuroto. icity 
demon trated both in vitro (primary cerebellar granul neuron ) ( arafian and Verity. 1991) 
and in vivo (rat cerebral cort ) tudie (Liu eta!.. 2014). R i an important factor in redox 
ignalling and maintain cellular oxygen homeo ta is. Imbalance bctv~een R production 
and anti-oxidative repair y tern can lead to <."'~ . idati ve tre (Shukla et al.. 2011 ). and 
sub quent damage the cellu lar macromolecule and disturb signa l tran ·duction path\\ a) .·. 
R formation canal o ind irect! mediate glutamate cxcitoxicity. For example. u ct al (Xu 
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t L 2 1 2) h vv d M I I g i gn i fi 
idati dam g 111 r bral 
d h m ta i a re ult of R 
~ rmati n. lipid. pr tei n and D 
rt . of rat. The auth r al dem n tr ted glutamate 
m diat d inhibiti n of glutamine , nth ase. ' 2+ a 
imbalan vva b n d a.· ne f th t .· ic mcchani m. ~ r Mel lg-indu ed R ._' generati n 
in mit h ndria f r t brain ·li e. and · ntributcd to the hain effect of mit ch ndrial 
dy fun ti n nd :idati\e . tre:· ( )ama et al.. 1994). Imp rtantly. R ,' i able t adversely 
af~ t llular ma r mole ule: u h a I thr ugh o. i dation . ( idati n au ·ed 
dam g i an thcr m I cular me hani sm )b ·ened in Me l Ig nclll·ot icity . C idative D A 
may n gativel) afT ct n ur de\ ~lopment thr ugh a non-mutation mechani sm to alter gene 
tran cripti n. fa ilitate formation of ·enobiotic-macromolccular adducts. and di rupt other 
macromolecular target uch a protein . lipid and ignal tran duction (Well s et al.. 201 0) . 
repair and ap pto i are normal I) t'v\ re pon e. ~ llo'v\ ing DNA damage which arc 
initiated by oxidative tre . It wa reported in murin embryonic fibrobla t · that 0 repa1 r 
protein oxoguamne glyco yla 1 ( 1) protect cell from D A double strand break 
damage following MeHg po ur . indicated D A repair y t m deficiency ( Gl -- null) 
and inc rea ed the cellular en itivity to MeHg to icity ( ndovcik et al.. 2012 ). 
lutathion ( H) is a critical part of cellular anti-oxidant defen e machinery and i required 
to prot ct c lls from RO induced pero. idation of lipid membrane and D A damage induced 
by MeHg (Gib on et al.. 2014 ). Anti-oxidative agent/drug can inc rea e G I I level and 
attenuated MeHg-induced n urotoxicity. For example. the antioxidant (quercitrin and 
quercetin) have been hown to provide neuron prote tive effect · against Me!Ig induced lipid 
peroxidation and ROS formation in cortical brain slices of rats (Wagner et al.. 201 0) . Pre-
treatment f tea polyphenol ( 1 mmol/kg) rever ·ed Mellg caused GPX I reduction and 
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glut mat uptak di rupti n 10 rebral rt frat (Liu t al.. 2 14 ). M ri ctin, a member 
f f1 n id Vvith nti . idant pr p rtie .. mpletely inhibited R gcn rati n and lipid 
n indu ed b cl lg, \\Cll . brain mit hondrial d · fun ti n (Fran ct al. , 
.... 01 ). ~h e e.· mpl ugge. t that anti -ox idati\ c agent. may . ervc a p t ntial treatment for 
Mellg int ti on. In additi n. cllg ha. hi gh affinit y f r cysteine a. mcnti ned ab c. and 
G rmation fa M llg ; . t me mplc.· . tructure i simil ar to that f the neutral amin acid . 
methi nine . r m thi a. p L methi mne ma; al. sef\ e a. potential treatment ~ r acute 
M llg c. p ure b mp titi n r r the bind ing . pot of th e Mel lg- 'ys tcinc compl ex (Roos ct 
al.. _o 11 ). 
2.2.2 Calcium hom eo tasi 
Cal ium and cal ium ignalling path'v\ a) pl ays an important role in Mcl-I g induced tox icity. 
Almo t all the id ntifi ed mechani m related to MeJ l g tox icit) 'v\ a initi ated or lead by oth r 
fac tor to increa f intrac llular calcium concentrati on ([ 'a2+]i ) (Roo · et al.. 201 2). There 
are two main way that [ a2 ]i can be affected: one i the regul ati on of intrace llular Ca2+ 
tore, and another is pla ma membrane permeability to rupti on of either ource can 
alter intrace llular calcium concentration (Atchi on and Hare, 1994 ). Intrace llular ca lcium 
signaling i required to timulate energy production by catalyz the key enzyme in Kreb 
cycle which can directly affect mitochondrial re pi ration fun cti on (Roo ct a!. . 20 12 ). 
acted a a dri ving force in the mitochondrial matri x, and an increa e or cytoso li c Ca 2• 
timulated a partate-glutamate exchanger ( l 25a 12, part or the malate-a. partate shuttl e). 
thus b o ting pyruvate upplicati on to ini ti al Kreb cyc le in cortica l neuron · (Liorente-Fo lch 
et a!. , 201 5 ) .• akamoto et a!. ( akamoto et al.. 1996) demon. tratcd that ca lcium bloc k. rs 
(flunari zine, nifedipine, nicardipinc, and erapami l) attenuated the to.· ic effects (hod\ \\ eight 
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and n ur g1 al mpt m ) m rat indu e b M llg. ' b . . u mg pnmar reb llar 
gr nular 11 , al ium bl k r Ounari7ine v.a h v.n t hav pr t ted fleet again t ce ll · 
death fr m M I lg t xi it; . n ther , tud; ondu ted b; ]a: . t a!. ( ' a o t a!., 2001) 
b rv d the reducti n [ [ 'a- ]i and cl Ig ' ) l<. t ·icit; in rat cerebell r granule neuron 
ultur b) u ing · 'a2' h nne! hi ' ker (ben/ami!). and inhibitor (thap ·igargin f ' a2 •-
P e Ill nd pia mic reti ' ulum . I he) al shO\\ed that Me l lg induced R S [! rmation that 
\\>a indep nd nt c f a2• m hili/ali n fr 1m endoplasmic reti ulum store and e tracellular 
a2 nth~ ther h nd. an earlier stud) puhli . hed h) ( ;ama et al. (Oyama et al., 1994) 
r p rt d that MeHg (I 0)1 ) induced increasing le\el~ of [ 'a2 ]i V\hich resulted in the 
enhancement f R , g n rati n in isolated cerebellar neurons )f rats . .'imilarly. another 
tudy dem n trat d in rat tri tal ·ynapt ome · that RO,' formation V\a a downstream event 
of mit chondrial dy function indue d h) Mellg V\hich ""a dependent on an increas of 
mitochondrial calcium level ( reiem and eegal. 2007) . Therefore. it i . till d batable 
whether [Ca2+]i o erload and R generation indue d h; MeHg are a cau. e-effect or an 
independent event . However. there i little doubt that r gulation of intracellular calcium 
level i a critical factor in the n urotoxicity outcome indue d by M Hg. In addition. it wa 
hown in 57BL/6J mice orally exposed to MeHg ( 1 or 5mg/kg) for 1 1 day led to R 
formation. [Ca2+]i alteration. decrea e mitochondrial membrane potential and r localization 
of cytochrome c (Bell um et al.. 2007). The e events did not accompany a ignificant n uronal 
ce ll (mic cerebellar granul ce ll ) death. indicating that ubcellular biochemical chang , 
occurred without lethal ce ll inj ury in hort term e. posure to Meiig in mice (Bellum et al.. 
2007). Though Mel lg may not direc tl y lead to neurona l death, inhibition c r glutamate uptake 
may cau e ce ll energy d fi cit ( ehinder et al.. 1996) as a resu lt of mitochondrial d) sfunction, 
ca lcium dy homeostati and reduced glutathi one leve l. bnormal calcium ·ignalling or 
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al i urn i n d h n1 ultim tel 1 ad t fl f bi n rg ti 1n mit hondrial 
tgn !ling r athv,a; i tn\ h d in man; impc 11ant neur nal function such a 
~ napti pia tici t). the g~nerati n of brain rh) thms and asso iated learning, mem r and 
c gniti n ( erridg . _o I ). Ph :ph lipa~e ' is knov.n a. initial fact( r of calcium signalling 
thr ugh ti\ ati n of J P~ In ~ it I tri pho ph ate). a sec md messenger. i capab le of regulate 
n entration betv.een e'tra and intracellular calcium store ( 'hang, ..... 011 : Venkatachalam et 
aL ' 2) . Mellg ( ~M) \\as r und to initiate calcium signalling by activation of 
Pho ph lipa e ' and phosph lipase 2 \\hich re . ulted in the release of interleukin-6 (IL-6) 
111 m u c r bra! glia ( 'hang. 2011 ). Ba ·ed on the bsef\ation of Mc11g increasing of 
[ a2+ Ji in pinal motor n uron culture . Ramanathan ct al. (Ramanathan and Atchi son. 2011) 
rep rt d that M Hg-induc d calcium alteration v.a. related v..ith the glutamate receptors 
mediated pathway. pplicati n of NM A receptor blockers ( AP-5 or MK- 01) ignificantly 
reduced MeHg-induc d calcium influx . In ummary. the con equence of increa ing 
intracellular 
.., 
a~ level is an important mechani m for th activati n/inhibition of 
downstream pathway that lead to neurodegeneration or cell death. alcium i al o the key 
ion in linking the proce s of synaptic transmission and neurotran mitt r relea . 
2. 2. 3 Synapl ic transmission and Neuro/ransmi//er release 
Another well-documented mechani m for MeHg to. ic action the alteration of the 
neurotransmitter (NT) r lea e in the proce of synaptic transmi ssion. xon terminals are 
distal termination of a on that functioning a storage and release of Ts . rhi · proces: i · aid 
by opening of vo ltage-gated Ca2-t channel · when depolari;:ation occurred in the pres) naptic 
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m mbran lin t L l 1 . B th intr - and e tr cllular l ium c ntribut t the high 
n f [ a~+ ]i in n n e t rmin 1 • nd the ignal f al ium th n an evoke a . ignalling 
a ad f fu i n f ;napti \e i le t r lea c ·1 b; e. c;t s1 t s napti left (I enn 
nd t hi . n. 19 ). el Ig \\ r 'P rtcd t blc k ' a2 ' channeL in the ncr c terminal 111 a 
n n mpetiti\e m nncr t inhibit ' a2 mflu ~ 11 v.ing an acti 1n p tcntiaL but incrca e the 
n ntrati n I [ a2 ]i in nene terminal (I nn) and tchi ·on. 1996) . ·1 h~ ma111 target d 
n ur tran mitter f Mel lg arc glutamate ( ' ]u). d paminc (I ). and cholinesterase ( 'hE). 
he human brain ntain · apprc '\imatel; 10 11 neur )n . . and each neuron has ab )Ut 7000 
ynap e. The . ;nap · ~ are the · mnccti\c stru ·turc that allov. s "cross talk" between 
n ur n ( adiq et a!.. 2012 ). It ha · b~en ·ho\'- n that Mel Ig altered the s; naptic transmi ssion 
by changing either th ndu ti n nene action potential or directly inhibiting synaptic 
tran mi i n. or both ( tchi nand Hare. 1 94 ). Mel Ig particularly inhibits e, citatory amino 
acid receptor in . Bl eking f ex itatory amino acid receptor of MDA receptor and 
non-NMD recept r po tponed th increa e of [ 'a2+]i mediated by Mel Ig (Ramanathan and 
Atchison. 2011 ). The amino acid L-glutamate a the major e citat ry ignal in the 
mammalian 
. plays a critical role in neuron development including ynap e induction. 
elimination, cell differentiation and death. Glutamate i con tantly ecret d from the cells but 
removed quickly from extrac lluJar fluid. and there are sev raJ thou and-fold gradi nt 
difference aero plasma membrane . In normal condition. only a mall amount glutamate i 
kept in extracellular pace (Danbolt. 200 1 ). Therefore. it i important to maintain a ll1\\er 
level of glutamate in the e tracellular fluid . lutamate uptake i the primary mechani m for 
maint nance of glutamate concentrati on whi ch protec t the brain from glutamate 
excitotox icity. There are a number of report prov ing that the inhibition of glutamate uptake 
an important mechani sm f Mel lg- induced exc itoto:icity. }~ or example . .luare/ et al 
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t aL 2 2 . u d mi r dial i t hniqu t b er e glutamate fluctuati n in the 
front l c rt f rat p d t M I Ig and [! und an remark ble increa e f e tra ellular 
glutamat c 11 e11trati n. It \Na al rep rted that Ia tational e p sur t M I Jg caused an 
inhibiti 11 of glutamate uptak 1n cerebellar . lice, f mou e pup ( Manfr i et a!.. 2 04 ). 
Anoth r tud; r ported Mel Ig at n entrati n: bet\\-een 2-1 011M inhibited icle glutamate 
uptake 111 a ncentrati n dependent manner. the authc r~ als dem 11strated the failure of 
glutamate upt kc \\a re ulted from inhibition f the proton gradient and I J +- 'I Pa e activity 
inrat") naptic\~ i le(P rciunculactal..200 ). 
Cdutamate re ept r ig11alli11g v..a f und t be an thcr ke) target for Mel Ig. MPA receptors 
( u-ami11o- -h) dr . ) -5-meth) 1-4-i oxaz lepropionic acid recept r) and M A recept r ( -
mdh) 1-d-a partat r cept r ) are glutamate receptor that play vital roles for modulation of 
. naptic tra11 mi 1011. y11aptic pia ticit; in ' (Danbolt. 2001: Ha himoto et a!.. 2001: 
Leveille et al.. 2008: ku and Huga11ir. 2013: ' hepherd and Huganir. 2007). motor learning 
and coordination (Ha himoto t al.. 2001: ku and H uganir. 2013 ). Activation of MD 
receptor was reported a a mechanism of MeHg-induc d excitator neurotoxicity. An in ' 'ivo 
c periment studying effect of MeHg on brain developm nt and vulnerability to NMDA 
r~c.eptors (Miyamoto et aL 2001) found that the mo t ever neuronal damage occurr d in 
the occ ipital cortex of P 16 rat . and the MeHg-induced neurodegeneration \\a ·ignificantl) 
attenuated by an NMDA receptor antagoni t. MK-80 1. dount e and Chan r ported in an in 
nlro study that exposure of MeHg 0.25 and ljlM to human H-SY5Y cells for 4h re ulted in 
an increa e of NMDA receptor level and ub equ ntl; cau ed cell death ( dount e and han. 
2008). Ba u et al. (Ba u et al., 2007) reported a decrease in NMDA receptor leveL in \\ ild 
mink brain exposed to 0-2ppm Mellg in dietary . The author. suggc ·ted that the decrea ed 
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M r pt r r ult f mp n at r m hani m [! r limiting Mellg mediat d 
indi at d ab vc. a tr ; tc arc more su cpti blc t cl lg a cumulate than neurons, and 
thu r pre ent an imp 11ant target fc r Mcl lg tox ici t; ( . chn r et al.. ... 007 ). Besides 
glutamat r uptake. the a. tr c; tic glutamate transp rtcr is an ther regulated mechani ·m t 
balan c glutamate home sta ·is and the le\el of extracellular c. citoto 1c amm J acid . 
Jut mat a partate tran. p rt r ( i L , ' I) and glutamate transporter- ] ( :iL'I- I) are primary 
glutamat tran port ~r. that are found prcdc minantl; in astrocytcs (Mutku · ct al., 2005). 
MeHg \\a h \\n t inhibit the tran port of c;stine and c;stcine in astrocytes (A ·chner ct al., 
2007). MeHg \\a al o rep rted to affect s dium transportation bet\\cen astrocyte and 
neur n through in hi bi ti n f a tr cyti cy. tine uptake on the ·ystcm X( A ' ) ( cysti nc 
tran port y t m in a trocyte ) ( II n et al.. 200 1 b). Treatment of ' II -K 1 cells with Mel Ig 
ignificantly increa ed the xpre n of LA T tran porter and decrea ed cxprc s1on of 
LT-1 in protein level (Mutku et al.. 2005). Another stud; al o reported that the mR A 
level of two lu transporter . LA T and L T -1. \\-ere down-regulated in the cerebral 
cortex of rat treated with MeHg (Liu tal.. 2013 ). 
In addition to lu, other NT such a cholinergic and the dopaminergic y t m \\-ere al o 
reported to be affected by MeHg. Musc le chol ine tera activity was hown to be inhibited in 
H. malaharicus fo llowing low do e of M Hg e po ure in a fi ·h model ( lve Co ta et al.. 
2007). However, Ba u et al. (Basu et a!.. 2006) reported no significant effect of Mellg on 
blood choline tera c ac tivity in captive mink, but hi gh ' hE activit) \\a detected in the 
occipital cortex and basa l gangli a of mink brain , also they ob erved a paralleled increased 
mu carini c cholin rgic receptor leve l. The c studies indicated a potential di ·ruption of 
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h lin rg1 n ur tr n mi n regul ted b Mellg. he f~ t fMeHg nth dopamin rg1c 
m iII b addr d In the ti n enti tied "M th lmer ur a ri k factor ~ r 
n ur d g ner ti\ di e el Ig . emingl) targeted multiple fa In the glutamate 
)11 pti tr n mt. 10n pr e . . ther pr ce .. es affected b; Mel lg invol ed 1n synaptic 
tran mi 1 n u h a neuronal p tential and the S)naptic do~n tream . ignal ling ar n t 
furth r addre cd a. it i be) ond the C pe of thi . re\ leV. . 
.... .... -1 Effects on C \to.\keleton microtuhuln am/ Other.\ 
Mi r tubule i ne of th" thr ~e mmn comp ment , r the cyt )Skeleton in eukaryotic cell ·, 
ther part 111 Jude mi rofilament (made or pr tein actin) and intermediate filaments . 
Micr tubule pia; a \ita! r lc in mit 1 · pro e ·. including mitotic :pindle in dividing cells, 
cell cycle arre t at M pha e and I at ap pto i ( M IIi ned and ' ajate, 2003 ). 'yto ·keletal 
protein are required for cell movement. mitotic ·pindle fom1ation. organelle and ve icle 
tran port chromo omal gregati n. cell ignaling and cell divi ·i n. thu any impairment f 
microtubule would affect th a ociat d function (Cre po-Lopez et al.. 2009) . ffects of 
Hg pecies on microtubule n twork ~a introduced in the 1970 . mercury preferabl; bind t 
protein that form the microtubul . tubulin and kine in . Microtubule di ruption ~a reported 
in a number of MeHg expo ed experimental model . Berget al. (Berget al.. 201 0) conducted 
a proteomic tudy where they identified the group function of tubulin/di ruption or 
microtubule in Mel Ig e po ed Atlantic cod brain. An in \'ilro study u ·ing di !Terentia ted N2 
neurobla toma cells showed that MeHg perturbed tubulin tyro ·ination. the earl; neuronal 
biomarker of mercury toxicity, implicating the neurite outgro'v\th 'v\as inhibited (La\\ ton et al.. 
2007). Mel Ig i known to di rupt cell c cle through microtubulcs hccau~c the mitotic spindle 
tructure comprises the most abundant microtuhulcs proteins. In neuronal (mouse 
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n ur bl t rna) nd n nn ur nal ( P L... c 11 , M 1 Ig tr atment I d t 2/ pha. arre ted 
and ub equ nt pt i , indi ted ell ) le p rturbati n thr ugh int rfcring with 
1111 r tubul an imp rtant v nt in th development of ap pt , i in b th ell line , (Miura 
) . icr tubule rc riti al fil ament us stru ture t regul ate the nset of t al ., 
ap pt , and th p5 independent path\\ a): \\ a. in\ olved in the Mel lg m dialed ap pt 
(Miura t a!.. ) . el lg- indu ed mi crotubul e dis rupti n v., as a! shown t inhibit 
migrat r; pr nd di . turb a'\ nal elongatio n in th e cultured embr nal carcin rna ce ll s, 
nd the e path I gi al h nge are important t ) un derstand )f Mel Ig induced tru turc crash 
f r b llum and ther brain regi n in the deve l pment of utero and postnatal tage 
(Philb rt t a!.. ~00 ). ince M Hg hi gh! ; rea t Vv ith sulfhydr; l gro up in cy teine re idues of 
ce llular microtubul pr tein (Philb rt t al. . 2000) . Mel Ig can potenti all y inhibit microtubul e 
polymeri zati on, and thi effe t i a um ed thr ugh binding to the free sulfh dry! group at the 
end and on the urface of mi crotubule : thi ha been proven in ' 'ilro e periment (Voge l et al. , 
1985 ). 
In recent year , the role of glial cell e pec iall ; a trocyte . in maintaining funct ions of 
neurons have been bett r defined. They not onl y pro\ ide phy ical structure to upport 
neuron , but also functi onall y interact with n uron or non-neuron ce ll in phy ical and 
di seas conditions, which include neuronal ynchroniza ti on, ynaptic tran. mi ion regul ati on 
and controlling blood flow (Volterra and Meldole i, 2005) . li a ce ll infl ammator; ignaling 
respon e to MeHg i a n wl y empha ized mechani m in re pon e to M 1-lg neuroto. icit) . In 
attempt to te t Mel lg on the re pon e of pro-inflammatory cytokine from gli a ce ll s. Ba ~' ' Ctt 
et al. (Ba sctt et a!., 201 2) found Mel lg dec rca ed I L-6 relea 'e in a do. e dependent manner in 
microglia/a tro yte culture with pre-stimulation with toll -like receptor li gand . AI ' O. the ratio 
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f mi r gli nd tr 111 ulture [! und t b an 1mp rtant fa t r affe ting lL-6 
11. h r ult indi at that eHg an a [! ct micr glia ell fun ti n thr ugh 
m difi ti nth int ra ti nb tvv en m1cr gli astr t . In an her lTilCf arra tud , 
h m kine L4. ' I 7. ' ' L9 and ' L 1 .... ) that were a ciatcd with 
inflammat f) r ti on \\ ere f und tc be , ignifi ntl ) in ' fCa cd ( .... - [! Jd hangc ) in re ponsc 
t eH g timuli 111 m u erebcllum ( I Omg kg da; for 10 da , ) (II an g ct al. . 20 II) . In 
dditi n. gap jun ti n hannel , a nncc ti n . tru turc bet-w een a. tr cytes, play · a vital role 
in n ur -gli int racti n (R ua h t al. . ~000) . ' nncx in protein c nditi on , arc important in 
th [! rmati n f gap JUn ti n 111 n ur n-glia communi ca ti ns. dj acent astr cytes JS 
connected thr ugh gap junction hannel ( ' J ' ).e.g .. '. 4 and hemi channcls t regul ate A TP 
relea and glutamate tran mi i n ~ 11 wing intrace llul ar calcium elevati on to respond 
neur nal glutamat r I a ing (Maragaki and R th tein . 2006: r Il ana et al. , 2009) . ,' far. 
ther i little r earch to inve ti gate the rol e of J ' fun cti on n mercury neuron tox icity 
(Kawa aki et al.. 2009 : Kothmann t al.. 2009). The arli er publi cati on howed that MeHg 
inhibited the function of J both in cultur d rat o teobla t-like cell (. chirrmacher et al.. 
1998) and rat pro imal tubular cell (Yo hida t al.. 1998). Mercury chl oride wa al o 
reported to affect junctional coupling in epithelial canine kidney cell ( leo et al.. 2002). 
Thi literature revtew highlighted a number of sing! mechani m re ponsible of Mellg 
neurotoxicity. It is important to note that there are many potenti al known and unkno\\ n inter-
connections b tween each of these m chani sms. For exampl e. both the event of ox idat ive 
tre and glutamate dy homeosta i were m chani m involved in M llg tox ic it) ob en ed 
in rat c rebral corte , and the potential f lu dy homeo tas i cau cd Ca2+ overl oad could 
al provoke m rc RO formation (Liu et al. , ~OL ). Mellg cxpo ·urc induced .· idati\e 
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dam g ( H d pl ti n, R ~ rm ti n and the it it p th a wa m diated b 
glut mate tr n p rt r and " rl ad f intr el lular calcium in the rat rt ( eng t a!., 
2 14 ). h t\.\ 0 nn t d pr e f R 
' 
gcnerati n and glutam tc d h meo ta i 
ffl ted h th fll1 ellg-indu ed neur t . icit; ( , chn r taL 2007). 
3. Methylmercur a a n k fa t r f r neurod e nerative di ea e 
h m 111 metal indu ing n ur heha\ i )ral hanges after dcvel pmental c p ure arc 
m th lm r ur; and le d ( 'arp nt --r. ~00 1 ). cure degenerative di · rd r uch a lzheimer' 
), p rkin n' . di ea ( rr ) and am) tr phic lateral ·cler (AL, ) affect 
v raJ million pe pie V\ rldV\ide (Migli re and 'oppcdc. 2009). The inheritance of m st of 
n urod g nerativ di · a rar ly [! II "' Mendelian laVv but in ·tead reflect a more complex 
interacti n V\ith multi pi predi p ing gene and en vir nm ntal factor · ( chner, 2009). The 
va t majority of AD. PD and L occur a p radi D rm , likely re ulting from th 
contribution of comple int raction betwe n gen tic and nvironmental pollutants uch a 
pe ticide and h avy metal . Interacti n between gene and environmental factor is crucial 
in modulating the vulnerability to PD ( L' Epi copo et a!., 201 0) . Th alteration of tubulin 
tructur , mitochondrial dysfunction and sub equent biological change in lipid, protein and 
DNA peroxidation are common change ob erved in AD ( Carocci t al.. 2014) and PD 
patients. These pathological changes are al o often ob erved in MeHg induced neurotoxicit) 
in different exp rimental model . 
PD i a commonly occurring neurodegenerati c di order characterized b.} elective lo, · of 
dopaminergic neuron and progres ive neurodegencrativc movement di ·order that produces 
mu cular rigidity, bradykinc ia, tremor of re ·ting limbs and loss of po ·turn! balance 
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( bdulwahid rif nd hm d Kh n. 2 10: Jiang t 1.. 2 7 . pamine ( ) i the m st 
pre I nt and d um nt d ate h lamin neur tran mitter am ng th h rm ne pinephrin , 
n r pin phrin . and in th br in. 1 · nthc i7 d ncur n main! in th sub tantia 
nigra. v ntral t gm ntal ar ~a nd h; p thalamu. ( i oullon. 2002). The dy. function of 
d paminergic rclat d pathv\ a) . c n pr du ncur I gical and en do rinol gical diseas s such 
a hi7 phrcnia. and I I untingt n · s, d i ca. e ( ' ui et a!.. ~006 ). neurons ha c been 
am ng them t v.idel; . tudied s;~tem · in the brain . ince iL di sc cry (Bjorklund and 
unn tt. _ 7 : J nc. and iller. _00 :Young et al.. 2011 ). In addition. dopamine rc carch 
ha b n unique \\ithin the neur . cience in a v.a; that is ahlc to bridge basic science and 
clinical pra ti (Bj rklund and unnetL 2 7b). ince I is involved in many important 
a pect of behavi r. uch a m tor controL m od regulation. cognitive ta k . addicti n, Jeep. 
puni hment and re\1\- ard ( i oull n. 2002) ( Li and Roeper. 2008 ). D paminergic 
neurotran mi i n m diat through everal linked pr ce es. including synthe i . rclea e. 
torage. r ceptor activation. uptake and metaboli m. Tyro inc hydroxyla (TH). an enzyme 
that limit DA ynthe i . convert L-tyro ine to L- P . \1\-hich i then decarboxylated to 
DA. Then DA is tran ported into ynaptic ve icle through the ve icular monoamine 
tran porter (VMA T). with presynaptic action potentiaL r leased from the cell. nee 
relea ed, DA activates a variety of po t ynaptic receptor \1\- hich ar I inked to different c II 
signaling pathway . DA transmi sion is inactivated by re-uptake the of D tran porter (DAT) 
into the pre ynaptic neuron where it i metabolized by catechol-0-methyltran ·fera e ( ' MT) 
and monoamine oxida e (M 0) (.lone and Miller, 2008). Environmental neurotoxicant · are 
able to depre or enhance dopaminergic n urotran mitter by impacting th D cycling 
proce , leading to pathological alteration in DA-assoc iated disorder such a PD and 
add iction (Jon and Mi ller, 2008). nd rslanding the molecular mechanism or hO\\ those 
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k nz m m th d pamm lib and d pamm rg t a ad path a re pond to 
n ur nt 'Will fa iii tate identifi ati n or d , 1gn f n ph arm I gical targe t to 
pr te t nd treat di e r lated to dopamine neur tran mi tter di order. 
lth ugh the eti 1 g; and path )gene, i. f P 1 • p rl; under. tood. interacti n between 
g ne · nd ~n\ ir nmental fa tc r. haH: been impli a ted a. critical fact rs 111 m dulating the 
vulnerabilit; t P (I Ieller t aL. 2000 ) .. 'e\ era! ·tudi s ha\ e rerorted that en vir nmental 
p llutant u h as pe. ticide: and hea\; metal pia; a ke; role in the pathogenesis f PO 
( j rklund, 1 M i h lk et al.. 200 : R s ct a!.. 2006h ). r, posure to heavy metal ha 
al been h 'Wn t link t a\ ariet; r 0 related di ea ·es . uch as ttenti n eficit isorder. 
lzheim r' di ea e and Parkin ni m (J n and Miller. 2008) . 'hr nic e p ·ur of 
rot n g n rati n ha h en pr po ed to contri hute to the neurodegenerati n 
f neuron ander and r enamyre. 20 l 3 ). ' harle. et al. ( 'harle et al.. 2006) 
analyzed data collected from L049 men aged het'Ween 7 l to 93 and D und a igni ficant 
a ociation between occupational e po ure to pe ticide . olvent . metal , mangane . and 
mercury (during their middle age) and 14 movement abnormalitie . It wa found that high r 
exposure to any metal , and p cifically mercury, wa a ociated with abnormal fa ial 
ex pres ion. Dantzig (Dantzig, 2006) tudi d 14 patient with Parkin on' di ea e, and found 
detectable amount of blood Hg in 13 patient who a! o had rover' di a e (tran ient 
acantholytic dermato i ) and proposed that llg cou ld be involved in the etiolog; or PD and 
rover's di ease. 
A di cu ed earl i r. the syndrome cau d by Mellg poi ·oning is called Minamata di ·ea:e 
( eccat IIi et al. , 20 1 0). The early ign or congenita l Mellg poi ·oning can he mistal-.en for 
other di ea c and over- looked, especia ll y in mild cases ( randjean et aL 20 I 0) . l--or 
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ample, th ndr m pr du d b Mel Ig b r d in adult during the Minamata and Iraq 
pi d h p the ta , n r di turban c , tr m r , d arthria, and lo f 
h aring ( . . 111 mt a t a!.. 1 ), v. hi h bar m n) imi I ri tic . t P . In a p pulation-ba cd 
c e ntr 1 tud; . rell ct al ( J rcll ct al.. 19 9) ~ und that hr 111 cupati nal e po ur 
t ith r m ngan r c pper \\ a. as iatcd 'v\ith P . 1 he als [t und th t dual 
mbin ti n f le d. 1r )n and ppcr. v.. a. a. iated 'v\ith P howe r, ccupational 
p ur t 1r n, m r un r nn al n \\ a: n t related t the n. et f P 
vid n doe indi ate that arl ) expc ure t chemi cals increased th e u ccptibility to 
metab lie ;ndr m lik di ea c and c ther health i ue in later life (F ct al. . 201 ). An 
ample i f the p ur t meth; lazo. ymcthanol (a ncuronto in ) from the ource of food 
or m dical treatm nt potenti ally contributed to the eti ology of AL,, and PO dementia 
comple ndrome in region pecifi c p pul ati n ( ' uam. Kii and W st Papua). ' urrent 
know! dg indicat that th re are van ou ri. k fac tor leadin g to the dev lopmcnt of PO 
phenotype. which e pre sed in th incr a ed odd rati o for PO in epid m1 g1c tudie and 
characteri tic ofthe ph notype produced in experimental model ( 'ory- , I chta t al. , 2005) . 
Wh ther MeHg expo ure i a ri sk factor in the formati on of PD phenotype i till not known. 
However. there are known ynergisti c effect of vari ou to in that can re ult in condition 
like PD. For example. oxidative tre is an important factor o curr d in the proce f 
neurodegen rati on ( hukla et al. , 2011 ). Many of the MeHg induced change uch a 
oxidative stre and di turbance of neurotransmitter functi on have al o been implicat d a 
major factor in PD. Moreover, there ar likely other overl apping and/or unknO\\n 
mechani ms in the etiology of PD. Re earch on the e. plorati on of envi ronmental toxicant · 
uch as M I lg e po urc and relevant di order ha e trcmcndou · impli ca ti o n ~ in prevention 
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and lini al gn ti ( ang n id n need d to larif 
m hani m fM 
MPP i a m t b lit pr du t f MPl P. a \\ell kn 'Wn to icant that el cti ely de troy 
d pamin rg1 neur n in the uh. tantial ni gra. v.hi h is haractcri ti of P (llarc et al. , 
.... 01 . MPT \\a identifi d b) a identl; in 19 ~ fr m pc pic \\h addi ted in admini ster a 
n 'vV nth ti mpound \\hi h c n induce imilar hrc nic . ign · of Parkins n · di ca c 
(Lang t n tal.. 19 ..., ). in ~ th n. MPTP MPP ' \\a. \\ide!] used a parkin on m mimic m 
th m hani ti tud; of u1 t al., 20 I 1: Zhang et al.. 2011) and devel pment of new 
drug in anti- P ( tal.. 20 l 0: ' a tal.. 201 0) . MPP + i · c nvert d from MPTP by MA , 
and th n entry ll through T. which particularly high e pre · ed in the cytopla m and 
membrane of ub tantia nigra par ( torch t al.. 2004 ). MPP ' i d liv r d from cytopla m 
into the mitochondrial matrix by the gradient betwe n inner m mbrane . and then combine 
with NADH dehydrogena e of complex I to top electron tran port. I ading to TP depletion . 
The ub equent effect of the energy d ficit cau of extracellular DA level in 
triatum, and further promote the generation of R S. uch a hydro yl radical ( · H) ( ing r 
and Ramsay. 1990). Therefore, the important manife tation of MPP+ excert it neurotoxicity 
is mediated through inhiting respiratory chain compl I in mintochondrial. Intraventricular 
infu ion of MPP on rat ha been shown to reduce triatal DA level and progr ive lo t of 
TH-positive neurons. Mitochondrial appear ~ woll n. and conden ed material \\ re found in 
DA neurons (Yazdani tal., 2006). Mor over. execs ive production of free radical in rea ·e 
memberane lipid p ro idation thu ace leratc the vulnerability of dopminergic cell death 
( bala, 2002) a wel l a ther neuro logical ympotom 'Which featured by PO patient . 
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High-throughput cr emng m th d ha e dem n, tr ted that multiple ignaling pathwa 
In ed int MPP indu ed d p mincrgi n ur ample, MPP + in 40~M 
. . id ti ve tr s. and ir n binding n indu d gen hang in th ateg ric f ap pt 
ell . a midbrain d rived d pamincrgic ncur nal cell line (Wang ct aL 2007). 
imilarl , in ha t al ( ' ha et a!. ~ 15) :tud\. PP + 'A a hown triggering signifi ant 
g n hang m d pam in rgic ignaling tran ·du ti n. tran, porter and iron transport. 
p pt and mit h ndrial d\ ·functi n. I paminergic signaling transduction was 
d m n tr ted a th m t affl ct d function affected b; MPP +. ther mechani ms related to 
MPP n ur t xi it; . . u h · ubiqui tin pro tea · me . ; tern (UP,' ). an intraccll ular protein 
d grad y tem. v. al h 'An a · ciation v .. ith MPP induced d pamincrgic n urotoxicity 
(Lim. 2007). It ha be n r p rt d that Puerarin. an anti-oxidative c mponent extracted from 
Pueraria I bata and h'A i Pu raria th m ni i Benth. v..as able t protect , , 11-SYS Y from 
MPP+ ( 1 mM) elicited c ll death through r gulation of UP ' functi n ( ' heng et al.. 2009) . 
Mor over. MPP e hi bit d neuroto icit; wa reported to be related to the metal m taboli . m 
in idiopathic Parkin on· di ea e (Hare et al.. 2013 ). In a population ba d ca e-control tud). 
Gorell et aL ( orell et aL 1997) howed that occupational expo ure (more than 20 year ) of 
lead-copper. lead-iron and iron-copper ignificantly as ociated 'Aith PD than any of the e 
metal alone, indicating the e metal may erv a n k factors alone or together to facilitate 
the d velopmcnt of PD. However. th mechani m underlying the e effect remam to be 
ill ustrated. 
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hapter III. ffect f M thylmercur n D pamin Relea e in MN9D 
eur nal ell 
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b tract 
_. pid mi l gi al evid n ha, h \\n a iati n b tV\ en pre len f Parkin. on' di ea e 
(P ) nd p ur t etnir nment l p llutant , but them chani m f path gen si are till 
un lear. he bj tiv f thi . tud L t tn\ • tigate effect. f meth lm r ur (M llg) on a 
d pamin rgi n ur n l ell line. and c mpare that t 1-meth l-4-phen lpyridinium 
(MPP , a \\ell-e ta li hed agent a.. iatcd \\ith pathogene i of PI . M D elL were 
e p d to Mellg (1-10)-lM) and MPP (10-400~tM) ~ r 24 or 4 h. ur results . howed that 
M Hg indu ed ell death v. ith b th time and de e dependently . M J lg al o dccrea ed the 
r I a of d pamine ( ). .4-dihydr x; phcn; !acetic acid (D P ' ).and hom anillic acid 
(H ) imilar t th effe t f MPP . . There V\a an incrca. e in I ( PA ' I IV AID ratio . At 
th ame tim . both MeHg and MPP .. de rea ed the ynthc i of tyr inc hydroxyla e (Ttl ) 
and dopamine tran p rter (D T) at the mR and pr t in level . Xpre I n f the U.-
ynuclein (a- yn). a hallmark neuropathological indicat r of PD. wa al o up-regulat d at 
the mR A level but not at th protein level after MeHg and MPP+ do ing. Monoamine 
oxida e B activity wa up pre ed in all MeHg treatment and MPP ( 1 ).lM )-treated c II . 
The e finding suggest that MeHg can disrupt th ynthe i . the uptake of D and th 
metaboli m as well as alter the biology of a- yn imilar to MPP . Expo ure to MeHg rna; 
potentially be a ri k factor for the development of PD. 
Key word : Heavy metaL Neuroto icity; MPP+; Parkin on· di ea · 
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Introduction 
Parkin n di ea (P ) i n f th m t c mm n neur d g n rati di ea e that affect 
milli n f p pie v. rldv. ide. The ·a t au ·e of P is , till unclear. I I e er. rec nt rk 
hav r gni7 d a p iti\e rr lati n bctv.cen indu. trializati )n and the ccurren e of PO 
(J n and iller. _ 0 ). r n' ir nm ntal p )llutants :u h as pesticide and hea metal · have 
b n r p rt d t be a ciated '' ith the path gene is f PI (R )OS, ..... 00 : Michalke, 2009). 
M rcur · a w 11-knO\\ en' ir nmental neur t icant. The orgamc [! rm '. such a 
m thylm r ur] (M Hg). re m re t 1c to li,ing organi ms than it 1n rgamc form 
( lark n. 197 ~). ntral n rv u ) tem i the mam target of rgam mercury ( ' lark n 
and Mag . 2 06). M r ury an b accumulated in the c rte , ·triatum. hipp ampu , brain 
t m, cerebellum. and pinal ord . The m t comm n clini al neur I gi al ympt m of 
MeHg p i oning ob erved in adult in Japan and Iraq epi de were hypoesthesia. ata 1a. 
, en ory di turbances. trem r . dy arthria. and lo of hearing ( inomiya et al.. 1995 ). 
Par the ia i u ually the fir t neurofunctional ymptom ob erved ( lark on and Magos. 
2006 ). Pathological re ult in the victim of Minamata our break al o indicated that the 
central nervou ystem wa th primary it of MeHg poi oning ( ' lark on and Mago . 2006 ). 
The motor dysfunction caused by MeHg e po ure ar 
Parkin n · disease. 
imilar to th ymptoms of 
The biological mechani m of MeHg on central nerv u y tem are ti ll unc lear. ne of the 
e tabli hed mechani m by whi ch MeHg can e ' ert to. icity i th rough the di . ruption of 
neur tran mitter functi on (Fitsanaki and A chner. 2005 b). Dopamine (OA) i the most 
preva lent catecholamine neurotran mitter compared to epinephrine and norepinephrine in the 
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br in. h di rupti n f d pamtn rg1 r !at d path a n au neur 1 gi al nd 
nd rin gi l di a u h P rkin n di hiz phrenia, and I luntingt n' 
di ea ( u i et aL .... 0 . Th re i m vid n e f Mellg affe ting th relea f . F r 
mpl . inje ti n f MeHg int the tri tum in fe ly m ing rat indue d a concentrati n-
dep nd nt in rca 111 1 ' eL (Far ct a!.. ~002 ). In th rat phc cr m c t rna cell I in 
P L ... , th intr - ellular dopamine ntent v. a. d ·c-dcpendcntl ] decrea cd after po ure t 
M Hg ( tt ri ct al.. _ ). Mel Ig can aL o medi ate its ncur t . icit) by interfering with 
meth 1- -a artate ( M ) or d pamine rgi rccept r. . egati e co rr lati on were ~ und 
betw n t talllg and d paminergic 2 receptor den. ity in v.. ild mink (Ba u ct al. , 2005a) and 
wild ri ver tt r ( a u et al. , 2 05b ). I . Mef Ig wa. reported to increa e NMDA recept r · 
both in vitro and in ,.i,·o (Mi yam t et al. . 200 1: d unt and han, 20 8) . The e re ulL 
ugge ted Me g c uld di rupt d paminergic pathv..ay in the central ner ou y tern . 
1-methyl-4-phen lp ridinium ion MPP+ i a we ll tudied comp und that can induce 
anatomicaL behavioraL and biochemical change im ilar to tho e een in Parkin on' di ea e, 
which i characterized by nigro tri atal dopaminergic n uro-d gen rati n (Heikkil a et al. . 
1984 ~ Yuan et aL 2008). MPP ha been hovvn to cau e a lo of the stri ata l nerve termi nal 
a indicated by decrease in tyro ine hydroxylase (TH) and dopamine tran porter (OAT) a 
well a dopamine and its metabolites leve l (Nakai et al. , 2003 ). a- ynuclein (a- yn ). a 
presynaptic protein closely related to DA regulati on (l·ounta in and R., 2007: Fountaine and 
Wade-Matiins, 2007: Herman on et a!.. 200 ~ Zhou et al. . 2006) i a neuropathological 
hallmark of PD. Prohibitive ac ti vity of DA ha been found to be high !) rela ted to 
accumulati on of the a- , yn protofi bri I (C onway et al. , _oo I ). M pp+ has been ho\\ n to cause 
an increa e in a-Syn aggrega ti on (Jeth va et al. , _o 1 I). In addition, Mon amine oxidase-B 
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(M n f th f M . 1 a mit h ndrial nz m that has b en 
d m n tr t d t n rt MPTP 1-meth '1-4-ph n l- L2 .. -t trah dr p rid inc) to th a tive 
m tab lit MPP~ ( udim and akhl ..... 0 ). M ts po i ti iatcd i th PO, 
and M inhibit r ha. be n de~ c l pcd in the treatment of P (Y udim and Ri dcrcr. 
2 4). 
Th mam bj cti\'e f thi ·tud ) i. t in\ c. ti ga tc the cflcc t of M ll g n regul ation and 
it me hani m 111 mpan , n to MPr ·. ~·c measured th e rclca. e f and its metabolites 
with MeHg and M P + • ·p ure u ing a neuronal ce ll I inc M 9 . whi ch have the properti es 
of ynth izing at ch I mine and ex prc. ing ncur n- ·pcc ifi c marker uch as tyro ·in 
h dr yla (Herman n. _00 ). We hvp the iz that Mellg can decrea ·c the relca c of A 
by: 1) d cr a ing the 
limiting nzyme for D 
ynthe i 'v\ith deer a e in l] r inc hydr xy la ·e (T ll ). the rate-
ynth i : 2) dec rea ing the DA re-uptake through the decrea e f 
dopamine tran porter (D T). a tran m mbrane protein that m di ate the r -uptak of DA; 
and 3) reducing DA metabolite by inhibition MA -B ac ti vity. W will al o in e ti gate the 
effect of MeHg on the synthe i of a- yn in the M 9D cell . 
Material and Methods 
Cell line and treatments 
MN9D cell s ( hoi et aL 199 1) were main tained in DM M ( igma. M . U ) 
uppl emented with 1 Oo/o (v/v) fetal bovin erum , 3. 7g/L Nal-JC 1. 1 OOU/mL penici ll in. and 
1 00!-lg/mL streptomyc in ( ibco, nt. , Canada) in an incubator 'v\ ith an atmosphere or 5° 0 
2 at 37° ell s were gr wn in poly-0 -ly ine coated lla ·k (BD. NJ, U,, ). MN9D celL 
w re e p cd to different d c of Mel lg or MPP +. Stock so lut ions ( 1 mM MeHg or 1 OmM 
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MPP ) er pr par d in \\at r. Medi wa r pi d er 48h. Mellg nd MPP 1 wer 
btain d fr m ]fa ar ) and igm - ldrich ( nt. ' anada) . 
ell viabi lity a ay 
n M a ) \\a arricd ut t1 '\aluatc ell \iahilit)' . bout x ]O c lL ere lated in 
a h \\ 11 f -v. 11 plate i r ~4h he~ r adding the neurot 1n Mellg or MPP + at 
n entrati n bet\\ n I ~tM t l 0 ~tM, r l O~tM t 400 ~M, r ·pe ti vel . , ample treatment 
ndu t d \\ith fi\ rcpli ate in each , periment and each e, periment wa onductcd 
in triplicate . ntr I and blank amp! \\ere in luded in all ample plate . Treated ce ll s were 
all ed t gr \\ [! r _4h and 4 h. The am unt r , oluhiliz d MTT ~ nnazan produ t wa 
determined by p troph t m tf) at 95 nm . ' ell viability \\a e pre ed a percentage of 
the contr I gr up. 
HPLC detection of DA and it metabolite in MN9D cell culture medium 
After 24h incubation with MeHg or MPP+. 200~1 aliquot of m dia from 1 x 107 ce ll w re 
mixed 1:1 with ice-cold 0.5M metaphosphoric acid, and filtered through a 0.22~M centrifuge 
tube filter ( orning. NY, U A) at 15,000 rpm 15 min at 4° . The flovv parts \\er collected 
and 20~L ample was then loaded. 0 , 3A-dihydroxyph nylacetic acid (0 P ) and 
homovanillic acid (HV A) were analyz d by IL N HPL y tern with electrochemical 
detector (pul ed Water 464, Millipore, M , ). The isocratic paration was perf rmed 
usmg a 18 rever e-pha e column ( 150 x 4.6 mm, 4~M: Phenomenex. ' . U A). The 
mobil e phase was made up of a 0.1 M acetate, 0.1 M citrate butTer at pl-14. cc ntaining 
228mg/L _, OTA tetra odium alt. 200mg/L sodium octyl sulfate and 10°o methanol a 
de cribed previously (Vicente-Torr s et al., 2002). The OA, DOP ' and IIV release le\ el 
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ln 11 1 ul t d ba d n a m1 d tandard ur a rding t n n c n ntrati n 
f !uti n. nl 
( nt. anada). 
th r\\-1 m nti n d. II reagent \\-er purcha ed from igma- ldrich 
em1-rever tran ript P R 
tal R V\a i )lated fr m ·e ll , mplc, arter 4 h of e. p sure. vvith th u. e f lumn 
R a 1 Plu Mini it ( tagen. nt.. 'anada) . R c nccntration V\a. mea ·urcd in a ubit 
Ou r m ter ln\·itr gen. nt. 'anada). 11g of i ·olatcd total R V\a. rever. ed tran cri bed 
u ing th T qman Rev r c Tr n. cription Reag nt · kit ( pplied io y ·tem , nt, anada) in 
a final\ ' lum f I 00 111 follov, ing the manufacturer's in tructions. Primers (Liu et al.. 2008; 
Zhang tal.. ~0 I Oa) u ed were T (forvvard 5' -T ' '1 GGT 'ATTC:iT'I 'T ' 'TC- 3'. 
-...,, ). 1 H (forward 5'-
A T 5'-T TC A A 'TT ACA A-3'),a-
ynuclein (forward 5'-T T T ' GT -3'. rever e 5'-
A T T T -3'). GAPDH (forward 5'-TTGTTACCA C GG CG-3'. 
revrse5'- ATAGA T TTTA G-3')a aninternalcontrol. 
ycling condition wer 95 ° for 5 min. 0 cycle of 95 ° for 30 ec. 56° - 60° for 30 ec. 
72° for 30 sec and follow d by a 5 min e ten ion tep at 72° . The product w reanalyzed 
u ing agaro e gel electrophoresi . Band inten itie w redetermined den itom trically u ing 
ene Tools oftware ( yngen . MD, U A). and the r ult ar hov.n a r lative e. pr 1011 
of ratio of target gene to internal c ntrol. 
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lmmun blot 
fter 4 h f p ur elL \\ere h n t d in Rl 1; i buffl r kit vvi th PM. F, pro tea. e 
ktail nd dium rth \anadate (,' anta ru1. ). The cell ere then 
h m gent7 d b) · Jni ati n and entrifugcd at I ~.OOOrpm for _ 0 mm at 4° ' . Pr te in 
·on entrati n \\a dermined b) Bradfl rd as. a) Bi -Rad. ll er ulcs, ' ). liqou ls f 
pr tein (_ -60~tg) \\ere . cparatcd n I 0-15° o a r) !amide ge ls and tran ferred nto 
nitro ellul e membrane ·. 1emhr ne: \\ere hi< eked \\ith 3° o BS sc lution 111 TBST 
.·olution befl re incuh tim \\ ith the fl liO\\ ing antihodic. : 'Ill ( ' hem icon. l :500), OAT 
( hem icon I : ~ ). and u-.') n ( ' hemic< n. 1: 0 ). ' P I I ( ,' anta ru7, I: 00) was used a a 
loading ntrol. Pr tein hand \\ere dete ted h) a .3'-Diaminohenzidine (0/\B) kit, and 
quantifi d b) 1ene T ol anal) ft\\are (, ;ngenc. MI . US ). 
Analy i of MAO-B activity 
ell were collected aft r 48h treatm nt. V\a h d and re- u pended in c ld a/K buffer (5 
mM K L 120 mM NaCL 50 mM al--bP 4. pH 7.4 ). then onicated . , upernatant were 
removed for protein concentration analy i (Bradford a . ay) . MA -B activity was mea ured 
a de cribed earlier with modification ( tamler et al.. 2005~ Zhou and Panchuk-Volo hina. 
1997). Briefly, the reacti on tarted when th M 0- inh ibi tor clorgyline ( 1 mM) V\a 
incubated with ample fo r 30 mi n at room temp rature, then 100111 of work ing olution 
contain ing Am plex Red (20 mM ), hor e radi sh pero, ida e typ IV (200 /mL). tyramine 
( 100 mM) and Na/K buffe r were add ed into the ce ll ample . Incubation. \\ re continu d for 
a minimum of 30 min . pecifi c fluore cenc of re orufin , the oxidati on produc t of Ample.· 
Red reagent, wa m a ured u ing a Multilabel Mi roplatc Reader (Bioscan Inc ., Wa ·hington 
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i th , itati n at Onm and m1 n det cti n at 9 nm. R rufin pr du t wa 
pr e a pm 1/mg pr t in/minut . 
tati tical nal 1 
II d t ar pre entcd a me n ' . . ,' tati . tical . ignific nee as obtained b vanance 
analy i V\ith ne-V\ay te ·t. [! II v.ed b) L,' 0 int r-group mpan n post ho test , 
r t-te t r tV\ gr up mpan n u ing ,' P,',' I .0 ,' ftV\arc . aluc f P<0.05 (*), ? <0.01 
(**) r P< . 01 ( *** v. a r garded a . igni fi ant. 
Re ult 
T he to icity of MeHg and M PP to th e M 90 ce ll v iabi li ty 
MeHg d crea d c ll viabilit at con ntrati n of 5~-tM, 7 . 5~-tM, and 1 0~-tM in 24 and 48h 
( ig. 1 ). The 50 wa e timated to b ~8~-tM in 4 h. In contra t MPP + do ing re ulted in a 
dec rea e of cell viability at all concentration ( 1 0~-tM -400~-tM) for both 24h and 48h (Fig . 1 B) . 
Changes in dopamine and it metabolites relea e from MN9D cell 
Typical HPL chromatogram of the culture m dia after the MN9D cell v..ere xpo ed to 
MeHg and MPP are hown in Fig 2. The quantitie of e. tracellular DA produced b) the 
MN9D cell declined with increa ing do es of MeHg (Table L (F(3,8)=, .607, ? =0.065) . The 
lowest DA relea e was 0 . 1 2 ~-tM when do d with 1 0~-tM MeHg for 24h compared to 0., 4 ~tM 
in the control. MPP+ exerted the stronge t effect at 50~tM resulting in 0.04~tM (P 0.0 I) on 
DA release in the media. here were decrea e tendencies in D PAC and I I A release from 
cell media treated with Mel Ig and MPP+. The DO PAC llV AIDA ratio increased slight!) 
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ith M Hg 
P<O. 1 ). 
p ur F . ) 0. .P ) nd ignifi anti wi th MPP+ e p ure 
ffect of in vitro e po, ure to MeHg and MPP n dopamin e ycling gene 
ann d agar gel of Rf-P ' R result · and the quantified den ·it fthc bands arc hown in 
T mR lc\cl in 1-7 . ')~M Mcl lg treatment did n t differ fr)m that in normal 
ell h 'v\e\er. ·ignifi nt rcdu tion appeared in the d se f 1 O~M (Fig. ). Til mR A 
level 111 c 11 do ed \\ith Mel lg ( 1-1 O~tM) remamcd unchanged . In comparison. u- ,' yn 
ho'v\ d an increa ·ing trend in a do e-depcndent manner 'v\ith both Mel Ig and MPP + 
tr atm nt ( ig . .., ). d -dependent dO\\n-regulation trend 'v\a al o ob ervcd ~ r DJ\T 
and THe, pr ion 'v\ ith MPP .. expo ure (Fig. 3 B). 
Effects of in vitro ex po ure to M eHg and MPP+ on dopamine cyclin g protein 
After 48h of expo ure. pr t in lev I f both TH and OAT were decrea ed ignificantly in 
MND9 cell do ed with 511M and 7.5~LM MeHg (Fig. 4A). The arne trend app ar in MPP -' 
treated group and the notable difference 'v\a induced at a do e of 50!-lM. a similarly 
effectiv dose reported in previou tudy ( pittau et al.. 2012) (Fig. 4B) . u- , yn expr · 10n 
level were reduced in the cells with either MeHg or MPP exposur (Fig. 4A and B). 
Effects of MeHg and MPP+ on M AO-B activ ity 
The en ymatic a say howed M -B activitie wcr uppre ed ignificantly in all MeHg 
treatments (0.111M , 0.5!-lM. I 11M and 5 ~LM ). with 18-fold dccn~a ·c in eel L do ed v~ ith 5 ~L 1 
Mell g (P<O.OO 1 ). The MA -B activity wa, lower in cells treated \\ ith 1 ~LM MPP \\ hil e 
higher at high do e ( 1 0011M) expo urcs (Fig . 5) . 
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p and I I ell ulture m dium after 
in ubati n \\lith M llg r MPP+ [! r .... h 
ncentration D DOP HV DOP +HVA/DA 
M Hg 0 1 00 0.65 0.25 0.20 4. 1 1.78 
.27 . 16 0 . 0.5- 0.26 0.2 5. 2.55 
15 0 10 0.8 0.5 0.1 0 16 8.5 6. 5 
10 0. 12 0.05 0. 0 0 0 0 08 0.10 9.08 6.78 
MPP 0 0. 4 0.1 1.00 0 5 25 0 20 . 1 1.78 
50 . 4 0.02 .. 0.69 01 D 25.49 1 .5 I ·• 
are mean ± . n t de tec table. ** P<O.O 1 \ '.\ contr 
ac id: }{ . h mo\·anill ic acid . 
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Figure} . Do e-respon e curve of (A) Methyl mercury (McHg) and (B) MPP + cytoto. icit) Ill 
MN9 0 cell s after 24 and 48h e po ure . e ll v iability wa mea ured b) MTT a a; a 
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Figure2. Typica l chromatogram of D , DOPAC and HV A. (A) 0.21JM tandard and cell 
culture medium from I 11M Mellg incubation analyzed by HPLC: (B) Cell culture medium 
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Figure3 . Dose-dep ndent effect of ( ) M Hg and (B) MPP+ on th e pre ion of TH. OAT 
and a-Syn mRNA analyzed by RT-PCR. Bar graph ho~ing that 0-1 011M M Hg e po ure 
on MN9D cells in 48h. Th mRN level wer hown ba ed on one repre entative data from 
three separate e periment . Each band wa quantified by d n itometry and normalized to that 
of APDH . *P<O.OL ***P<O.OOl vs control. 
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Figure4. Dose-re pon e effect of (A) MeHg and (8) MPP+ on th e pre ion of TIL DA T 
and a- yn protein analyz d by immunoblot. MN9D cell were exposed t MeHg or MPP + at 
diffi rent concentration for 48h. The total homogenate wer prepared from M 9D c II . 
Data how a typical e periment performed in triplicat . ach band wa quantified b; 
den itometry and nonnalized to that of GAPDH. Value are mean ± .D from three 
independent xperim nts. * P<O.OS, ** P<O.O L *"'* P<O.OO 1 rs control. 
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~ igure5 . ffect of MeHg and MPP~ on M -B acti\ it} in MN9D cell . M 9 cell were 
e po d to a dif:D rent range of M Hg and MPP~ [! r 48h . A one tep nuorom tric method 
wa u d t determine M -B activit} . Re rutin pr duct wa e pre ed a pmol/mg 
protein/minute. perim nt wer run in triplicate . "**P<O.OOl 1'S control. 
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Di cu 
h d . . ammergt 11 line ha. been . ho\\ n t l e an ffecti v model [! r the stud of 
MPP indu d n ur ·icit; in P Kim et al.. ~0 11: Wang et aL ~008 ). It ha b en shown 
th t the ~ "o f MPP f r 1 9I ells i O~t 1. and at 40~M. MPP + induced ignificant 
yt t xicit) in elL (llu:sametal..l ). In this stud) \\e se lected 0-.... 00~M MPP t 
a ur p iti\e ntrol \\hi ·h au. ed 40°o cell mortalit; (hgl ). In the MTT a ·ay. we found 
that th E "0 f Mel Ig f r M 9I cells ,,a. around 8 ~tM . ur results sh wed that Me l Ig 
d r a ed II pr t in '\pre .. ic n at ~ ~l and decreased the pre tei n level )f I ·1 at 7.5 ~M . 
Th effect"' r benedatd e belov .. thei· ·~o.inthe80°osurvivedcells(Fig.l )that 
mparable t th c nditi n f th PP + treated c II . rhu . ur results howing effect 
in MN9 c 11 tr at d \1\ith the . perimental d range r r Mel Jg and MPP + are relevant in 
th under ·tanding f th comparabl ffi ct of th e t\1\ c mpound. on e pre sian f 
d pamine cycling protein and D content . 
Thi i the fir t report that how M Hg may har imilar path logical mechani m a tho e 
of MPP in dopaminergic cell . Our r ult hoVved MN9D cells exposur to M Hg re ulted 
in a decrea ed relea e of DA and DA metabolite (D P and HV ) in a imilar manner a 
that of MPP+. HV A leve l were more sen itively affected by MeHg compared to D P ' in 
the present tudy. which could e plain in part the lower media I v 1 of D due to HV 
being its primary extrac llular metabolic product (El worth and Roth . 1997). imilar r ult 
were reported in an in vitro (Wang et aL 2008) and an in ' 'h'o tudy (Xu et al.. 2005 ) \1\here 
they reported MPP+ or MPTP cou ld induce a decrea ing re ponse of D . D P and I IV 
from MN9D cell and m use triatum. n th other hand. some in ,.i,·o tudie illu ·trated a 
con entrati on dep ndent in rease of e trace llu lar D and it metabolites in free!) mo\'mg 
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triatum u ing a mi r dial t hnique timulat d b M llg and MPP+ ( ar l al. , 
200 : ar t al.. 2 07: ang et al.. 2 ). The e re ~ ult ugge t that effe t of MeHg on the 
rna ar d p nding n d i ffl r n t m d L n /or nditi n . 
p 
f 
H rati a an inde. h been u ed t a . e. d paminergic a ti ity (Lee et al.. 
2005 ). Th rati ~ a c n idered a a marker f turn ver with a hi gher rati repre enting 
a hi gh r turn " r (Thiffault et aL 2000) . We h. erved an increa e in p I IV A 
rati ~ith the ncurrent dee r ~ase in I relea e after incubate ~ith Mel Ig and MPP + 24h 
( ab.1 ), indi ating that the rate r dec rea ·e of relea e was fa ·ter than that of it 
m tab lit p and 1 I 
Th li fl c cle of d pamtn rgic neurotran mt n includ OJ\ ynthe. i , relea · , t rage, re-
uptake and m tab li m. hi dynami c pr c determine OA de tinati n. In norm al 
conditi on , r lea ed D interact 'vV ith a variety of po t ynapti c rec ptor , then ac ti vate 
different ce ll ignaling pathway (Jone and Mill er. 2008), re ult in di ffl rent b havior effect . 
To d tem1ine whether the decrea e in culture medi a level of D and it metabolite 'vV ere 
associated with M Hg-induc d alterati on in dopaminergic neur tran mi ion, key protein 
involved in the li fe cycle of dopamine including tyrosin hydroxyla e (TH). DA tran porter 
(DAT) and monoamine oxidase-B (M -B) , we re mea ured to examin the D ynthe i , 
re-uptake and metabolite, respecti vely. The e pr teins have pr viou ly heen reported to be 
expre ed in MN9D dopaminergic neuronal cell line (L 'vV er et al., 2008). ur r ul ts 
howed that DAT and 1 I decreased with increa ing MeHg concentrati on at both the mR 
and protein levels (Fi g. and 4 ). Thi agr es with the r suit oh erved by Faro e/ a/. (Faro et 
al., 2002) that OJ\ uptake wa inhibited by trea ting Mell g in 1'h 'o. Mice expressing ltn\er 
leve l of DAT was al o proved to cau e reducti on or intrace llular I stor --s (Egana ~t al.. 
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2 0 r p n e ffl t vva n th pr f Til in M 11 
p d t ~-tM, 7. ~-tM and 1 1-l M llg, ~ith an ppr imat -fl Ids de rea e in the 
~-tM tr atm nt gr up mpared t th ntrol group ( ig. 4 ). ur re ult ugge t th t 
M Hg p ur vvill ( 1 u e the uppr r that\ uld inhibit 0 re-upt ke fr m 
th tra ellul r en vir nm nt nd ( ~ de rea, ed e. pre ion f Tl I that uld decrease the 
f 
Tran ripti nal pr filing identified an incrca ·c in u- ,' ]n cxpres, 1011 with do e dependent 
mann r by Mellg (Fig. ). a- , ; n aggregati n ~a · rep rted to be highly related to PD. 
Incr a ing pr t in ncentrati n v. a ne fl rm of a-Synuclein aggregation process 
(Pal log u et al., 200 ). Tran fecti n ~ith mutant u- ,' ;n led to u-.'yn aggregation in MN9D 
cell (Wu et al.. 2011 ). Th increa ·ed u- ;n gene expre i n timulated by MPP+ or MPTP 
was con i tent with m t rep rt (Vila et al., 2000) but diffl r nt from the re ult , f Xu eta/. 
(Xu et al.. 2005; 2005 ) and KUhn et a/ (KUhn t al.. 2003 ). They ob er ed a decrea e of u-
yn gen expre ion treated with MPTP 24h in \'iro. The slight r duction in a-, yn protein 
expres ion ( ig.4) wa diffl rent from it mRNA level vvhich may be the re ult of the 
relatively hort duration of incubation ( 48h) or the po t-tran lational modification of a- .. yn in 
re ponse to high do e of MeHg and MPP+. Recent report have identified that a- yn i 
involved in regulation of TH and DA T trafficking. Overe. pres ing a-, yn ould dec rea e D 
ynthesis in MN90 cell (Tehranian tal. , 2006). By reducing the activit; ofTH (Perez tal.. 
2002) and forming comple e with D T (Wer inger et aL 200., ). a- yn could regulate D 
bio ynthe i and DA T amount in th pia ma membrane . 
Monoamine oxida e (MA ) involved 111 metaboli 'm of man) monoamm 
neurontran mitter , uch a erotonin and D (Chakrabarti et al., 1998). ur result shO\\ed 
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that M -B acti iti r inhibit d after po ur t dif[i rent do e of M Hg. his re ult 
wa ith pre iou report that MeHg ha b n d m n trated t reduce M 0 
acti it in different rat brain napto m s and impacted embr o brain development 
(Beyr ut t aL 2006: hakrabarti et aL 1998) . loVver M a ti ity i a ociated with 
human bl od-Hg c n ntrati n ( tam! r et al.. 2006) . ell tr ated with 1 )J.M MPP+ also 
ho d a r du ing M -B activity. but th trend wa rever ed at the higher do e of MPP t at 
1 00)J.M (P<0.01. Fig. ). Therefore. ef:fl t f MPP+ on M -B activity vary dep nding on 
the do e. The effect f the d f MPP+ ( 1 OO)J.M) i more c n i tent with the hyp thesi that 
high M -B activity c uld mediate neuroto icity in P model by increasing the metabolic 
rate of D . There i al o report that patients with idi pathic PD have an increased MA -B 
activit in platelets (Bonucc lli et aL 1990). Th difference in effects between MeHg and 
MPP+ on MAO-B activity can be attributed to the trong affinity of MeHg to thiol group. e.g. 
cysteine residue in protein. A MAO wa reported to be inactivated by methylmercuric 
iodide (Gomes et aL 1976). MeHg may bind directly to cysteine residues of MAO enzyme 
and inhibit its activity. 
Conclusions 
Our results show that MeHg. at least in high concentration, can exert similar effect on 
MN9D cells that are comparable to those by MPP+. MeHg can decrease the release of DA by 
decreasing the DA synthesis with decrease in TH. and by decreasing the DA re-uptake 
through the decrease of DAT. However. MeHg decreased MAO-B activitie while MPP+ in 
high dose treatment showed an increa e. This comparative tudy improve our under tanding 
concerning DA a sociated gene/protein and metaboli m changes underlying the MeHg 
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indue d path I gical alteration . ur r ult ugge t that e p ur t M Hg may potentially 
b a ri k factor forth de 1 pm nt f P . 
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... p ure to n ir nmental hemical ha been impli at d a risk fact r for th development 
f n ur degenerative di ea e. ur prevt u tudy hov.ed that methylmercury (MeHg) 
e. p ure can di rupt ) nthe. i . th uptake and the metaboli m f dopamine similar to I-
meth 1-4-phen ·Ipyridinium (MPP _._ ). The objective of thi study wa to inve tigate the effect 
of M Hg , po ure n gen and protein profiles in a d paminergic M 9 cell line . MN9D 
cell w r treated -with MeHg ( 1 JlM) and MPP+ (I 0 0!-lM) for 48 h urs. RNA and 
p ptid w r e. tracted fr m different treat d c II and analy7ed using a real-time P R 
Parkin n' di ea e (P ) rray and high-performance liquid chromatography/el ctro pray 
ionization tandem ma pectrometry (HPL ' -E I-M /MS). PCR array result showed that 
16 out of the 84 PD related genes ( 19°/o) were ignificantly changed in the MeHg 2.51-lM 
treated cells. and 33 genes (39o/o) were changed in the 5~-LM MeHg treated cell . In 
comparison, MPP+ treatment resulted in significant changes in 22 gene (25%). A total of 15 
common genes were altered by both MeHg and MPP+. and dopaminergic ignaling 
transduction was the most affected pathway. Proteomic analysis identified a total of 2496 
proteins of which 188 proteins were differentially changed by MeHg 111M treatment and 233 
proteins were changed by MeHg 2.5!-lM treatment. MPP+ treatment resulted in 395 protein 
changes. A total of 61 common proteins were changed by both MeHg and MPP+ treatment. 
Altered proteins were mainly involved in energetic generation related metaboli m pathway 
(propanoate metabolism, pyruvate metabolism and fatty acid metaboli m). oxidative 
phosphorylation, protea orne, PD and other neurodegencrative di order . A total of 7 
genes/proteins including Ube213 ( biquitin-conjugating enzyme E2 L3) and Th ( fyrosine 3-
monooxygenase) were changed imilar by both the genomic and proteomic anal) sis. These 
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re ult ugg t that MeHg and MP + har man imilar ignaling pathwa and endp int 
e ffl t in th path gene i of P and o ther neur degenerati e di ea e . 
Ke w rd : M eth; !mer Uf). eurot xic i t;. ' ene e. pre ion. Proteome. Parkin on 's d i ease 
Introduction 
Parkin n · di a e ( P ) i.· chara teri7ed b.: the pr gressive los f do paminergic neuro ns in 
the ub tanti a nigra par · compac ta ( hinta and nder en. 2005). The e ac t cause o f PD is 
till uncl ear: h ~ever. there evidence that dy functio nal m itochondri a l metab Ji sm , 
unc ntr li ed r a ti ve oxygen ·pec1e pr d ucti n. and d i rupti n of ubiq uitin pro tea ome 
t m pl ay central ro le in the pathogene ·i of PD (H t al. , 20 12). In addi tion, geneti c 
d feet have al been hown a potentia l ri k factor via the mutat ions or polymorphi sm of 
Snca. Pinkl . Lrrk2. Park ~. Htra2 and Park2 (the gene that en cod s Park in) (Bogaerts et a!., 
2008). tudie has hown a po iti ve corre lation b tween indu tri ali zati on and the occurrence 
of PD (G itler, 2009: Jones and M ill er. 2008 ). Environmental pollutant uch as pesti cid s 
and heavy 1netals have been reported to be ri sk facto rs leading to the pathogenesi of PD 
(Michalke et al., 2009: Roos et al., 2006a). 
Methylmercury (MeHg) is one of the most toxic fo rn1s of mercury (Keyvan hokooh et a] .. 
2009). MeH g causes damages to the nervous ystem in the early developmental tage as it 
a lters both the structure and functi onality of the nervous system (Grand jean et a!., 201 0). It 
was showed that possible mechani sms of Mel lg neurotoxic ity include inh ibit ion of glutamate 
uptake, increased reacti ve oxygen species generation, ind uction of oxidative damage. 
depl eti on of glutathi one (GSH ), increase of cyto olic and mitoc hondrial Ca 2+ levels, and 
mitochondrial dy fun cti on (Farina et aL 2011 : Fonnum and Lock, 2004: m·afian and Veritv. 
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1991; Wagn r tal.. 2010). number f tudi rep rted that M Hg could al o induce 
microtubule di rupti n, ubiquitin-pr tea me tern p Iiurbation and dy regulation of c 11 
c le ( r p -L pez et aL 200 ) ( eccatelli et al., 2007: reiem and egaL 2007: Yu et aL 
20 1 0) . Th fD t f MeHg n di rupti n of n rmal neur nal functi n, induction of 
o idati e tre and damage. and impairment of mitoch ndrial function uggest that it c uld 
a] o be a p tential cau ativ agent for development of Parkin on ·s di eas (Ho et al., 20 12). 
an active metab lie product of n uroto in 1-methyl-4-phenyl-12J.6-
tetrah dropyridin (MPTP) . MPP ")MP P ha been widely d monstrated to be a se lective 
inhibitor of c mplex I of th mit chondrial electr n tran port chain and can induce a 
ndrome cl e to PD in both cellular and animal mod ( berhardt and , chulz, 2003~ Petit-
Paitel et al.. 2009) . Energy depletion and oxidative tr are well documented to be the main 
contributors to neuronal death in the substantia nigra following MPP+ admini tration 
(Mizuno et aL 1998). Dy functional ubiquitination and proteasomal-mediated protein 
degradation have been demonstrated to be common features in PD patients (Fishman-Jacob 
et aL 2009: Zhou et al.. 2005). In addition. it has been revealed that gene involved in cell 
cycle, vesicle trafficking. synaptic transmission. dopamine metabolism, and cell 
adhesion!cytoskeleton display sharp changes in expression in sporadic PD cases (Grunblatt et 
al., 2004: Hauser et al., 2005: Moran et al., 2006: Zhang et aL 2005). 
High-throughput test such as array technologies and proteomics are powerful tools that can 
be used for sys tematic analysis of cellular events and interpretation biological pathway 
affected by environmental chemicals (Dowd. 20 12: Jennings, 2014 ). In our previou study. 
we showed that MeHg ex hi bi ted toxic effects simi lar to MPP+ re ulting in a decrease in 
tyrosi ne hydroxy lase (TH) and dopamine transporter, as well a dopamine and its metabolites 
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uch a M n amm id 111 M 9 c ll . The purp e f thi study i to 
111 e tigat the under! ing me bani m of the ffect of MeHg u mg a gen m1c and 
appr a h in a d paminergi c M ll line . W h pothe ized that the profile of 
hang m g n and pr t m , pr 1on. indue d b; Mcllg imilar to th c of MPP+ 
cau ing path fP . 
Material and Method 
ell culture and chemical e po ure 
MN90 cell ( h i et aL 1991) Vvere maintained in OM ~M (, igma, M ) upplementcd with 
10°/o ( /v) fetal bovine erum. 3.7g/L aH . 1 OOU/mL penicillin. and 1 OO!lglmL 
treptomycin (Life Technologi Inc.. urlingt n. ) in an incubator with an atmosphere of 
So/o 02 at "'7°C ell were grown in poly-0-ly in coated fia k (BD lnc, Mi i auga, ON) . 
MeHg and MPP+ compounds were obtained from Alfa e ar. MA and igma (Mi is auga, 
ON). Sodium Butyrate ( igma. Missi sauga. ON) with 1 mM was u ed for cell differentiation 
for 5-8 day before MeHg or MPP+ exposure . 
PD PCR Array assay 
The mouse RT2 ProfilerTM PCR array (Qiagen. Toronto. ON) wa u ed for thi study. Thi 
array contains 84 key genes directly or potentially involved in Parkin on's disea e. and also 5 
house-keeping genes were included as reference genes in the same array plate. In addition. 
thi array comprises one well for mea ure genome contamination. 3 well of po itive PCR 
control (PP ) and 3 well of RTC (reverse tran cription control. reaction without rever e 
transcript enzyme) . 
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Triplicat 11 amp! re p d t M Hg and MPP+ (MeHg 2.5!-LM, M Hg 5!-LM and 
MPP+ 40!-LM) and ntrol. h incubation, t tal R fr m th [! ur group were 
e tra t d b u mg 1agen R ea Mini Kit [! II wing manufacturer' in truction . RNA 
qual it a e timated b) runmng [! m1ald hyde denaturing g L and Nan Drop 
pectroph t m rm Fi h r c1 ntific. Waltham, M ) wa used to te t R purity 
and quantit~. h rati of 260/2 0 for each R ample must be reached above 1.8. The 
R quality wa furth r confirm d u mg a m u RT2 RN 
). R v r e-tr n cripti on reaction Vvere c nductcd u ing 
' P ' R rray ( iagen, 
iagen RT2 Fir t trand T rant 
kit for nth i . RT2 YBR reen qP R rna termi x ( iagen, Toronto, ), water 
and cD aliquot ample from fo ur gr up Vv ere loading to P 'R Array pl ate, and run in 
Bio-Rad FX96 real-time P R in trum nt. Running condition was appli ed accordin g to the 
array in truction. The a erag expre i n of two hou ek eping genes (Gapdh and I Isp90ab 1) 
were u ed for normali zation. The !'J.!'J. t method wa u ed to calcul ate the fold-change 
difference between treatment and control group . Gene differenti ated expre sion wa tested 
by student' s I test between each treatment and control group . Data were expr sed as 
mean±SD, and fold change with p<O.OS was considered significant difference. Ther fore. a 
total of 12 PD PCR Array were appli ed in this study. 
Proteomic Analys is 
Sample pre para! ion and l-IP LC-ESI-MSIMS 
For proteomic stud y, MN9D cell s were expo ed to different do es of MeHg (O!JM, 1 ~L M. and 
5!-LM) and MPP+ (} O~tM) for 48h . After 48h, ce ll were wa hed with cold PBS and harve ted 
by scrapping. The total proteins were ex trac ted from the ce ll · using RIP A lysi butTer 
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c ntaining PM F, pr tea 
Biot chn log In ., alia . 
inhibitor co ktail and dium xih anadate ( anta ruz 
). he e tract ere th n h m g nized by onication and 
c ntrifug d at 12.000rpm ~ r 0 min at 4 o . Pr tein c ncentration wa determined by an 
impro d Lowr m th d u mg Protein ay kit (Bio-Rad, Mis i auga, ). The 
pr cedure of in luti n dige tion and Rever ed-Pha e iquid hromatography (RP-L ) 
wer p r[i nned a de ribed b; ha et al. (, ha et aL 2015) . riefly. protein in the cell 
e tra t w re pr cipi tated. dige ted. and dried ample ere ubjected to StageTip X 
fra tionation by five t p f pH elution (pH .0. 4.0. 6.0. .0. 1 0.0). Digested peptides were 
analyzed u ing an gil nt 1100 capillary HP 1 tem ( gi I nt Technologies. anta lara, 
A) coupled with L T -Orbitrap rna pectr m ter (Thermo lectron. Waltham, MA). 
equipped with a nano-el ctro pray interface operated in positive ion mode. All data were 
recorded with Xcalibur software (Thermo Fi her cientific. an Jo e, A). 
Database search and Bioinformatic analysis 
All raw files were processed and analyzed with software MaxQuant (Version 1.3.0.5) against 
Swissprot protein database of mouse (20 12, July Release). including commonly observed 
contmninants. The criteria for protein quantitation and identification were perfom1ed as 
previously reported (Shao et aL 20 15). All the identifications from contaminants and 
reversed database were removed using Persues software (Version 1.3.0.4). Abundance ratios 
of proteins were calculated from the label-free quantitation of each group in the format of the 
fo ld changes. Proteins with two-fold changes of treated/control ratio were filtered for the 
subsequent data analysis. Heat map functional classification, correlation analysi . and the rav~ 
ratio of LFQ treated/contro l were transformed to logarithm (base 2) cale. 
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ld ntifi ation f nrich d pathwa wa c nduct d b earching DAVID bioinfonnatics 
re urc . 7 ( ataba :D r nnotation, 
t aL 2009) . The 2-[i ld dif:D r ntiall 
id ntificati n w re uploaded int VI 
i uali zati n, and Integrated i covery)(Huang da 
e pre ed protein from M Hg and MPP+ M 
:Dr K bi logical pathway analy is. he Mus 
musculu, pec1e wa elected a backgr und gene et. K ~ was e lected as re:D rene 
ann tati n databa . M difi ed Fi h r e ac t te t wa adju ted for multipl e test usmg 
Benjamini and B n:D rroni pr cedur The to ta l identifi ed prote ins and 2 fo ld -changed 
prot in w r upl oad d int IP ftv.,are to perforn1 compan sons. Identification of 
mol cular functi on (MF) in G ne O nco logy ( ) was onduct d u ing Panther c las ification 
sy tern (Mi et aL 201 3 ), and the uncla ified prote in were earched and de fin ed usin g 
niprot protein knowledgeba e ( n ortium . 20 15) . Fo r prote in w ith multipl e MF, the be t 
two known function were a igned fo r each category. Prote in remain uncl assifi ed in both 
Panther and niprot tool were a signed to the category in "other ". Furthermore, the 
abundance change patterns of selected protein were di spl ayed as heat maps using Per ues 
software, and proteins with similar MF were further grouped . Correlation ana lys i for all th e 
identified proteins from MeHg and MPP+ treated cell wa conducted by u ing PS 16.0 
(SPSS Inc., Chicago, IL). 
Western blot analys is 
MN9D cell s were harvested, lysed and quantified as described as in MS (mass pectrometry) 
sampl e preparation. Total prote ins extract with 6!J.g were eparated on 1 0°/o ae ry lam ide gel 
before transfer of prote ins onto PVDF membranes by usi ng conventi onal vvet tran -b lot unit 
(Bio-Rad, Mi ssissauga, ON ). Membranes were bl ocked w ith So/o ki m milk in TB T (Tri -
Buffered Saline and Tween 20) so lution for one hour befo re incubation with the primary 
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napti v i le m mbran protein -1 h mol g-lik ( T1 L) and yro in -protein 
kina e B Z1B ( Z1 ) antib die . P II (g at p 1 cl nal antib d ) was used as a 
1 ading contr 1. ft r wa bing time with TB (Tri -Buffered aline and Tween 20) 
oluti n. the membrane ~ re incubated ~ith appr priate second antib dies. Prot in bands 
w re d te ted by hemido imaging y tern ( i -Rad. Hercules. ). and quantified by 
!mag J oftwar . 11 antibodie were purcha ed from , anta ' ru7 Biotechnology Inc . . anta 
ruz. and - beam. ambridge. M . 
Re ult 
PD PCR A rray analy is 
Volcano plot how d that out of the 84 PD related gene included in the P R Array, 16 
gene were ignificantly changed with 2.5 ~-tM MeHg treatment (Fig. 1 A). and 33 gene were 
ignificantly changed in MeHg ( 5 ~-tM) exposed MN9D cells (Fig. I B). In MPP+ treatement 
( 40~-tM) group. 21 genes were changed significantly (Fig. I C). Among all the statistically 
changed genes, a total of 15 genes were found to be common between MeHg and MPP+. 
They are mainly distributed in the 10 functions associated with PD: dopaminergic signal 
transduction pathway (Ddc. Park2. Park7. Slc6a3. nca and Th). Transporters and ion 
transport (Atp2b2, Psen2. Slc 18a2, Slc6a3 and Snca). mitochondria (Park7. Snca and Th), 
pro-apoptosis and anti-apoptosis (Tcf712 and Snca). parkin substrate and complex (Atxn3 and 
Park7), cytoskeletal organization (Mapt and Park2). ubiquitination (Park2). ynaptic v sicle 
(Th), cell adhesion (Nfasc), and MAP kinase (Fgfl 3) (TabS.l ). 
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The protein abundance profilin g 
In thi tud;. vv u ed label-free quantitation (Luber taL .... 01 ) meth d t mea ure relative 
pr tein abundan e in M I Ig nd MPP+ treated M 90 cells . total of 185 , 2005, 2061 and 
19 0 pr tein were identified fr m non-treatment. Mellg I ~M . Mellg5~M. and MPP+ 1 O~M 
gr up after filtrati n of the n )n-detccted \alucs. .... -fold change of treated/control ratio of 
th e pr tein v. re filtered manual!;. and table ,' 1 illustrates all the 2-fold changed 
protein (IP mapped) in Mel lg and MPr · groups v .. ith gene entry name, fold changes. cell 
I cation and protein t) pc . total )f 16 changed pr tein . were found in the Mel Jg and 
MPP+ treat d M 9 cell v.hich v.erc u ·cd for the[! llov.ing anal yses. 
Pathw ay enrichm ent analy i 
To get an overviev.- of th biological function and pathv.-ay induced by the two toxicant ·. a 
pathway enrichment analy i vva conduct d u ing D VID online urcc. The results showed 
that pathway in cyto keleton. amino acid metaboli m. glutathione metaboli . m. and 
neurodegenerative di ease (PD. AL . AZ. HD) are pecific enriched in MeHg treated 
MN9D cells (Fig.2A and 28) . Hungtinton · · di ea e wa the most afD cted categoric which 
contained eight protein in MeHg 1 ~M (P=O.Ol 0) and ten protein in the MeHg S~M 
(P=2.99E-06) treated cells. Notable gene involved in G H metaboli m included R. 
G6PDX, IDH 1, G LM and HNRPLL that are required for the bio ynth 
production, and the reduction of glutathione di ulfide ( ) back to 
f H. ADPJ-I 
H. While. MPP+ 
treated MN9D cells was howed to be enriched (P=1.61 E-18) in spliceo ome path\\ay which 
included 28 proteins ( ~ ig.2 ). Protein in propanoate metabolism. p) ru,·ate metaboli ·m. fatt\ 
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acid m taboli m, idativ ph phor lati n, prot a m . and Parkin n' di ea e were 
chang d b both MeHg and MPP treatm nt ( ig.2 ). 
GO Molecular function and orrelation analy i 
We c mpar d the pr tc m hange ( 2- ~ ld ) of MPP+ and Mellg, a well a 2 d f 
M Hg in MN9 ell . When c mparing the prole me pr filin g between MPP+ and Mel lg 
tr ated cell , 1 pr tein V\ r comm nl ; changed. The e prot ins were expressed similar 
manner f up and d V\n-regul ati n ( 1g. ). The main MF of th common proteins are 
main! involv d in id r ducta e activ ity. cyt keleton. tran fera e activity, nucl eic acid 
binding and pi icing. C) to k leton protein , rec ptor and signal tran ducti on. xidorcducta e 
activity with eight pr tein ( ADM. L H7 A 1. LBR. ND FS 1, PMPCA, PR X4, SDHC 
and V AT1 L), i the mo t numbered molecul ar fun cti on hared between two toxins (Fi g.3A). 
onsistent with the above observations, the correlation analys is gave a coeffici ent of 0.504 
and 0.525 with both P value < 0. 0001 when comparing protein abundance ratio of MeHg 
1 ~M with MPP+ 1 O~M. and MeHg 5 ~M with MPP+ 1 O~M . re pecti vely (F ig.3B and Fig.3C). 
Using our experimental paradigm, we also identified change in the expre sion of speci fi c 
proteins between two different dose of MeHg, ( 1 ~M and 5 ~M ) . MeHg treatment ( 1 ~M and 
5 ~M MeHg) resulted in alteration in expression of 90 protein compared to the control. A 
total of 68 and 69 proteins were found up-regulated in MeHg 1 ~tM and 5 ~M expo ed MN9D 
ce ll s~ 22 and 21 proteins were down-regulated in 1 ~M and 5 ~tM MeHg treatments. The tV\o 
doses of MeHg induced a dose-re pon e effect for the identifi ed protein (F ig.4 ). Protei n 
with 2-fold change were further di splayed a heat map in Fig.5. The molecul ar f'unction of 
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MeHg l 1-1M (Gene symbol) 
Ode (0 .68), Snca (0 .73) 
Gria3 (0.62), Kcnj6 ( 1.3 7), 
Sic 18a2 (1.27), S I OOb ( 1.3), 
Snca (0.73), Sytll ( 1.35) 
Snca (0.73), Uchll ( 1.32) 
Casp9 (0.79), Snca (0.73), 
Tcf712 (0. 78). Ubc (I .43) 
Sytll (1.35) 
Ubc(l.43), Uchll (1 .32) 
Fn I (0 .63) 
Sytl I ( 1.35) 
Fn I (0 .63) 
MeHg S1-1M (Gene symbol) 
Ode (0.33), Park2 (0 .63), Park7 (0 .58), 
Slc6a3 (0 .33). Snca (0 .68), Th (0.49) 
Atp2b2 (0.45), Sic 18a2 ( 1.43 ), Slc6a3 
(0.33 ), Snca (0.68), Gria3 (0 .3 7), S I OOb 
(0 .63), Slit I (0.07). Sytl (0.43) 
Park7 (0 .58), Snca (0 .68). Th (0.49), Casp7 
(0.58). Vamp! (0.46) 
Tcf712 (0.47), Snca (0 .68). Ape (0 .72). Bdnf 
(2 .3 8), Casp9 (0 .5 I ), Ubc (3 .05) 
At:\.113 (0 .58). Park 7 (0 .58), At:\.112 (0 .5) 
Mapt (0 .54 ). Park2 (0 .63 ). Ape (0 . 72) 
Park2 (0.63). Ubc (3 .05), Ube2k (0 .66), 
Ube213(0 .55) 
Nfasc (0 .64), Ape (0 .72). Fn I (0.34) 
Th (0.49), Sy11 (0 .43) 
Fgfl3 (0 .51 ), Ape (0 . 72) 
F11 I (0.34) 
Chgb (0 .62), Olk I (0.43). Rtn I (0.48) 
Note: the numbers in bracket indicate the fold change of each of gene. 
MPP+ 401-!M (Gene symbol) 
Ode (0 .63), Park2 (2 . 17). Park7 ( 1.29), 
Slc6a3 (2 .58}, Snca ( 1.61 ), Th (0.68), 
Ord2 ( 1.73). Nr4a2 ( 1.72) 
Atp2b2 ( 1.61 ), Sic 18a2 ( 1.45), Slc6a3 
(2 .58). Snca ( 1.61 ), Drd2 ( 1.73) 
Park 7 (I .29), Snca ( 1.61 ), Th (0.68) 
Tcf712 ( 1.68). Snca ( 1.61 ), Nr4a2 ( 1.72), 
Pse112 ( 1.67). Casp3 ( 1.26) 
AtxnJ ( 1.28). Park7 ( 1.29). Gpr37 (2.40), 
stub I (I ,29) 
Mapt (I .51). Park2 (2 . 17) 
Park2 (2 .17). stub I ( 1,29) 
Nfasc ( 1.54), NrxnJ ( 1.64) 
Th ( 0.68) 
FgflJ ( 1.58) 
Ncoal (1.45) 
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Table2. P r lat d g n /pr tein ere id ntifi d in the two a ay of P P R Arra and 



























Protein Na me 
Brain ac id olubl protein 1 
a pa -
ell di vi ion ontrol prot in 42 
h molog 
e retogranin-1 
Heat h ck 70 kDa pro te in 4 
Microtubule-a oc iat d prote in 
euroftl ament light p I) pept ide 
e icle-fu ing A TPa e 
Pr teinDJ -1 
Peptidyl-prol I ci -tran 
1 omera D 
Peroxiredox in-2 
eptin-5 
-pha e kinase-a oc iated protein 
1 
ADP/ATP tran toea e 1 
Serine/arginine-ri ch splicing 
factor 7 
STIP1 homology and U box-
containing protein 1 
Tyros ine 3-monooxygenase 
Ubiquitin-40S ribo omal protein 
S27a 
SU MO-conjugating enzyme 
UBC9 
Ubiquitin-conjugating enzyme E2 
K 
Ubiquitin-conjugating enzyme E2 
L3 
Ubiquitin carboxyl-term inal 
hyd rolase isozyme L 1 
Voltage-dependent anion-
se lecti ve channel protein 3 
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7 5 l 
Log2 Fold Differen ce (MeHg2.51JM/C ontrol ) 
-7 -5 -3 -1 3 5 7 
Log2 Fold Differen ce (MPP+401JM/Control) 
9 
log2 Fold Differen ce (MeHg51AM/Control) 
Figure 1. Vo lcano plot how the gene 
expre sion in 1.5 -foJd chan ge in M eH g 
2.5 ~M and S ~M (A and B), MPP+ 40~M 
(C) expo ed MN 9D ce ll s. The blue Jines 
indicate the thre hold for the P value of 
the /-tes t. 
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Fatty ac1d metabolism 





Ox 1dat1ve phosphorylation 
Insulin signaling pathway 
Parkinson 's disease 
Regulation of actin cytoskeleton 
Pur1ne metabolism 
Huntington 's d1sease 
Pyruvate metabolism 
Cit rate cycle (TCA cycle) 
Fatty acid metabolism 
Propanoate metabolism 
Amyotrophic lateral sclerosis (ALS) 
Glutathione metabolism 
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Ribosome 
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Proteasome 
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Ubiquitin mediated proteol ysis 
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Figure2. nrichment analy i of KE G Pathwa; in (A) MeHg 111M. (B) MeHg S11M and 
(C) MPP+l 011M treated MN9D cells analyzed by D VID . Th elected 12 enriched 
categories were applied in the figure . 
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MPP+10~M/Con (log2 ) 
Figure3 . (A) Heat map of common changed proteins for GO molecular functional 
classification in MeHg and MPP+ treated MN9D cells. Protein abundance ratio 
(treated/contro l) are compared between (B) MeHgl1-1M/Con (log2) and MPP+l 01-1M/Con 
(log2) (Spearman correlation coefficient rs=0.504 with a p-va1u <0.0001) and (C) MeHg 
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FigureS. Protein abundance changes induced by MeHg ba ed on molecular function 
classification. Protein abundance was disp layed as fold chang in log2 cale. Oth rs 
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( o nt rol l ~l \1\l e ll g SJ.! '\1\I ellg IOJ.~MMPP+ 
\ 1\l l L 
BAZI B 
Figur 6. We tern bl t verified expre . ion of t'AO proteins (V ATl L and BAZ1 B) from 
M analy i . . r pre entative blot from t'AO protein . B. quantifying data were obtained 
through three individual run with or without Mel-Ig and MPP+ treatment for VA Tl L and 
BAZlB. 
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Di cu wn 
nal of th impa t f M Hg r MPP + n protein or gene e pre sion patt rn in the 
c nte t f n ur to icity ha be n rep rted in the pre 1ou tudie (Kc an h k oh et al., 
200 ) ( endrell et al.. .... 0 10: Xie et aL ~0 11 ). This i the fir t rep 1i to usc both genomic 
and pr teomic ppr a h to tud; the effec ts of MeHg and it relation hip with PD u ing a 
d paminergi cell line . lJ ing a known PI mimic chemical MPP+ as a positive control, 
th comparati\· r ult hov, that Mel Ig and MPP • to icity affected many similar 
function and pathway 
In our P R anay re ult . V\ c nfirrned that MPP+ . ignificantl y changed 22 genes that 
have been invo lved in P pathogene i . With eight proteins changed. dopaminergic 
ignal transduction i the most biological pathway affected by MPP+. It is well 
documented that dopaminergic signaling i compromi ed during the pathogene i of PD 
(Girault and Greengard, 2004 ). It i also known that MeHg affect neurotran mitter release 
including DA (Faro et al.. 2003 ). A total of 15 g nes were found to b common between 
MeHg and MPP+ treated groups. and 6 of them ( 40o/o) were functioned in dopaminergic 
signal transduction pathway (Ddc. Park2. Park7, Slc6a3. Snca and Th). Ddc i an enzyme 
to catalyze syntheses of dopamine and serotonin (Hwu et al.. 20 13) . MPP+ in low do e of 
1 OOnM was shown to inhibit Ddc activity in PC 12h cells (Naoi et a!., 1988 ). Our re ults 
showed that Ddc was down-regulated in both MeHg and MPP+ treated group , indicated 
that MeHg and MPP+ have overlapping toxicity in term of altering gene expre sion 
patterns in dopaminergic ignaling of PD. Other functions shared by the t\\O toxicants 
included tran portation, mitochondria, apoptosis, cytoskeleton organization and 
ubiquitination . These functions are the well accepted mechani sms as ociat d \\ ith PD 
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pathogene i ( run blatt et aL 2004 ). We noti that a numb r of c mm n hared 
ignificant hanged gene w re pre d ppo it b tween the tw to in , for e ample, 
two gene ( t n and Park7) in parkin ub trate and comple . and D ur gene (Park2, 
Park?, lc6a and n a) in d paminergic ignal tran duction were d wn-regulated with 
M Hg 5 )lM treatm nt. but up-regulat d in the MPP + 40 )lM treated cell ( ab. 1 ). This 
impli MeHg bared imilar path\\a. \\ith MPP+ but may function in different manner 
in term of targeting prot in . In additi n. function in tran portation including gene 
fun tionalized a tran porter and i n tran port \\ere the most affected category by MeHg, 
thi re ult support tran portation di rupti n 1 ne f the imp rtant mechani sm of 
MeHg neuroto icity ( lien et al.. 2001 a). 
In compared of PO P R array. proteomic appr ach provides a global proteome change of 
the two toxicant in MN9D cell . We ob erved 13 prot in (2-fold changes) in MPP+ 
group were overlapped with the changed proteins in MPTP induced PD mouse brain 
(Zhang et aL 201 Ob ). The different numbers of dysregulated protein between our study 
and Zhang et al study may cause by differences in experimental paradigm . We u ed cell 
lines as subjects . and they used mou e brain tissue . Pathway in propanoate metabolism, 
pyruvate metabolism, fatty acid metabolism. ribosome. proteasome. neurodegenerative 
disorders, and oxidative phosphorylation were showed enrichment in both MeHg and 
MPP+ treated MN9D cells (Fig.2). The catabolism of propanoat i involved in succinate 
and fatty acid synthesis (Wayne A. Fenton .. 2001 ). Metabolic alteration such a pyruvate 
metabolism. mitochondrial fatty acids o idation is critical proces 111 triggeri ng 
mitochondrial impairment (Parra et al., 2001 ). The resu lts of path\\lay analysi suggest an 
energy d ficit occurred in Mel l g and MPP + exposed MN9D cells. and support 
72 
mit hondrial d functi n i an imp 1iant m chani m in P path genesis and MeHg 
al D un that pathwa) in idati e ph phorylation ( XPH 
P=2.29 -05) wa tr ngl · afD ted b MPP+ and MeHg e po ure pecially with 
M Hg5~-tM with 11 pr t in . pre wn altered ( DlJF B L N F, L NO 2, 
F 4, 10, TP5L, TP5 . TP J, ' X5 . X , and SOil ) (Fig.2). 
In mitochondria, idative pho phorylation i. required to couple nutrient xidation to the 
bio ynthe i [ TP, the uni\er a! energy currency (KVvok et aL 2010) . These findings 
indicated that MPP+ and Mellg can trigger the obstruction of o idative phosphorylation 
pr ce by altering the expres ion of ke; protein required for the assembly and function 
of the re piratory chain in mit chondrial. which further confirmed our ob ervation of 
energy d ficit occurred in both two toxicant treated M 90 ce ll s. [n line with pathway 
analysis, a previous report showed that MeHg inhibits XPHOS and increase ce llul ar 
reactive oxygen species (ROS) (Mazzio and oliman. 20 12). and treatment with 
glutathione pero ida e mimetic (eb elen) rever es MeHg-induced neurotoxicity (Yin et 
aL 2011 ). Except OXPHO pathway. we ob erved that MeHg 5~-tM al o induced the 
alteration of 5 proteins (G R. G6PDX. IDH 1. GCLM and HNRPLL) in glutathione 
metabolism. The protein alterations in GSH metabolism indicate the di abi lity to protect 
oxidative damage including its rol e in rendering toxic soft ac id metal like MeHg 
nontoxic in mitochondrial (Ballatori, 1994 ). 
Intri guingly. except PO, we found that MeHg also targeted proteins as ocia ted \vith other 
neurodegenerative di sorders such as Huntington disease. A lzheimer disease (AD) and 
ALS. Actually, Huntington di sease was the most signifi cant enriched pathway aiTected 
by MeHg, with 8 proteins in 1 ~-tM and 10 proteins in 5~tM Mellg (Fig. 2A and B) . MeHg 
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ha be n i1npli ated to indu e neur deg n rati 
a (Zahir t aL 2 06) and L (J hn n and tchi on. 2009). ur re ults indi ate 
MeHg har man imilar biol gical pathwa a in other neurodeg nerativ di ease. 
MeHg d af[i cted imilar gene /protein a MPP+ in Parkins n' disease but no t 
pecificall in P . euronal accumulati n f M Hg rna be a predi po ing fact r [i r 
vera! neur degenerative di ea e . 
m I cular fun tion f M Hg and MPP .. in heatmap exhibited ' imilar up and down-
regulated common protein. ( 61) bet\\.een the tv...o to ins (Fig. A), with 8 proteins 
(A ADM. AL H7 1. LBR. D F 1. PMP A. PRDX4. SDJIC and V ATl L) 
identifi d. o idoreducta e activity wa the mo t numbered molecular function hared 
between two toxins. which confirmed pathway in OXPH S i a critical process shared by 
MeHg and MPP+. V··/e tern blot howed that expre ions of V ATI L induced by two 
toxicants agree with prot omic prediction (Fig.6). In addition, we ob erved a dose 
response effect of MeHg 111M and S11M in term of regulation protein expres ion in 
MN9D cells (Fig.4). The molecular function of those dysregulated protein in MeHg 
treatments, mainly involved in hydrolase activity and tran ferase activity may reflect the 
specific mechanisms for MeHg neurotoxicity that different from MPP+ (Fig.5). 
Consistent with the above observations, a positive correlation of protein abundance ratios 
was observed between MeHg I 11M and MPP+ (rs=0.504) and MeHg 5~LM with 
MPP+l 011M (rs=0.525) (Fig.3B and 3C). Thi re ult futiher confirms the identification of 
changed prote ins ind uced by two tox ins wa corr lated. and MeHg in high dose present 
more correlati on with M PP 1 than Mel Ig in low dose. 
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inall , c mbined th data f P P 'R rra and prote mic profil . We found v n 
pr tein /g ne in tw t m e pre ed imilar manner in b th pr teomic and P R array 
a . a (Tab.2). The ubiquitin-prot a orne play an 1mp rtant r le in mitochondrial protein 
d gradati n (lie and Rutter, 2011: Margineantu et aL 2007) . be213 ( biquitin-
c njugating n7ym E~ L ) i an ubiquitin liga e en?yme to mediate PD related genes 
Parkin (Park2) degradati n f mit chondria organelle and mitochondrial protein, 
kn ckdown of Ub 21 enzyme lead t ignifi ant decrea e of autophagic clearance of 
depolariz d mit ch ndria ( ei ler et aL 2014 ). thu block f mitochondrial metaboli m. 
In th pre ent tudy. Ube213 were ignificantly d wn-regulated in MeHg and MPP+ 
treated M 9D cell in b th tran cript and protein level (Tab.2) . Which uggest a critical 
role of Ube213, similar to MPP+. in MeHg mediated mitochondrial dysfunction. , imilarly, 
a ignificant pathway of protea orne was identified in both Mellg ( P= 0.024) and MPP+ 
(P=0.031) treated MN9D cells (Fig. I A and ). A dysfunctional proteosomal degradation 
pathway has been implicated in the neurodegenerative proce of PD and mercury 
neurotoxicity (Li and Guo. 2009: Lim and Tan. 2007: Yu et a!., 201 0) . The e finding 
suggest that ubiquitin-proteasome system were common target affected in both MeHg 
and MPP+ treated MN9D cells. Moreover. tyro ine hydroxylase, an enzyme to limit 
dopamine synthesis, were down-regulated in both MPP+ and MeHg-treated cell . This i 
also consistent with our previous result that Th expre sion in mRNA level was decrea ed 
with the dose increasing of MeHg (chapter I II), which further confirmed Th as an 
important target enzyme, i inhibited dopamine synthesis process in both two toxicants . 
Taken together, these re ult upport our hypothesis that MeHg share many similar 
biological function and pathway in the pathogene -is of PD. 
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onclu 100 
MeHg har man imilar ignaling pathwa with MPP+ in the path gen s1 of P 
wh re th tw t , m affected e. pre 1 n f pr teins invol d In o idative 
ph ph r Jati n. H homeo ta propanoate metaboli ·m. and p ruvate metaboli m 
which c ntribute to energy defi cit. opaminergic . ignal tran ducti on and mitochondri al 
d functi n w re addr d in tran ription leve l in both MeHg and MPP+ e po ed ce ll . 
Whil pr t in change abundance for M J-I g uch as hydro la e acti vity may r present the 
di tinct tox ic mechani m of neuroto. ici ty ~ r M Hg. MeHg not only correlated with 
MPP+ neuroto icity but may in vo lve in the dev 1 pment of ther neurodegenerati ve 
di order uch a Huntington di ea. e. ur re ult h v-. th at MeHg e posure can induce 
hifts in protein/gene e pre sion pattern that are akin to change observed in a ce ll 
culture imulation of Parkin on· s di ea e. The current prote mi c and PCR arrays data 
are complementary by providing the di ffe rent sets of regul ated protein /genes for MeHg 
and MPP+. 
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The cereb llum i kn wn th maJ r target region f m th lmer ur (Mellg) to ici ty, 
but the mechani m ar till not full) under t d. We tudied the effects f Mel Ig 
e p ure in the erebellum of comm n marmo et ( 'u/lithrix iacchus) using a shotgun 
pr te mic appr a h with liquid chr matorgraph) coupled to ma spectrometry. A total 
of 1000 pr t in 'v\ere identified. and 102 pr tcin 'v\ere ignificantly dif~ r ntially 
e pre ed in the er bellum of common marm ct 'v\ith orally dosed Mel lg ( 1.5 mg 
M Hg/kg b dy w ight ~ r t\\ v. eek ) c mpared to th e of th control group. Functional 
enrichment analy i and path'v\ay predictions show d that the differentially expre sed 
protein were involved 111 carbohydrat d rivative metabolic procc . ion transport 
including ynaptic tran mi Ion. cell development and calcium signaling pathway and 
cellular component enrichment analy i ho'v\ed that the] were mainly distributed in 
pla rna membrane. excitatory ynap e and ynaptic membrane . These results indicate that 
synaptic transmission and calcium ignaling pathways are the core functions affected by 
MeHg. We found a total of 21 novel proteins affected by MeHg in ynaptic tran n1i sion 
and calcium signaling pathways. DLG4 (PSD-95) and MIR-19A/MIR-19B were found to 
be potential key targets leading to the multiple effects of MeHg neurotoxicity. These 
comprehensive results show the global effect of MeHg on cellular function and 
pathway leading to neurological deficits in common manna et. 
Key words: Methylmercury, proteomics, neurotoxicity. synaptic tran mi ion. calcium 
signaling pathway, primate 
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Introduction 
M th lm rcur (MeHg) i a wid 1 kn n nvironmental neurot icant and the 
cer b llum i ne f the maj r target region again t M Hg-e p ur ( lark on and 
Mago , 200 ). The mo t well-knov.,n MeHg poi oning incident happened in Minamata, 
Japan in the 1950 wh re Minamata di ea. e patient uffered from ata ia a a r ult of 
cereb liar dy functi n ( ' lark n et aL 2 0 ). The central type f atrophy was b erved 
in th ermi and it urr unding region in cerebellum in pr l nged ca e of Minamata 
di ea e. erebellar impairment v.erc featured by the l of granule cell and relatively 
integrated purkinje cell (Takeuchi and Eto. ] 999) . large amount of mercury was found 
in the remaining nerv c II . glia cell and phag cyte in the le ioned granular layer of 
Minamata di ea ca es (Okabe and Takeuchi. 1980). 
Numerous experimental tudie have been publi hed on the molecular mechani ms of 
MeHg neurotoxicity (Farina et al.. 2011 ). However. most of these studies focu ed on the 
effects of MeHg on a specific mechanism or pathway, and very few studie report the 
systemic effects in the brain. Omics technologies such as proteomics provide a poVverful 
tool to study cellular function in response to environmental stimulus at the biological 
level (Dowd, 2012; Jennings. 2014). In a recent proteomic study. Kong eta! .. found a 
deficit of metabolic statu in rat somatosensory corte with chronic exposure of MeHg 
( 40flg/kg/day) (Kong et al., 2013 ). Another proteon1ic study for MeHg toxicity reported 
that non-phosphorylated cofilin, an important protein to regulate actin dynamics. \\as 
significantly increased with 60nM MeHg e posure for 10 days in primary culture of 
cerebel lar granule neuron (Yendrell et al.. 201 0). Rodents and primary cell culture \\ere 
used a tested models in these studie . 
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on-human primate ha e a c mm n ance tr to human being, and in many a pect they 
har man imilaritie ith human than rodent . uch a neuroanat my, intricacy of 
brain organization and c mple ognitiv capabilitie . Therefl re, primat are r garded 
a th be t model for the under tanding f m le ular mechani m for human particularly 
inn ur d g n rativ di ea e ( apitani and Emborg. 2008). mmon marmo et i one 
of the m t utiliz d n n-human primate specie in biomedical research offering unique 
b havi raL neuroanat mica!. and neurobiochemcial simi laritie to human . It ha been 
repo1ied that comm n marn1 et ar particularly appropriate model for Mel Ig 
icity tudie ver u other primate model . a the pathological changes in target 
brain regi n (cerebellum. cerebrum and peripheral nerves) induced by MeHg were 
pre en ted in common marmoset ( to et al.. 2002; _. to et al.. 2001) but not in other type of 
monkey uch a rh su monkey ( hav. tal.. 1975 ). 
The objective of this study is to use a hot-gun proteomic approach to tudy the effect of 
MeHg on protein expression and their consequent change in biological function 
through functional and pathway analysis in the cerebellum of common marmoset. 
Materials and Methods 
A nimals and methylmercury trea tm ent 
Experimental conditions concermng MeHg-exposure in common marmoset wa 
previously described (Yamamoto et al.. 2012) . Briefly, six fl male common man11oset 
were administered MeHg chloride orally (1 .5 mg Hg/kg body weight) or vvith a vehicle 
so lution (containing 7.5 mM -cysteine) daily for two vvceks follovvcd by tv.o v.eek 
without treatment (n=3 in each group). The manno et were betvvecn two and three year 
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ld and their bod eight re betw en 250g and Og. he cereb llum regi n were 
di ct d aft r n the ia and were imm diat 1 fr z n in liquid nitr g n and tored at -
0° [i r pr te mic analy i 11 animal pr cedure were appro ed by the Animal 
R ear h mmittee at the ati nal In titut for Minamata Disease. and all procedures 
conD nned t the uide [! r the ' are and LJ e of Laborat ry nimal by the Institute of 
Lab ratory nimal Re ource .. 
HPLC-E 1-M fM ' 
In solution degistion and strong cationic exchange (SC)() fi·aclionation 
erebellum ample di ected from mam1o et treated with Mel-Ig and v hicle were 
thawed, homogenized in 100 mM mmonia bicarbonate (AB ), 8M Urea, 50 mM 
Dithiothreitol (DTT). protease inhibitor. 1 mM Ethylenediaminetetraacetic acid, and 
lysed with sonication. The ampl were centrifuged at 16.000 g for 10 minutes and the 
protein concentration in the supernatant of each sample was determined by modified 
DC rM Protein Assay (Bio-Rad, Mississauga, ON) . 
Protein extracts from each ample ( 1 OO)J.g) were precipitated by cold acetone overnight. 
A mixture of 8M Urea with SOmM ABC was used to recon titute protein pellet. 
Reduction and alky lation were performed by addition of DTT to a final concentration of 
20mM at 56° for 30min followed by 60mM iodoacetamide at room temperature for 
another 30min. Samples were then digested with tryp in at a protein-enzyme ratio of 20:1 
at 37° overnight with gentle baking. The dige ted peptides vvere acidified"' ith formic 
acid (FA, O.So/o (v/v)), and fractionated by tageTip SCX into fiv fraction b; tive pH 
steps (p i l3 .0, 4.0, 6.0, 8.0, 1 0.0). The peptide vvere then desalted on a Sep-Pak column 
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(Wat r, Mi aug a, ) and ly philiz d u ing a peed ac (Thermo h r c1 ntific, 
an J ). 
Mas . . pee/rom J/ric analysi. 
gilent 1100 apilar)-liPL y tcm ( gilent Technologic , , anta lara, ) oupled 
with - rbitrap ma pectr meter (Thermo Fi her , cientific, an Jose, C ) was 
u ed to anal ze the peptide mixture . The olvent sy tcm contained buffer A (0.1 °/o FA 
in water) and buffer (0.1 o/o F in acetonitrile) . Each peptide ample was acidified with 
20j..d 0.5o/o (v/v) formic acid and 8).11 of \\hich v,a loaded on a fused silica analytical 
column (75 ).lm I. D. x 100 mm) packed in-hou Vvith 3)-lm ReproSil-Pur C 18 beads ( 100 
: Dr. Mai ch mbH. Amm rbuch. Germany) . eparation of peptide wa performed at a 
flow of 200nL/min u ing a gradient elution from 5 30°/o buffer B in 2 hour . 
LTQ-Orbitrap mass spectrometer was equipped with a nano-electrospray interface, 
operating in positive ion mode . The spray voltage wa set to 2.0 kV and th t mperature 
of heated capillary was 200 °C. One full MS scan from 300 to 1700 m/z was performed 
followed by data-dependent MS/MS scan of the 5 mo t intense ions. Dynamic exclusion 
was set to repeat count of 1 in 30s, and exclusion duration of 90s. For the full M scan, 
the scan range was defined at m/z 400 with R = 60,000 in Orbitrap analyzer, and the L TQ 
analyzer was applied for subsequent MS/MS analysis. To achieve an impr ved mass 
accuracy, a real time internal calibration was performed by locking the ma s background 
ion at 445.120025 in the Orbitrap mass analyzer. 
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Data analy i 
he p ak li t fr m ra file w reg nerat d with ftware Ma uant (Ver ion l. .0.5) 
and earch d again t wi Prot pr tein databa e f human ( er i n 20120711 ), including 
comm nl ob erved ntaminant . The foll wing criteria were applied: cy teine 
arbamid m th lati n \\a et a a fi ed m dificati n: the methionine o idation 
( + 15 .99492 a) and pr tein -ten11inal acet; lati n vvere , et a ariable modification . 
nzyme pecificity wa et to tr]p m, n t all \\ing ~ r clea age N-terminal t proline. 
nl two mi ing cl avage of tryp ·in v.er alloV~ed. For M /M , pectra, the precur or 
1on rna toleranc were 7ppm, and fragm nt ion rna tolerance wa set to 0 .8 Da. 
Razor and unique peptide \\ere applied for quantitation. The false di scovery rate was 
limited to 0.01 on both protein and peptide I vel. A minimum equence length of six 
amino acid wa required for peptide identification. 
Protein ident({tcation and cellular component distrihution 
For protein identification. if the identified peptide sequence of one protein was equal to 
or contained in another protein's peptide seL these two proteins were group d together by 
MaxQuant and reported as one protein group. For quantitation, a minimum of 2 spectra 
counts is needed. All the identification from contaminants and reversed databa were 
removed by Persues software (Version 1.3 .0.4 ). Abundance ratios of protein were based 
on the label-free quantitation of each group in the format of fold change . The calculation 
of differentialJ y ex pres ed proteins was performed u ing Mann-Whitney U test v'v ith 
SPS 16 (SP S Inc., hicago, IL) . The differentially expressed proteins in each triplicat 
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ampl f th ontrol and M Hg-treated gr up er lu t red into a heatmap and th 
n i tenc f ampl within ea h f gr up wa te ted u ing Per ue oftware. 
ellular component attribute f a ll the identifi d pr te ins were clas ificd u ing Ingenuity 
Pathwa nal i (IP ) ft\\ are ( iagen. Red\\ ood. ). Th cellular component 
di tri buti n b twe n ll identifi d pro tein and th e di ffe rentia ll pre ed proteins were 
compared. Th di tribution \\ a : pre ed a the percentage of pr tcin as iated with 
ach c ll comp n nt aga in t the di stributi on of the to ta l identifi d prot ins. A Fi sher' 
e act t t wa per~ nned to te. t the diffe rence between the di stributi ons o f the 
dif:D rentia ll y d pro te in and tho o f the to tal identifi ed prote ins. 
Functional group mapping GO enrichment dep letion analys is 
The functional enrichment analysi of the 102 differentia ll y changed prote in was 
conducted using Cytoscape ClueG plug- in (Bindea et al.. 2009) against the identifi ed 
proteome. i.e . the 1000 proteins. The fun ctional class ificati on was based on the Gene 
Oncology (GO) biological proce . A two-tail ed hypergeometri c stati sti c te t wa 
conducted to determine the most disturbed biological function s re u]t fro m the 
di fferentially expressed prote ins. Bonferroni method was used to correct the probability 
value. and the GO term restrictions (# of gene/term > 18 and o/o of term gene 2:. 15o/o) were 
applied to reduce the related term redundancy. Only 0 tem1s with P va lue Ie , than 
0.05 were accepted and presented . Cytoscape Cl uePedi a plug- in (Bindea et a!.. 20 13) wa 
used to visuali ze the known interactions (from STRING 9.0) between the GO term s and 
the associated prote ins. 
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Two nlin b r er oftware, ab I m1 4 .2 (M dina t al.. 20 1 0) and ori lla ( den 
t aL 2009), ere u ed D r 
than 0.05 a u ed a ut ff. 
ellular c mp nent nrichment anal P value les 
In rder t explore the p tential regulated tran cri ption factor o [ Mel-Ig on ion tran port, 
Web talt (WE -ba ed Ene ._ eT naLy i Toolkit) (Wang et aL 2013) wa used t 
identify enrichment of miR targe ted genes in the GO term of ynaptic tran mi 1 n. 
Pathway enrichment anu/ysi.\ 
Pathway enrichm nt analy i on the differentially e pressed protein were conducted 
u ing IP and Web talt onlin ource . li t of 102 differentially expressed protein 
in marmo et cerebellum wa uploaded into the IPA database. ne hundred proteins were 
identified and were eligible for generating Canonical ignaling pathways . Web e talt 
online source was also u ed for pathway analy is which provided the direct connection to 
biological pathway from Kyoto Encyclopedia of ene and Genomes (KEGG ). 
Hypergeometric test was u ed to calculat P value from the differentially expressed 
proteins against the identified 1000 proteome . Bonferroni method wa applied to correct 
the P-value for KEGG pathway analysis. 
Western blot analys is 
To validate the results from the proteomic analysi , four proteins, Disks large homolog 4 
(DLG4), Sodium/calcium exchanger 1 (SLC8A 1) Vesicular glutamate transporter 1 
( L l 7A7) and T-complex protein 1 subunit zeta (C T6A) were quantified u ing 
western blot. Protein extraction and concentration determination were the same as 
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rib d in tion 2. 1. Pr t in ampl (1 0-401-lg) ere 1 ad d and eparated by 1 0-12°/o 
). Membrane er block d for lhr with 5o/o kim 
milk in B (Tri Buffered aline + Tw en-20), and incubated with . . anou pnmary 
antib di 50. ab 1825 ). , L 17 7 ( 1: 00. ab 104 98), and L ' 8 1 ( 1:800, 
ab 1779 2) ( beam. ambridge, M ), and T6 ( I :200, sc-1 896) ( anta ruz 
Biot chnolog Inc. anta ruz. ' ) at 4° overn ight. fter wa hing by TB T, 
membrane wer incubated \\ith llor radi h peroxidase-conjugated (liRP) econdary 
antibodi ( an ta ruz iotechnolog; In . anta Cruz. C ). goat anti-rabbit lgG-1 IRP 
( 1:12000. c-2004) or mou e anti-goat Ig -HRP ( 1:12000. sc-2354) for 1 hr at room 
temperatur . The blot were tained b; Iarity We tern ECL Sub trate (Bio-Rad, 
Mi i auga, ON). and target band vvere vi ualized by using Chemidoc imaging system 
(B io-Rad, Hercules, CA). The target band wa quantifi d by using image J software and 
the density of each band wa normalized against GAPDH . 
Results 
Protein identification and cellular component distribution 
Proteomic analysis across the 6 cerebellum sample in control and the MeHg-treated 
groups resulted in the identification of 2563 proteins (TabS.l ). Representative MS/MS 
spectra for two proteins DLG4 (P78 52, Disks large homolog 4) and L 17 A 7 (Q9P2U7. 
Vesicular glutamate transporter 1) are shown in FigureS .1. Only proteins identified in all 
6 samples in control and MeHg-treated mamoset cerebellum were included in our 
analysis, which resulted in 1000 proteins. total of 102 proteins -were found to be 
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differ ntiall e pr d ( d crea ed and 16 increa ed) in the M Hg tr ated ample 
c m ared t th c ntr l (Tab, .2 ). 
ig. 1 h w th abundance chang f di fferenti ally changed protein between the 
contr and M Hg-tr ated manno. et cer bellum ample . Th tripli cate sampl e in the 
c ntr 1 gr up and the the MeHg treatment group ~ere clearl y eparated and a good 
y in the pr tein patt rn wa. fou nd ~ ithin each gr up . Re ults of IPA gene 
ont log ( ) analy i f c llular component are ho\\. n in Fig. ! B. The relative 
abundance f id ntifi d pro tein wa a. ciated \\. ith vario us cellular components in the 
following d ending order: cyto pla m ( 62o/o) > nucl eu ( 16o/o) > plasma membrane 
(1 5o/o) > extrace llular space (3o/o). The remaining 4°/o w re a oc iated with other 
organelles. The relativ percentage of di fferenti all y ex pres ed proteins distribution 
fo llowed the order of cytopla m (55o/o) > pl asma membrane (27o/o) > nucleu (14°/o) > 
extracellular space (1 o/o), and other organell es comprising 3o/o. There was a signifi cant 
difference in organell e di tribution between all the identified proteins and the 
differentially expressed proteins conducted by Fisher's exact te t (P=0.046). 
GO analys is of differentially expressed proteins in cerebellum 
The functional enri chment analysis results showed that 62 out of the 102 differentially 
expressed proteins were included in 24 significant GO terms (P<0.05) (Table 1 ). All the 
proteins associated with each of these 24 significant GO terms are hown in Table .1. 
These signifi cant GO terms were grouped into three groups and th key biological 
functi ons of these groups include: 1) ca rbohydrate derivative metabolic proce s and 
purine as oc iated nucleotide metaboli c process; 2) ion transport inc luding vesicle-
87 
m diat d tran p rt and ynapti tran mi wn: and ) cell de el pment a well a 11 
m rph gen i in ol d in n ur n differentiation. Ba d n the pr tein imilarity, the 
functi nal annotati n net vvork analy i clu tered the ignificant tenn into three 
different bi gical function group (Fig. 2 ). It , hovv n i ually that 1110 t of the 
differential! e. pre ed protein are a ociatcd vvith the carbohydrate derivativ 
m tabolic proce , and purine and ribonu leotide m tab lie proce se . ~ore proteins uch 
a D 4. TP2 2 and PL 1 \\ere found to be important m linking biological 
functi n m arbohydrate deri\'ative metabolic proces . synaptic transmi s10n and cell 
development. 
Web e talt miR A enrichment analy i result showed the top 10 enriched miRNA 
targetting the 20 proteins included in the GO function term of ynaptic tran mi ssion 
(Table 2). MIR-19A and MIR-19B were the only significant miRNA that targeted five 
down-regulated protein (NAPB, PLCBl, SYTl, BSN, ATP2B2 and NAPB) in th 
process of synaptic tran mission (Table 2). 
Results of the GO cellular component enrichment analysi showed the differentially 
expressed proteins was significantly enriched in pia rna membrane ( 46.1 o/o). pia rna 
membrane part (33.3o/o). membrane fraction (21.6%) and cell junction (15.7o/o) 
(Babelomics, Fisher's exact test, P<O.OS) (Fig.3 ). Results from the Gorilla analysis also 
showed similar results that plasma membrane part (a chi ld term under plasma membrane). 
excitatory synapse and synaptic membrane were the most enriched cellular component 
(TabS.4) . 
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Pathway analy i 
Path a anal i u ing IP identifi d a t tal f 72 ignificant an nical pathway . The 
top 16 anonical pathway are hown in Figure 4. alcium transp rt 1 and calcium 
ignaling were id ntified a the t p and the 4111 ranked pathway . ther important 
an nical pathway included protein ignaling mediated by Tubby, remodelling of 
epith lial adh rent , glutamat rgic ~ ynap e and gap juncti n (Fig.4 ). Results of KI~ 
Pathway pr dicti n u ing Web ' e ~ talt t ol al o ho\\-ed the calcium ignaling pathway a 
th nly ignificant path\\- a; that included I 0 f the l 02 differentially ex pre ed proteins 
from M Hg treatm nt (Fig . 1-2) . 
Verification of protein express ion us in g an alternative meth od 
Results of We tern blot are hown in Figure 5. hese protein were chosen as they are 
important in ion tran port/ ynaptic transmi ssion (SLC 17 A 7), and calcium pathway 
(SLC8A 1 ). DLG4 was the common protein involved in all the significant terms 
(carbohydrate derivative metabolic process, ion transportation and cell development a 
well as cell morphogenesis in neuron differentiation) in MeHg-treated cerebellum. 
CCT6A, a protein that was not differentially expressed was also elected as a negative 
control for validation. There was a decrease expression of DLG4, and L 17 A 7 and no 
significant change in T6A. These results agree with the MS result . H wever. while 
SLC8A 1 was shown to be significantly decreased in the MS results, the we tern blot 
resu lts showed a decrease trend but the resu lt wa not significant (Table ., ). 
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Tabl 1. ignificant ( i logical Pr term ba d et f differentially pre ed 
Group GOlD 
pr t in in M Hg-treat d m rm et cerebellum 
rm 
arb h; drate deri' ati' c metaboli c proce 
rganopho phat metaboli c pr ce . 
nu I ba c-co ntaining mall molec ule metaboli c 
:0055 0 6 proc 
:000 75 nucleo ide pho phate metab li e proces 
G0:00091 17 nu I otid m tabo li c pr ce 






G :19011 36 
purin -containing ompound mctaboli proces 
purine nucleotide metaboli c proce 
ribo e pho phate metabolic proce s 
ribonucleotide metabo li c proce 
purine ribonucleotid metaboli c proce 
carbohydrate deri va ti cataboli c proce 
roup 2 G0 :0006811 ion tran port 
Group 3 
G0 :0051 049 regulati on of tran port 
GO:OO 16192 ve icle-m ediated tran port 
G0 :0046903 secretion 








tran mi sian of nerve impul e 
synaptic transmi ss ion 
ce ll deve lopment 
ce ll part morphogenes is 
ce ll morphogenes i in vo lved in di fferenti ati on 
ce ll proj ection morphogenes is 
ce ll morphogenes is in vo lved in neuron 
differentiation 
A ociated 
Protein # ( 0/o) 
22 (1 5.7) 
25 (I 5. 9) 
22 ( 15. 7) 
22 (1 7.2) 
22 ( 17.2) 
18(1 5.8) 
20 ( 18 .0) 
20(18 .3) 
20 ( 19 .2) 
20 (19 .2) 
20( 19 .4) 
18 (22.0) 
2 1 (15. 8) 
2 1 (15.3) 
23 ( 15. 1 ) 




28 (15 .2) 
19 ( 16.1) 
18 (15 .8) 
19( 16.4) 
18(17.0) 
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4.29 -3 5 
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6. 73 -32 
3. 12£-2 1 
5.95£- 105 
3.80 -104 
4.49 - 10 1 
2.22 -99 





I .24 -46 
4.49 -46 
2.44£-22 
Tablc2. nri h d rni r R and th ir targ t g n in th fun ti n t rm f naptic 





,MIR-19 .M IR-19 
.MIR-15 
h a_ TT ,MIR-17-S P.M IR-
20 .MlR-1 06 .M IR-1 068.M I R-
208,MIR-519D 
h a CT GGG,MIR-1258.MIR-
125 
h a A TGT .MIR-128 ,M IR-
1288 
h a TTTTG G.MIR-373 
h a_TGCACTT,MIR-519C,MIR-
519B.M IR-519A 
h a AAGCAAT,MIR-137 
hsa CACTGCC,M IR-34A,MIR-
34 ,MIR-449 
tran mi i n 
#of Gene Gene ymbol P-va lue (corr. Bonferroni ) 
0.0297 
4 P25. PL I. YTI, 0.069 
4 TN Pl. PL BL 8 0.1122 
4 K J10. PL ' 81, SL 17/\7. TP282 0.] 287 
3 'A , L ' 17A7. 8 0.24 75 
.'L 6 L A , SYT1 0.3201 
3 DLG4. RA 11A. L 17A7 0.4059 
3 KCN.J I 0. PLCB I. SYT I 0.5049 
3 PLCBI, YT1. 8 N 0.5049 
3 CNTNA PL PLCBL , YT1 0.5049 
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Tabl 01npan n pr t in quantificati n re ult using W tern blot and 
pr teomi anal 
niqu e Fold hange (Trea t/ ontro l) 
ene y mbol Protein a rn e wi s-Pro t ID 
Peptid e HP W estern blo t 
") 0. 6 0. P78 52 ... 
v icular glutamate 
17 7 10 0.47 0.61 9P2 7 
tran p rter 1 
dium/ al iurn 
L 8 I 9 0.26 0.75 P32418 
exchanger 1 
T-cornpl e protein 1 
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• Differential expression 
Cytoplasm Plasma Nucleus Extracellular Other 
Membrane Space 
F igure 1. A. Heatmap of prote in abundance pattern in di ffe renti all y expressed proteins. B. 
ellular component di stributi on fo r the tota l identifi ed proteins (n=998, IPA mapped ID ) 
and differentially expre ed proteins (n= l 02) in marm o et cerebe llum. There was a 
significant difference in the di stribution of subce llular locali zation between total 
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Figure2. An annotation network of three functional group for differentially expressed 
proteins m MeHg-treated marmoset cerebellum. The network was generated by 
ClueGO+Cluepedia, the GO "Biological Process" was selected, GO term connection 
restriction (Kappa score2:0.3 ). Colour nodes represent the functional groups of GO term, 
and the size of node indicates the significance of the terms. The identified changed 
proteins associated with each term are high lighted in red . 
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• Identified proteome • Differential expression 
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Figure3. G enrichment cellular components analysi u ing Babelomics. The a teri ks 
indicate ignificant enrichment (P<O.OS) of differentially expres ed protein against 
identified proteome. The percentage repre ents the ratio of po itive genes annotated in 
blue bar (differentially ex pres ed protein ) and red bar (identified proteome) compared to 
































































































































Figure4. The top 16 Canonical pathways identified by the Ingenuity Pathway Analysis software sorted by their P-values. The ratio 
presented is defined as the number of the differentially expressed proteins found in the MeHg treated marmoset cerebellum over the 
total number of proteins involved in each ofthe pathway. 
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A 8 0. 0.6 
- X • Control MeHg :X: 0. 0 • c ~ • a.. • < • < • !2 0.4 • •• Q • 0.4 • ..... • DLG4 ~ < 0 • ... • ....1 • 0 • c ...... 0.2 
0.2 • w • 
SLC17A7 
0. 0.0 
Control M Hg ConiJol MHg SLC8A1 
2. ,.,. 
CCT6A X 0 X 
~ 0 0. < 1. ~ • !2 < 
GAPDH ... !2 • < 1. • < 0. ... 
•• 
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• ..... 1-0 0 
• ...... 0 
<D 0. •• 0. 
•• 
0. 0. 
Control MeHg Control MeHg 
FigureS. We t m blot ve rifi d four protein identi fied fr m M analy i in marmo et 
cereb llum. A . r pre entati ve blot were e l cted from fo ur prote in , and the intcn ity of 
each band wa quantified by den itometry. Plot on B how each valu obta ined from 
intensity of indi idual band before and after MeHg treatm ent in cerebellum for those fo ur 
proteins (n=6, 2 rep! icate I ampl e) . 
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Di cu wn 
hi i the fir t tud u mg n n-human primate a a model to inv tigate the global -
pr t orne change f MeHg neur ic it in th cerebellum of common marm e l. MeHg 
tr at d maim et m nkey h wed li ght akine ia and drunk-kind o f m tor dy function 
mpt m a (Yamamoto et a!.. 20 1 ~) . Mellg trea tment increa d th e t tal concentrati n 
f t tal m r ur) (Hg) in the c rebe llum of the three MeHg- treated mam oset monkey to 
2 .5, 2 . and 2 1.1 ~g/g re pecti ve l;, c mpar d t 0 ~gig in th contro l (Yamamoto et a!., 
201 2). Th f_G ct on motor fun ti on are imil ar t th e b 'erved in humans e posed 
t high level of MeHg ( lark on and Magos, 2006; Frum kin et al. , 200 1) sugge ting that 
marmo et monkey i a good model fo r human MeHg to ic logy tud y. In thi tudy, we 
used human databa e earching fo r prot in ide nti fica ti on from M /MS data. The ma in 
reason are the similari ty of n uroanatomy and behav ior of common marmose t to humans, 
and the gene ontology fo r marmo et database was not full y built at the time thi tudy 
was conducted . Moreover, our result of Western blot using hum an ori gina ted antibodi e 
were found to be applicable fo r marmoset bra in samples . Thi a] o sugge t the 
homology of genome sequence between the two species . 
MeHg treatment resulted m a decreased expressiOn of 86 proteins and an increas d 
expressiOn of 16 protein m the cerebellum. The number of di ffe rentia ll y expre sed 
protein are similar to those reported by Zhang et al. studying effec ts of MPTP on rat 
cerebellum (Zhang et a!., 201 Ob) . The ce llular component di stributi on analy i howed 
that MeHg treatment did not just cau e global non- pecific effec t o n a ll ce llular 
components but had specifi c effec t on the prote ins in the cerebe ll ar plasma membranes 
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( ~ ig.l ). Re ult f th ellular component nrichm nt anal i al o h w d that 
M Hg af-D ct d pr t in main! 1 cated in the la ma membran (part), m re p ifically 
nrich d in nap e, naptic membrane and c ll juncti n (Fig. and Tab .4) . 
MeHg treatment ~a ~ und to affect three mam functi n including carbohydrate 
deri ati e metab lie proc . 1 n tran port and cell devel pment (Tab . I). total of 22 
differential! e pre ed protein \\er found involving in carbohydrate derivative 
metabolic proce 11 f th e pr tein ~ere d wn-regulated except for FBX02 , GNAQ 
and VCP, indi ating MeHg n gatively affect d carb hydrate m tabolic pr ce s which 
wa the main urce fen rg) upply . , imilar effects on carb hydrate metaboli m were 
al o reported in ur arli r tudy in mato n ory cortex of rat with a 1 w do e of MeHg 
treatment (Kong et al.. 2013 ). 
Among all the ion transport functions, ynaptic tran mi ssion was the most important 
function affected which is similar to the observation in MeHg expo ed rat cerebellum 
(Radonjic et al.. 201 3) . Twenty differentially changed protein were a ociated with 
synaptic transmission (TabS.3 ). and four of them (ATP2B2, CAMK2A, SLC17 A 7 and 
SYP) had previously been reported to be related to mercury toxicity (Fujimura et al.. 
2012; Reddy et al., 1988; Yoshida et al.. 201 1) . Furthermore, the 20 proteins as ociated 
with synaptic transm ission are mainly involved in the neurotransmitter regulation ( BSN, 
DLG4, LGll , NAPB, RABllB, RAB3A and SLC6Al ), glutamate secretion and 
glutamate receptor signaling pathway (DLG4, PLCBl , SHANKl , SLC17A7, SYP and 
SYTl ), synapse calc ium-dependent bi nding (ATP2B2 , SNAP25 and SYT l ) and other ' 
(AMPH, CNTNAPl , ITPKA, KCNJ10, NCAN). The identification of cellular 
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mp n nt t rm f nap e and naptic membrane (Tab .4) al ugge ted 
that MeHg impa t th n ur tran mi i n b di rupti n protein m citator ynap 
tran mi ion naptic m mbrane . The e re ult are c n i tent with the previou tudie 
that citatot am in acid glutamate imbalance inn urons wa on f them t impotiant 
me hani m in MeHg ·p ur (Yin et aL .... 009): ( arina et al., 20 11 ). 
MeHg effect n brain tructure and ell m rph logy ha e been ten ' ively r port d 
(Radonj i t a!.. 201 ). W al found igni ficant effec t on prot in a ociatcd with c II 
de elopment cell part m rph g n i , cell m rphogen i involved in differentiati n, 
cell proje ti n morph gene i and cell morph gene i (group 3, Tab. I) . The e re ult 
demon trate the global effect f MeHg on cell development neuronal morphology 
feature and n uronal differentiation in the cere bell urn . 
alcium homeo tasis di sruption ha been well documented as one of the core 
mechanisms of MeHg toxicity (Limke et al.. 2004: Yallapragada et al., 1996). Calcium is 
involved in almost all types of the synapses plasticity regarding motor learning proce s in 
cerebellum (Lamont and Weber. 2012). Our re ults showed calcium ignaling pathway 
was the top pathway affected by MeHg as predicted by both IPA (Fig.4) and WebGestalt 
tools (FigS.2). Also, when a more broad-term examination using #gene/term <5 with 
term fusion was applied for GO functional analysi , calcium ion transport and cellular 
calcium ion homeosta is were observed in the 60 significant GO term (TableS.3 ). 
Moreover, a total of 10 (ATP2A2, ATP2B2, ATP2Bl, CAMK2A, GNAS, GNAQ, 
ITPKA, PLCBl , SLC8Al and SLC8A2) of th 102 changed protein were mapped in 
K GG calcium signaling pathway (Fig .3). Out of which, five protein , 
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TP2Bl/ATP2B2 (Burl ndo t a!., 2004), TP2 2 ( a o et al., 2001 ), MK2A 
(Yo hida t al., 2011 ), L SAl ( urieri et aL 2011 ), ha been pr viously reported to 
re lat t mercur t , icity. Th r ~ r . the c re ult confinn d that di rupti n f calcium 
path a i a ke mecahni m [! r Mcllg neur to icity . 
mong th 102 differ ntially changed pr tein . DLG4. also kn \ n a P , D-95. i a core 
protein that afD ted multipl fun tion a it \\as inv 1\ed in all of the 22 significant 
bioi gical functional term . Thi ;naptic maker \\US down-regulated (about -folds) as 
h wn by both L -M /M and \\e tern blot re ults (Tab.3 ). DL 4 ha been ·hown to 
play a maj r role in regulating the interaction bet\.\een po t-synaptic receptor particularly 
ionotropic glutamate re eptor and a ociatcd ignaling mol cules (Nash et al.. 2005~ 
Porras et al.. 2012). nother key target wa MIR-19A/MIR-19B as they were shown to 
target 5 down-regulated protein (N APB, PLCB 1, SYTl , BSN, A TP2B2 and NA PB ) 
involved in synaptic transmi sion (Tab.2). MiR-19 family plays an important role in 
regulation of key gene in the neurodegenerative di ea e and variety of cancer proces . 
For example. MIR-19 is a co-regulator to regulat the ataxin 1. a gene that contribute to 
the progress of spinocerebellar ataxia type 1 (Lee et a!., 2008). The effects of MeHg on 
miRNA warrant further investigation . 
In summary, usmg a prin1ate model. we have shown the effect of MeHg on th 
dysfunction of motor function was mainly caused by disruption of carbohydrate 
derivative metabolic proces . synaptic transmission process particularly calcium 
signaling pathway, and cell morphogene is. We r ported a total of 21 novel protein 
affected by Mel-lg in ynaptic transmi sion (Tab . ., ) and calcium associated path\.\ a)' 
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( 1g . ). DLG4 nd MIR-19 /MIR-19 re [! und a th k targ ts involved in 
nap tic tran mi 1 n f MeHg n ur t it; . Furth r in e tigation of th ir function wi ll 
contribute t the impr ed under tanding f the path gene 1 of Mel Ig neur to ity in 
human . 
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hapter VI: Proteome profiling reveal regional protein alteration in 
cerebrum of common marmo et (Cal/ithrixjacchus) e po ed to 
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Meth lmercur (MeHg) i kn wn t lecti ely damage the cal anne and precentral 
rtic along deep ul i and fi ur The m lecu lar ent of Mel lg le ion 111 the e 
r gwn till unclear. Thi tudy aim to identify and analyze the differential pr teome 
e pr ion in t\\ reg1on f th cerebrum (pr fr ntal c rtex of the frontal lobe and the 
cipital 1 b around the ca lcarine ul cus in cerebrum ) of the marm t ( Callithrix 
j acchus) treated Vvith McHg ( 1. mg/kg body Vve ight ~ r 14 days) using a shot-gun 
prot omic appr ach. t tal of 1045 and 1062 pro t in Vv ere identifi ed in the frontal lobe 
(FL) and occipital lob ( L), of which. 62 and 89 protein were found ignifi cantl y 
changed in FL and L re pecti ve ly. uncti onal enri chment/depleti on analys is showed 
that the lipid metabolic proce and prot olys is occuned in both two lobes. Differenti all y 
e pres ed proteins in FL are pecificall y enri ched in the functi on of ce ll cycle and cell 
division, sul fur compound metaboli c proce s, microtubule-ba ed process and glycerolipid 
metabolic process. In compari son, protein were enriched in the functions of transport, 
carbohydrate metabolic process, chemical caused homeo tas is and regulati on of body 
fluid levels in OL. Pathway analysi predi cted that vasopress in -regul ated water 
reabsorption was di sturbed in MeHg-treated FL. Disrupti on of energy production were 
shown by changes in pyrimidine metaboli sm and pyruvate metabolism in FL, and 
butan ate metaboli sm in OL. Our results showed that MeHg induced regiona l spec ific 
protein changes in FL and OL but with similar endpoint effects such a energy dimi ni h 
and edema. The resul t of water transport dysfunction upport the phenotype effects of 
edema observed in the marmoset brain. APO and G PX 1 were fo und to b key target 
protein dedi cating Mell g multiple functi ons in OL. This is the fi r t report of the \\hole 
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prot m hang f primate cerebrum ~ r MeHg t icit tudy, and th r ults improve 
the und r tanding f m lecular ba i f MeHg int ati n in human. 
Key word : Meth lm rcur , Prot m1c , erebrum, curoto icit , ammon marmoset 
Introduction 
Mercur a a global envir nmental to. icant po ed a potential health ri sk for wild-life and 
human ( ri coil et al.. 201 ). Mercury ha been used for ecd fungicide and as an 
indu trial byprodu t (acetaldehyde cataly t ) in the Ia t century. Fi h and marine mammal 
con umpti n are th main urce f mercur) expo urc for human ( ' larkson and train, 
2003). inc th fir t outbreak of m rcury p i oning in Minamata, 1956s, mechani sms 
for mercury to icity effects in different pecie have been widely studied (Farina et al., 
2011 ). erebellum and cerebrum are the main target for MeHg neurotoxicity. The 
typical symptoms ofMeHg in Minamata di ease were ataxic gait low movement as well 
as vision deficit (Eto, 1997). The autopsy re ults of Minamata di sea e cases hawed that 
in acute phase, the level of mercury wa found highest in cerebrum and cerebellum 
compared to the other regions in nervous system (Okabe and Takeuchi, 1980) . 
Methylmercury induced brain morphology changes, including neuron los , particularly 
occurred in the calcarine cortex and cerebellar cortex (0 hmichen, 2006; Takeuchi T. 
1979). Brain edema happened in the perivascular space and neuron swo llen in th 
cerebral cortex in acute case (Eto, 1997). erebrum in frontal lobe and occipital lobe 
have been documented as sensiti ve bra in regions for mercury accumulation in different 
spec ies, such as ringed seal (Krey et a l. , 20 14 ), be luga whales ( 0 tertag e/ a/., 20 13 ), 
otters (Dornbos el a/. , 20 13) and common mam1o et (Yamamoto el a/., 2012). 
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De it the num r u tudi reporting neurot icit f MeHg in dif:fl rent pec1 of 
mammal , ther i little in:fl rn1ation on the c mpari n m chanism f M llg in differ nt 
brain regi n pecifi ally. Thi i partly du t a lack fa relevant model and tool to 
t maticall tud , the global mechani m f mercury to icit in the regwns. ue to 
the imilar character with human being in anatomy and behavior, non-human primate 
uch a c mm n marm t e. hibit m rc advantage than the other primate , and rodent 
p c1e in biomedical re earch e, pec iall ; in neuro cicnce and tox icological screening 
(Ki hi et a!.. 20 14: kan el of , 20 12 ). Th bjecti e of thi s stud y wa to explore the 
u of common marmo et a , a model to tud] the mec hani sm of Mel-l g sub-acute 
toxicity. The pecific bj ctiv wa to identi fy and compare the global proteome changes 
of frontal lobe ( L ) and occipital lob ( L ) of the ce rebrum induced by McHg ex po ure. 
Us ing bioinfonnatic analys i including biological cellular functi on, pathway and protein 
network anal ysis. the mechani sms underl ying th e phenotypic change induced by MeHg 
were investigated. Western blot was u ed to validate the important proteins re ult from 
proteomic prediction. 
Material and Methods 
Experim ental animals and Methylmercury Administration 
Experimental conditions concernmg MeHg exposure tn common 1narmo et was 
previously described (Yamamoto el aL 20 12). Briefl y, s1x common marmoset we re 
divided into MeHg-treated and vehi cle groups. Methylmercury chl ori de ( 1.5mg/kg bod) 
weight) was admini strated using an indwe ll ing infant reeding tube ~ ith 3 marmo et for 
14 days, foll owing 14 days without treatment . The contro l group \\as given the ame 
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c ncentration f -c t 111 (7.5M a MeHg-tr ated gr up. 11 animal pr cedur were 
appr d b the nimal Re ar h mmitt e at th ati nal In titut for Minamata 
i ea e, and all pr c dure c nform d to th uide for the are and e of Laboratory 
nimal b th In titute of Lab ratory nimal Re ource . The L and regwn 111 
hi I and MeHg-treat d group \"vere di ected after anesthesia. Di ected ti ue 
ample were immediately fr zen in liquid nitr gen and stored at -80°C for proteomic 
analy i 
ample Preparation and Ma S pectrom etric naly i 
FL and L ample in triplicate from vehicle and Mel Ig-admini trated groups were used 
for liquid chromatography-tandem ma pectrometry (L -M. IM. ) analy i . Tissue 
preparation and protein quantification u d the ame methodology and pr cedu re as 
described previou ly ( hao et a/., 2015 ). Briefly, proteins extracts ( 1 0011g) w re 
precipitated, reduced and alkylated, followed by tryp in digestion. The digested peptides 
were acidified by formic acid, and fractionated by tageTip strong cationic exchange 
fractionation into five fractions by five pH steps (pH3.0, 4.0, 6.0, 8.0, 1 0.0). Lastly, the 
peptides were desalted on Sep-Pak column (Waters Corp., Milford, MA) and lyophilized 
in a SpeedVac (ThermoFisher Sc ientific, San Jose, CA). An Agilent 1100 capillary-
HPLC system (Agilent Technologies, Santa Clara, CA) coupled with L TQ-Orbitrap mass 
spectrometer (Thermo Fisher Scientific, San Jose, C A) was u ed to analyze the peptide 
mixtures. 
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Homo apaen Databa e earch and Quantitation 
The arne human databa e r h and pr tein identificati n procedure were u ed a 
d cribed pre iou 1 ( hao et al., 2 15). The peak I i t fr m raw fi le wer general d 
wi th ftware Ma. uant ( er ion 1 .. 0.5 ) and earched against , wissProt pr tein 
databa f human (ver i n .... 0 120711 )_ including comm nly b cr ed ontaminants. For 
M /M pectra. the precur r ion mass tolerance \\ere 7ppm. and fragment i n mass 
t 1 ranc wa t t 0 . Da. Raz rand unique peptide Y\ere applied for quantitation . The 
fal e di cov ry rate v.a limited to 0.01 on b th pr tein and peptide level. A minimum 
equenc length of ix amino acid wa requir d for peptide identification . 
For protein identificati n. if the id ntified p ptide sequence of one protein was equal to 
or contained in another protein· peptide et. the . e tVvo proteins were grouped together by 
MaxQuant and reported as one protein group. For quantitation. a minimum of 2 spectra 
count i needed . 
Data Analys is and Cellular Component Distribution 
All the contaminant and reverse data were removed. and then the identified protein were 
converted to niprot gene ID by Persues software (Version 1.3.0.4). bundance ratio of 
proteins were based on the label-free quantitation of each group in the format of the fo ld 
changes. The calcul ation of different ly expressed proteins was performed u ing Mann-
Whitney U test with SPSS 16.0 ( P Inc., Chicago, IL) . Differentiall y expressed 
prote ins in each of control and MeHg- treated group were furt her clustered into heat map 
to test the group vari ance using Persues software. 
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ellular c mp n nt d i tributi n wa cla ifi d b u ing lng nuit Path a nalysi (IP ) 
ft are (Qiag n, R dw d. 
mpari on of total id ntified pr tein and differ ntiall e pre cd pr tein was given by 
th p r ntag f ach ub-c llular locati on aga inst it total number . A Fi her' _. act 
e t a c nduct d to te t the rganelle di tribution difference betwe n t tal proteins 
and di fferentially e. pr , ed pro tein in the tV\ lobe of cerebrum . 
GO Functional Enrichment naly i for Frontal Lobe and Occipital Lobe 
To identify th 
anal y i for 
v r-r pr entati ve functi onal catego rie 111 FL and L, enri chment 
(g ne ont logy) biological fun ction wa conducted usmg 'ytoscape 
lueGO plug- in (Bindea el a/. 2009) . The di ffe renti all y ex pre s d protein wer te ted 
in the ba e of the reference of human G (biological process) annotati on again t the 
proteome identifi ed in FL (1 045) and L ( 1 062). A two-sid hypergeom tri c 
(Enrichment/Depletion) test wa used to calcul ate the enri ched catego ri es. and Bonfe rroni 
test was applied to correct the P value. Only P <0.05 was considered as ignificant terms. 
To reduce the redundancy of the GO terms. we applied the restri ct parameter in OL (# of 
genes as 9, and min °/o as 1 0). 
Hierarchy groupmg was undertaken to clust r the functio nal tenn based on the 
perspective of their parent tenns. We defined the min # common parent a 3 and max # 
as 4 for the mapped clusters that representing from the total associated gene with the 
term . To visualize the bi ological relevance of related proteins in FL and OL. a functional 
annotati on network was generated based on the gene similar ity (Kappa core wa set as 
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0. ) D r h of the t o 1 b lueP dia (Bindea e/ a!. , 201 ) wa applied to vi ualize 
the kn wn int racti n (fr m RIN 9.0) b twe n a ciat d gene . 
Pathway Enrichment naly i and Mappin 
further addre the identifi d biological function affec ted by M Hg, the diffe rentiall y 
pre ed pr tein in FL ( 6-) and L ( 9) V\Cre further appli ed for path way predicti n 
u ing Webge talt (WEB-ba ed ~ne , eT naL is Too lkit) (Wang et ul. . 201 3 )which 
linked K path'vVay databa e. The identified proteom in FL and OL were u ed a 
reD r nc background D r th enriched KE (Kyoto Encyc lopedia of ene and 
enome ) path'vV ay term predi ctio n. I lypergeometri c te t was used to calcul ate P values 
fr m th diffe rentiall y xpre d prot in ~ the ize of GO et equal or above 2 genes 
were included in KEG pathway analy i . Bonfe rroni method was appli ed to correct the 
P value. Protein involved in int rested pathway were further mapped into online K GG 
pathway mapping sy tern (http ://www.genome. jp/kegg/). 
Western Blot A nalys is 
To verify the quantitative changes of the proteomics data. fo ur proteins were elected 
including Disks large homolog 4 (DLG4), Cytopl asmic dynein I li ght intermediate chain 
2 (DYNC l LI2), Glutathione pero idase 1 (GPX l ) and Aquaporin -4 (AQP4) to be 
analyzed by We tern bl t. We select these 4 proteins because they arc important protei n 
in linking multi functi ons (DYN 1 LI2 and GPX1) and key protein in interpretati on brain 
edema (DYN 1 LI2 and AQP4) in the region of FL and OL. In additi on. wea l o \\ant to 
verify the expre sion of non-differential ly expressed pro teins such a DLG4. Briefl y. 
protein 1 0-40!-!g were loaded into I 0-12o/o SDS-PA 1E pre-cast ge l , (Bio-Rad. 
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Mi aug a, ) D r paration, then tran ferred into PV m mbrane by u mg 
tank bl tting tern (Bio-Rad. Mi auga, ). he membran were blocked 
with So/o fat-free milk in T T ( n Buf[i red alin + Tween-20) for 1 h ur. and 
appropriate primar anti bodie were incubated v. i th membrane in So/o TB overnight 
(4° ). fter probing v.ith hor eradi h per . idase-conjugated econdary antibodies ( anta 
ruz Biotechnology Inc, anta ' ruz, ). membrane v.ere wa hed and target band 
wer d teet d u ing enhanced chemilumine cence clarity reagent (Bio-Rad, Mi ssi sauga, 
), and i ualized by ' hemi-doc ( io-Rad, Hercule , A) Imager. The quantification 
of band inten iti wa performed u. ing Image J oft ware . All the primary antibodie 
were purcha d from beam ( beam. Cambridge. MA) and , anta Cruz Biotechnology 
Inc. (Santa ruz. A): DL 4 ( 1: 50. ab 18258 ). PX 1 ( 1:1 000, ab l 08427), DYN 1 LI 2 
(1 :300, sc-66866), AQP4 (1 :400. c-9888) and econdary antibodie were from , anta 
Cruz Biotechnology. The equences of antigen amino acid for tho e human originat d 
primary antibodies were 2: 90o/o similarity with common marmo et. 
Results 
Methylm ercury-indu ced Protein A bundance Changes an the Frontal Lo be and 
Occipital Lobe of Ma rmoset 
A total of 1045 and 1062 proteins in triplicate runs were identified from frontal lob and 
occipital lobe, among them 168 and 185 protein were uniquel y expres ed in FL and OL 
respectively. Typical MS/MS spectra for DYN l LI2 (04323 7. Cytopla mic dyne in 1 
light intermediate chain 2) in FL and APOE (P02649. polipoprotein E) in OL were 
presented in Figure S 1. Man-Whitney U test showed that 62 proteins (28 up-regulation 
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and 4 d - n-regulation ) in L and 89 ( 18 up-regulati n and 71 down-r gulation ) in 
re differ ntiall 
ere commonly e pr 
pr ed. nl pr tein ( YN ' 1 I2. HI Tl H2BH and P ) 
d between tVv regi n (Fig. I ). 
Heat map from and L hov.- ed th con i terr e of protein abundance change of 
diH rentiall e. pre ed protein . and a clear eparati on wa ob erved between Mel Ig-
treated and untreated ample (Fig 2 and ' ). i tri buti on of cellular component in 
L and are hov,:n in F i g~ (B and ). In FL the total and di fferenti ally ex pressed 
prot in wer di tributed in the fo ll ov.- ing order: cyt pl asm (63o/o. 70o/o), pi a ma 
membrane ( 17o/o. 11 ° o). nucleus ( l ., o/o. 1.,o/o). ex tracellul ar space (3°/o, 3%) and the 
remaining other organell e ( 4°/o. 3°/o). In L. the relevance percentage for ub -cellular 
location fo r total protein and differenti all y expre sed pr teins are cytoplasm (63%, 66o/o), 
plasma membrane ( 17o/o. 17°/o). nucleu ( 12o/o, 1 Oo/o), extrace ll ular pace (3o/o, 5o/o). and 
other organelles taking 5% and 2o/o re pectively. There are no ignifi cant diffe rence of 
organelle distribution between the identified proteins and the di ffe renti all y expressed 
proteins in FL and 0 L. 
GO Enrichment Functional Analysis Differentially Expressed Proteins for FL and OL 
An enriched functional analysis fo r FL and OL were conducted using Cl ueGO software. 
In FL. the analysis indicated fi ve signi ficant hi erarchy groups and non-grouped term 
(Fig.3A) with 39 proteins and 24 terms were included (Tab 1 ). The hierarchy terms 'Were 
clustered manuall y into 5 parent terms: 1) Ce ll cyc le and Ce ll di vi ion; 2) Cel luar 
metabo li c process; 3) Proteoly is; 4) microtubu le-based procc s: 5) Mult i-organism 
process including modifi cati on of morphology or phys iology of other organism. The non-
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gr uped functi n t nn includ d pr tein ubiquitinati n (P=5 .24 - 14) and developmental 
gr wth (P- 1.45 -- -04 ). ell divi i n wa the m t ignificant t rm ( .56 -1 4) id ntified 
in all 24 tenn f . In . 55 out f 9 differential] e pre d proteins were includ d 
in 19 t rm in re pon e t Mel Ig expo ure. These 19 term were manually 
clu t r d int 4 parent group and 5 non-gr uped tenns (Fig. B): l) llomeo tatic process; 
2) rganic ub tance me tab li e pr cc ; ) Tran port ; 4) ' ell ular metabolic process; 
ulfur mp und metabolic proce (P- 0.0 8) and glycerolipid metabolic pr cess 
(P=7. 1 ~ -05 ) \\1 re in luded in cellular metabolic process. The non -grouped term 
compri ed intracellular ignal transducti n. regul ati on of multi cellular organismal 
development n gative r gul ati on of re pon e to timulus. proteo ly i · and regul ation of 
body fluid level . Biological proce in intracellular signal transduction contained the 
highe t proteins number ( 19) again t it associ ated protein (Tab2). Lipid as. ociated 
metabolic proce s and proteo lys is were the functi ons that were commonl y affec ted by 
MeHg in both the FL and OL. 
Functional Annotation Network of FL and OL of Marm oset by Clu eGO 
The functional annotation network provided the visuali zation of the functi onal connecti on 
and associated proteins between group terms. A total of 3 7 GO term connections 'W re 
found in the FL ( ig.3A) and 12 term connections in OL clustered network (F ig.3 B). due 
to the restriction of parameter set in OL. Each of the e cluster represent di tTerent 
biological functi ons based on their protein similarity. Cytopla mic dynei n 1 light 
intermediate chain I (DYN 1 L ll ) in FL and Apolipoprotein E (APOE) in OL net\\Ork 
were shown as the co re protein to connect mu lt ip le ce ll ular biological processes . 
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KEGG ignificant Pathway 
here ult of K pathway predicti n refl ected the functi nal ef~ t of differentially 
pr ed protein on p cific ce llular pathwa re pond to mer ur timuli in L and 
orre ponding t 1 gical function analy i . the re ult f K .. pathway in 
M Hg-tr at d L h wed va. pre in-rcgulat d water reab orpti n, pyrimidin 
metaboli m. pyruvate m tab li m and neurodegenerative di ord er such as Parkinson · 
di ea e and Huntingt n ' di ea e (Tab.3 ), though no signifi cance bowed in adjustm ent P 
alue . Pathway in va o pr in-r gulated \\ ater reab orption includ d 4 pr te ins out of the 
62 differential!) e pr ed protein in FL (Fi g. 6 ). For the L. KE .J pathways anal ysis 
identifi ed the important pathway uch a tryptophan metaboli sm, butanoate metaboli m , 
valine, leucine and isol eucine d gradati on. metabo li c pathways and ti ght junction (Tab.4 ). 
Pathways associated with energy producti on such as pyruvate metabo li sm and butanoate 
metaboli m , and neurodegenerati ve di sea es (Parkinson ' di ea e and Huntington 's 
di sease) were found in common in the two lobe of cerebrum . 
Validation of Differentially Expressed Proteins 
We tern blot was conducted to veri fy the four screened protein from the r ult of ma 
spectrometry. As expected, the express ions of DLG4 and DYNC 1 LI2 from MeHg-tr ated 
L were up-regul ated (Fi g.5 ), and GPX 1 was significantly down-regul ated w ith 2.6 fo ld 
(P<O.Ol) in OL region (Table] ). However, the ex pre sia n of AQP4 in OL intends to be 
increased, but was not stati sti call y significant. Genera ll y, We tern blot resul t were in 
















Table 1. Functional GO terms (BP) differentially expressed proteins in MeHg-treated Frontal Lobe 
GO Tenn 
cell cycle checkpoint 
cell cycle process 
cell cycle phase transition 
cell division 
mitotic cell cycle phase transition 
regulation of cell cycle phase 
transition 
regulation of mitotic cell cycle phase 
transition 
regulation of mitotic cell cycle 
negative regulation of cell cycle 
process 
modulation by virus of host 
morphology or phys iology 
modification of morphology or 
physiology of other organism 
modification by symbiont of host 
morphology or physiology 
modification of morphology or 









4 ( 16.0) 
4 (16.0) 
4(12.5) 
4 ( 16.0) 
7(13.0) 



















Associated Genes Found 
DYNC1 LJL PSMAL PSMB6. PSMC4 
ANK3. ANXAI 1. CHMPIA. DYNClLIL MAP4. 
PPP 1 CB. PRKAR2B. PSMA 1. PSMB6. PSMC4, 
RABIIA. RAB35. TUBB2A. TUBB4A 
DYNC I LIL PPPl CB. PRKAR2B. PSMAL 
PSMB6. PSMC4. TUBB4A 
ANK3. ANXAI L CHMPlA. DYNClLIL MAP4. 
PPP1 CB. RAB II A. RAB35 
DYNC I LI 1. PPP 1 CB. PRKAR2B. PSMA 1. 
PSMB6. PSMC4. TUBB4A 
DYNCI LIL PSMAL PSMB6. PSMC4 
DYNCI LIL PSMAL PSMB6. PSMC4 
DYNC 1 LI I. PSMA 1. PSMB6. PSMC4 
DYNC 1 LI I. PSTv1A 1. PSMB6. PSMC4 
DYNC1LI1. EIF~H. KLCI. PPIA. PSMB6. 
SLC25A5. VIM 
DYNCl LIL EIF-lH. KLCL PPIA. PSMB6, 
SLC25A5. VIM 
DYNCl Lll. EIF4H. KLCI. PPIA. PSMB6. 
SLC25A5. VIM 





















lipid metabolic process 




regulation of transport 
positi ve regulation of transport 
endocytosis 
Associated 
Protein # (%) 
12 ( 14.0) 






16 (10.3 ) 
10(13 .3) 














Associated Proteins Found 
ADDL APOE. GLRX. GPXL HP. IMMT, 
OXCTL PICALM. PPTl. PRKCB. PRNP. TXNLl 
ADD!. APOE. AQP4. GLRX, GPXL HP, IMMT, 
LAMTORl. OXCTL PICALM, PPTL PRKCB, 
PRNP. TXNLl 
APO E. AQP4, HP. IMMT. LAMTORL OXCTL 
PI CALM. PPTI. PRKCB. PRNP 
AK 1. AK5. ALDH5A l, APOE. ARL8B. A TP5F 1. 
CMAS. DGKB. DNMl. GANAS. GUCY1A2, 
NGEF. OGT. RAB18, RAB5A 
ALDf-15A l. APOE. CMAS. DLAT. GPXL 
LAMTORl. LRPI. OXCTl. PC. PPTL TECR 
ALDH5Al. APOE. CMAS. DLAT, GPXL 
LAtviTORl. LRP I. OXCTL PPTL TECR 
AGL. ALDH5A l. CMAS. DLA T. GANAB. 
OGDHL. OGT. PC. PICALM 
ADDL APOE. CDH13. GFAP. LAMTORl. LRPL 
MAOB. NCS 1. OXCTl. PI CALM. PPTI. PRKCB, 
RAB5A. SCAMPS. SNAP25. WDRl 
ADDl. APOE. LRPL NCS 1. OXCTL PICALM. 
PPTl. RAB5A. SCAMPS. WDRl 
ADDL AP2A2. APOE. CDH13. CLINTL DNML 











cellular amino acid metabolic 
process 
punne nucleotide metabolic 
process 
nucleobase-containing smal I 





regulation of multicellular 
organismal development 
negative regulation of 
response to stimulus 





















ALDH1LL ALDHSAL ALDH6AL ASRGLl, 
GPXl, PRNP. PSMB 1, PSMB4, V ARS 
AKL AK5, APOE, ARL8B, ATPSFL DGKB, 
DNML GPXl. GUCY1A2, NGEF. RAB18, 
RABSA 
AKL AK5, ALDH6AL APOE, ARL8B, ATPSFL 
DGKB, DNML GLRX, GPXL GUCY1A2, NGEF. 
PICALM, RAB 18. RABSA 
AK1. AK5. APOE. ARL8B. ATPSFL DGKB, 
DNML GPXI. GUCY1A2. NGEF, RAB18, 
RABSA 
APOE, ARL8B. CDHI3, DGKB, GPXL 
GUCYIA2, LAMTORl. MRAS. NCSL NGEF, 
OGT. PI CALM, PRKCB. PRNP, PSMB L PSMB4, 
RAB18. RABSA, \VORl 
ADD!. APOE. DGKB. GFAP, GPXL NCSL 
NGEF, OGT, PRKCB, PURB, WDRl 
AP2A2, APOE, CTNNA2, GPXL HP, LRPL 
PRKCB. PRNP. PSMB4. WDR1 
APOE. AQP4. ATP1B3. DGKB. GUCYIA2. 
PIC ALM, PRKCB. RABSA. WDR 1 
APOE. ASRGLL GPXl. HP, LAP3. OGT. 
PITRMl. PSMB L PSMB4 
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Table3. KEGG pathway identified in MeHg exposed marmoset frontal lobe 
Associate 
KEGG ID Pathway Name d Proteins Gene Symbol P-value 6 P-value 
# (%) 
ID:04962 Vasopressin-regulated water 4 (23.5) NSF. DYNC I Lll. DYNC 1 LJ2. 0.015 0.345 
reabsorption and RAB 11 A 
ID:04910 Insulin signaling pathway 4(21.1) PPP1 CB. PRKAR28. PYGM and 0.0223 0.5129 FASN 
ID:00240 Pyrimidine metabolism 2 (40) TXNRD I and CMPK 1 0 .0309 0 .710 
ID:05130 Pathogenic Escherichia coli infection 2 (8) TUBB4A and Tl f882A 0.4438 
ID:05012 Parkinson's disease 2 ( 4.4) NDUFA8 and SLC25A5 1 1 
ID:04540 Gap junction 3 (12.5) TUBB4A. GNAQ and rUBB2A 0.1663 1 
ID:04270 Vascular smooth muscle contraction 2(11.1) PPP I CB and GNAQ 0.2903 
ID:00620 Pyruvate metabolism 3 (15.8) ACYP2. PC and PKM 0.098 
ID:0451 0 Focal adhesion 2 (7. 7) PPPlCB and TLNl 0.4644 1 





















Leukocyte transendothelial migration 
Phagosome 
Huntington's disease 
















MAOB and OGDHL 
ALDH5A 1 and OXCT1 
ALDH6A 1 and OXCTl 
AK5, AKL AGL, ATP5fL 
ALDH5A LALDII6A 1. CMAS, 
DGKB. DLAT. GANAB. MAOB. 
LAP3. NNT, OGDIIL PC and 
PPTI 
MRAS. PRKCB and CTNNA_ 
CTNNA2 and PRKCB 
DYNCI Ll2. RAB5A and TUBA8 
AP2A2. GPX1 and ATPSF l 
DNM 1 and PRKCB 





















TableS . Proteomics results were confirmed by Western blot in marmoset two brain regions 
Unique Fold Change Brain 
Swiss-Prot ID Gene Symbol Protein N arne 
Pep tides HPLC-ESI- Region 
MS/MS Western Blot 
P78352 DLG4 Disks large homolog 4 26 1.12 1.73 FL 
Cytoplasmic dynein 1 light 
043237 DYNClLI2 intermediate chain 2 9 2.69 1.29 FL 
P07203 GPXl Glutathione peroxidase 1 9 0.42 0.39 OL 
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Figure I. Quantification analysis of identified protein in frontal lobe and occipital lobe in 
MeHg exposed marmoset. Numbers and PPI network of total identified proteins in upper 
panel and differentially expressed (statistical difference) protein in lower panel. A total 
of 1230 proteins were identified, and 877 overlapping protein were detected from the 
frontal lobe and occipital lobe in triplicate runs (upper panel). 148 protein are 
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• Total identified proteins 
• Slgmficant changed proteins 
Cytoplasm Plasma Nucleus Extracellular Other 
Membrane Space 
Figure2. Heatmap of protein abundant changes in differentially expressed proteins in FL 
(A) and OL (C), and cellular components distribution for identified proteins in frontal 
lobes (B) and occipital lobes (D). There was no significant difference in the distribution 
of subcellular localization between total identified proteins and changed proteins in FL 
and OL. 
Note: IPA mapped total identified proteins m FL, n= l 039. differentially e. pre sed 
protein n=62; IPA mapped total identified proteins in OL, n= 1059, diff rentially 
expressed protein n=89 
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A developmental growth protern ubtqurtlnatron 
M. tub 1 b .., L mrcrotubule-based process lcro u e- ase~ process microtubule cytoskeleton orgamzatron 
P t ly . L proteasome-medrated ubrqurtrn-<Jependent protern catabolic process ro eo s1s 
...._ ___________ proteasomal protern catabolic process 
c: glyceroliprd metabolic process Cellular metabolic ur compound metabolic process process cofactor metabolic process cellular amrno acrd metabolic process 
r------------------------- rnteractron wrth host 
Multi-organism modrfrcatron of morphology or physrology of other organrsm rnvolved rn symbrohc rnteractmn 
process modrfrcatron by symbront of host morphology or physrology 
modrfrcatron of morphology or physrology of other organrsm 
L------------- modulatron by vrrus of host morphology or physiOlogy 
r- negative regulatron of cell cycle process 
regulatron of mrtotrc cell cycle 
regulatJon of mrtotrc cell cycle phase transrtron 
Cell cycle and 
Cell division 
regulatron of cell cycle phase transrtron 
mrtotrc cell cycle phase transrtron 
cell cycle phase transrtron 
cell diVISIOn 
cell cycle checkpornt 
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8 proteolysis 
regulation of body flu1d levels 
negat1ve regulation of response to st1mulus 
regulation of multicellular orgamsmal development 
Intracellular s1gnal transduction 
Cellular metabolic 
L cellula' ammo ac<d metabolic pmcess 
purrne-contarnrng compound metabolic process 
punne nucleotide metabolic process 
nucleobase-conta1n111g small molecule metabolic process 
I posrt1ve regulation or transport 
process 
Transport L_ endocytosis 
regulat1on of transport 
Organic. c mgle-orgamsm carbohydrate metabolic process 
substance cellular hp1d metabolic process 
metabolic process hp1d metabolic process 
carbohydrate denvat1ve metabolic process 
chem1cal homeostasis 
Homeostatic I ' cellular homeostasrs 
process L_ homeostatic process 
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#Proteins I Term 
Figure3. GO Enrichment/depletion analysis of differential expressed proteins for frontal lobe and occipital lobe in MeHg-treated 
marmoset only the significant functional terms (P<O.OS) are appear in bar charts. The functional terms were clustered manually 
into each of parent term based on QuickGO web-based too l (Binns et a!.. 2009) . A. Functional groups of differentially expressed 
proteins specific for MeHg induced fronta l lobe. B. Functional groups of differentially expressed proteins specific for MeHg 







cellular amino actd 
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nucleobase-contalmng lntJacellular signal 
small molecule transducbon 
metabolic process 
endocytosis 
regulabon of body negative regulation 
fluid levels of response to 
stimulus 
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Figure4. Annotation network of di ffe renti ally expressed proteins in FL (A) and OL (B) were visualized by ClueGO+Cluepedia. 
Co lor nodes indicate functi onal group terms connected based on the ontology' s hierarchies. and gray nodes are terms not grouped. 
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FigureS. Validation of the prot om1c re ult u ing WB analy is of 4 proteins in frontal 
lobe and occipital lobe . . Representative blot of 4 protein from control and MeHg-
treated marmo et occipital lobes. B. emi-quantitative mea urement of target proteins as 
indicated by 6-7 WB analysi . Target proteins were first normalized by against their 
corresponding housekeeping proteins-GAPDH (n=6. 2 replicates/sample) . 
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VASOPRESSIN REGULATED WATER REABSORPTION 
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Figure6. Vasopress in-regulated water reab orption pathway was clas ified by K G 
pathway mapping system from upload d 62 differentially expressed proteins in FL. Protein 
hi ghlight with red were the one mapped in Vasopre in-regulated \\later reabsorption path\\a). 
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Di cu ton 
er brum, e p iall in fr ntal 1 b (F ) and ccipital 1 b ( ) ha been h wn to b 
n f th main targ t r gi n f M Hg neur to i ity ( t . 1997) . With tw d ep fi sure 
(cal arine and ylvian) in cer brum. marmo et ha e more imilar neuroanat my to 
human than rodent Vvhich lack de p fi ure. in the erebrum. Therefore , mann et i a 
good model [! r n uro 1 n e tudy relevant to human (Eto e/ a!. 2001 ). We searched 
human databa [! r pr tein id ntifi ati n from marmo et M , /M data, and us d human 
originat d antib die in We tern bl t for validation . There ults (Fig.5) further proved the 
genom imilarity f the two pecie . and the trategie vve used in thi tudy were 
appropriat . MeHg treatment cau d m r ury accumulati n in FL and L. The average 
concentration of total m rcury in OL (31.41Jg/g) wa higher than FL (26.71Jg/g) in the 
MeHg treated marmo et (Yama1noto et al.. 2012).The e results agree with other studies 
howing that OL were more usceptible to MeHg effects compared to other cortical 
regions in Minamata disease patient (Okabe and Takeuchi 1980) and in common 
marmoset (Eto et al., 2001 ). 
The global proteome of FL and OL in the cerebrum of the MeHg expo ed manno et wa 
examined. A total of 877 proteins were identified in both FL and OL regions. The 
number of the identified proteins was similar to those reported by We seling et al 
(Wesseling el a!., 20 13) using similar label-free LC-MS methods in rat frontal cortex. 
Out of the 151 differentially expres ed protein identified in FL and OL, only 3 proteins 
(DYNCI LI2, HISTI H2BH and PC) were common! af[i cted in both region (Fig.1 ). 
Thi s indicated that the effects of Mel fg on protein abundance change Vvere regionally 
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p iii in the t lob f c rebrum. hi ob rvation i further upported by the re ults 
of the h at map anal 1 that h wed high d gre f con i tenc of protein e pre ion 
ithin th tr atment and c ntr 1 group but a clear di fferen c in protein pattern betwe n 
th t gr up 111 and ( ig.2 and ). Ther were more differ ntially xpressed 
protein in the L ( 6) than in the L (5 9). he majorit pr tein were di tributed in the 
cyt pia min both L and L ( ig.2 and ). her wa al no difference in subcellul ar 
location betw n th differentially e. pre ed protein and that f the t tal identifi ed 
prot in in the t\\ region . The e re ult ugge t that Mel lg did not target parti cul ar sub-
cellular organ ll e within th FL and L of cer brum . 
ur re ult how that the effect of M J-I g in th e FL were not very specifi c and were 
mediated primarily through the di rupti on of c II divi ion, decrease in key anti ox idant 
protein , and interference in the proce ses of energy generati on. These are refl ected by 
the protein affected by MeHg in the FL are mainl y involved in cell cyc le and cell 
division, microtubul e-based process, cellular metaboli c proces including cellul ar amino 
acid metabolic process and sulfur compound metaboli c proce , proteolys is, and growth 
development (Fig.3A). The e findings are similar to those reported in a previous 
proteomics study (Keyvanshokooh et a/.. 2009) that proteins in ce ll metabolism, cell 
division and signal transduction were affected in juvenile beluga brain with 0.8ppm 
MeHg exposure for 70 day . Among the significant changed functions, su lfur compound 
metabolic process accounted fo r the highest percentage (20o/o) of proteins compared to 
other functions in FL (Fig3 .A). As MeHg is known to react particularly with ulfhydryl 
group ( -SH) and elenohydryl group to form MeHg amino ac id or protein complex 
( arocci et a/. , 2014 ), the significant change in protei ns invo lved in ulfur compound 
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m tab lie pr c (BPNTl , MTHFDl , N N, P , TXNRDl ) pr ided the 
m hani tic iden e [i r u h pr e h re ul t al ugge t that Mel Ig can au e 
idati tr b d rea ing ulfl1 dr I prote in u h a T RDl , a major antio idant 
elen nz m ll c cle and cell di i i n wa the large t ategor f function affected 
b M Hg. I o. the mi r tubul ba ed proce wa identifi ed n itive to Mellg 
e p ure ( able I ). micr tubul e i, imp rtant c. to kelenton tructure in manipula tion 
f ce ll di vi i n in mit i . M ll g \\a likely di rupting ce ll di vi i n pr ce s through 
microtubul e d p lymeri zati on (Clark on. 199 : Miura et al., 1 999). Moreove r, we 
ob rved functi onal enrichment in the glyce r lipid metab li e process a oc iated w ith 4 
di f£ r nti all y chang d pr te in (A LY, BPNT 1, F S , PPPl B ) in the FL (Tab 1 ). 
ACLY and FASN are key enzyme fo r lipogene i and chole terogenesis w hich are 
parti ularl important for the generati on of acetyl- oA for acetylcholine ynthesis 
(Beigneux e/ al. . 2004 ), and de novo fatty acid synthe is (Knobloch e/ a/. . 20 13 ). A 
acetyl- oA is the core enzyme connecting fatty acid metabolism enter into Krebs cyc le 
(Edmund s e/ a!. . 2014 ). MeHg can target the processes of energy generati on and interrupt 
nutrition support in FL of mannoset brain . In parall eled w ith the biological functi on 
analy is. we al so identifi ed specific pathways in pyrin1idine metabo li m and pyruvate 
metaboli sm in FL (Tab.3 ), which act as the essential energy source in Kreb cycle 
(Prasad e/ a/. , 201 1; Schroder e/ a!. . 2005). 
In comparison, the effect of MeHg on the OL proteins were more x ten ive but appeared 
to target some key prote ins uch a apolipoprotein (APOE), G luta thi one Perox idase- ] 
(GPXl ) and Aquaporin 4 (AQP4). MeHg wa observed impairing the function in li pid 
metabo li c process (A LDHSAl , APOE, CMAS, DLAT, GPX l , LAMTORI, LRPl, 
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OX Tl , P , PP 1, E R) and llular lipid metab li proc s ( LDHS 1, PO , 
MA , D AT, GP 1 L MTORl RPl , 0 Tl, PPTl , TE R) ( ab2). Vendr ll 
tal.( ndre ll et a/ .. 2007) a l rep rt d that -ketoacid- enz m tran ferase L a k y 
nz m in the nthe i of neural lipid . wa d crea cd in cer be liar granule cell 
e p d to 60nM MeHg ~ r 1 0 da . 
In dditional t impairment f lipid metab li m . encrg gen rati on wa di rupted in the 
a evidenced by functi n alterati n of carb hydrate deri vati ve metabo li c process and 
ingl - rgani m arbohydrate metabo li c proc . Moreo er, the ob erved change in 
butanoate metabo li m (Tab.4 ), an important pathway under carbohydrate metabo li sm 
provide further evid ence that M eHg indirec tl y influenced th e energy metabo li sm . Th se 
results agree w ith our previou prot omi c tudy (K ong et a/.. 20 13) bowing that 25o/o of 
their protein changed in the metaboli c of carbohydrates and energy generati on 
associated metaboli m in the omatosensory cortexes of rats dosed wi th MeHg. 
Our results also confirm that APOE is a key protein in mercury neurotoxicity (Godfrey e/ 
a!. , 2003). APOE was fo und to be the mo t intense interacti on hub in OL network 
(Fig.4B) w ith 3.7-fo]d increase. APO is a famil y member of apolipoprotein 
functioning as regulate lipid transport in the body (Hatters e/ a/. , 2006 ). n epid miology 
study showed a significant correlation between APOE 4 genotyping and 465 pati ent 
diagnosed with chronic mercury to icily (Woj cik el a/. . 2006 ). APO ~ and other a ltered 
proteins in lipid associated categorie in OL indi cated that different pro teins and 
separated biochemical processes in the two region contribute to the en rgy uppl y deficit. 
These type of prote ins and associated functions ugge ted that change in energy derived 
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carb h drate and lipid metab li m are a c re featur of M Hg neur to icity in both F 
and L. 
B id carb h drat and lipid metabolic pr c e , Me l Ig al ar~ ct transport, 
intracellular ignal tran duction, prot oly i , multicellular organismal development, 
cellular amin a id and nucle tide metabolic proce in the L. 11 of the e function 
were r pot1ed previou 1; t be related t Mel Ig into ication (Allen et al., 2001 a; 
K an hoko h t al.. 2009: Kong et a!., 2013 ). lutathi ne Per xidase-1 (G PXl ) was 
invol ed in 12 MeHg affected functi n ut [the total identified 19 functional term 111 
th L. PX1 1 a family member of elenoprotein which catalyze the reduction of 
hydrogen pero ide . he down-regulation of GPXl (2.5-folds in both LC-M /MS and 
We tern blot) ugge ted glutathion depletion occurred in M Hg affected multiple 
functions, and the decrea e in anti-oxidant capacity could also be one of th of MeHg 
toxicity in the OL. 
We observed the brain edema occurred in MeHg treated marmoset (Yamamoto et al., 
2012). The identification of water transport related pathway in the vasopressin-regulated 
water reabsorption in the FL (Tab.3) provides the biological pathway evidence to the 
observed effects of the brain edema. Vasopression regulate water reabsorption by 
secreting A VP (antidiuretic hormone vasopressin) through neurons projection to regulate 
water reabsorption in kidney (Boone and Deen, 2008). This pathway is one of the main 
ystems to maintain water homeostasis in our body. A total of 4 differentially expressed 
prote ins (DYNClLil , DYNC1LI2, NSF, RABll A) can be mapp d in pathwa; of 
Vasopre sion-regulated water reabsorption (Fig.6 ). In contrast, we found a ignificant 
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alter d functi n in regulati n of b d fluid 1 el ith 9 protein 111 olved (APOE, 
AQP4, A TPl 83, DGKB, G Y1A2, PI M, PRK B, R BSA, WDRl ) in th L 
( ab2). In th previ u tudy, al r p rted the ver- pre ion of QP4 and it 
r lati n hip with brain edema in MeHg- p d marm set (Yamam t et aJ., 20 12). 
P4 wa rep rted t be clo el relat d t the reablorption of erebr pinal 0 uid , 
m r gulati n and r gulati n of brain edema (King and gre, 1996). In this study, 
ignificant up-regulation QP4 \\a aL b erved in MS results, th ugh not in We tern 
blot analy i (Tab. and Fig. ). and thi may due to technical variation between the two 
te t . The re ult f P4 activati n indicat d that MeHg can increase permeability of 
AQP4 channel to enhance brain wat r flu , resulting in brain edema. 1 aken together 
with other 8 protein identified in functi nal group of regulation of body f1 uid levels 
itnplied a water transport dy hom o ta i occurred in the L of Mel-Ig- treated mamoset. 
These re ults offered the mechani tic explanations of observed edema in both FL and OL 
of the cerebrum in the MeHg exposed manno et . 
Conclusion 
This is the first report of whole proteome alteration in primate cerebrum region with 
MeHg exposure. Occipital lobe was more susceptible to MeHg effects than the frontal 
lobe. We demonstrated the importance of energy diminish (carbohydrate and lipid 
metabolic processes), anti-oxidant depletion, and dysfunctions of water transport as a 
conseq uence of MeHg exposure. The two brain regions showed imilar endpoint effect in 
energy metabolism but acting through different proteins and biological pathways . 
Disruptions of regulation of body fluid levels including pathway in vasopression-
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r gulat d ater reab rpti n are th Imp rtant mechani m f MeHg cau ing marmoset 
brain edema. POE wa the re pr t in linking multi functi n in Meilg-treated occipita! 
lob . Th id ntifi d bi I gical functi n and pathwa pr vide the po sible 1nechani m 
f MeHg-indu d neur nal dcfici t in frontal! be and ccipi tal lob . 
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hapter VII. onclu ion 
Ba ic life c1en r ar h i t d t rmme the prec1 e tep f the compl c scade and 
p t ntiall target m le ul and bi logical pathv.ay involved in different functi n or di ea es. 
The g al i to devel p n v l therapj t target these proc se and impr e or promote health. 
under tanding f the neur hemical and fun ti nal circuitry deficits 1 an 
important trategy particularly for neur degenerati e di ea e ( olde, 2009) . There are 
eviden e h v.ing that envir nmcntal p llutant uch a methylmercury (MeHg) potentially 
can be linked with neur degenerative di a e . H wever, very I ittle i known of the 
interaction f to i ant-di ea e uch a M I-Ig and PD . The entry and di tribution of MeHg in 
organi m i a com pi , proc . In pite of progre in under tanding of the initiating factor 
of MeHg poi oning, it i till no cure so far to remove mercury/MeHg even in the early stage 
of mercury poi oning (Farina et al., 2011 ). How to prevent MeHg-caused neuron dysfunction 
as well as the sub equent cell death i the key point to treat or prevent the MeHg-cau ed 
pathological progress. In this respect. a strategy which aims at systematic identifying 
sensitive molecular targets of MeHg as well as the association with neurodeg nerative 
disease posed a critical role in prevention and treatment of mercury poisoning and other type 
of neurodegenerative conditions. 
Key findings of thi tudy 
Thi s the is has two aims: one was to investi gate the assoc iation of MeHg toxicity with PD. 
MPP+, a well -known neurotox icant that can induce PO like symptoms i used a the positive 
contro l. The second a im was to systemati call y tudy the protein profi le in respon e to Mel Ig, 
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a ell a identifi ati n th ub equ nt chang in bi 1 gical fun lion and pathway to seek 
planati n fl r d ffl ct indu ed b M I lg. 
Th P1 manu cript pr nted 1n hapter III h w d th c mparative changes of key 
g ne /pr tein for d pamin ) c cl induced b MeHg and MPP ~ using a dopaminergic 
n ur n cell model. The rat -limiting nz 'm T I I [! r nthesis , dopamine transporter 
DAT, and nz m re p n ible ~ r D metaboli m M -B were ignificantly down-
r gulat d by th e, p ure f both toxicant , re ulting in a decrea e in extracellular DA 
content . he e re ~ ult ugge ted MeHg c uld affect many c mm n key gene /protein in 
regulation dopamine dynamic imilar t MPP +. To further explore the underlying 
mechani m of the effl ct of MeHg and MPP+, a gen mic and proteomic approach was used 
to study their effects on key PD gene and on the total proteome u ing the same MN9D cell 
model in the 2nd manu cript pre ented in hapter IV . A total of 6 genes including TH in 
dopaminergic transduction signaling pathway were found to be affected by both MeHg and 
MPP+ treated MN9D cells. This result further confirmed our ob ervations that the two 
toxicants can induce similar pathophysiological vulnerability to DA and dopaminergic 
associated signaling. Proteins in energy metabolism including propanoate metabolism, 
pyruvate metabolism and fatty acid metabolism, oxidative pho phorylation were altered with 
treatment of MeHg and MPP+. The disruptions of these cellular functions in the dominergic 
celJs can be the underlying mechanism of PD. In addition, we also found that MeHg 
interrupted pathways involved in other neurodegenerative diseases including AD, ALS and 
especially in HD. Resu lts from these two chapters clearly sho\\- that MeHg can b a potential 
risk factor for PD by affecting imilar biochemical pathway and endpoint effect uch a 
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en rg d fi it that ar affl t d b MPP+. M re er, MeHg rna al involve m other 
n ur d g nerati e condition . 
Th yd and 4111 manu ript pre ented in hapt r and VI h wed for the first time the 
c mpr hen i prote me change 1n di f[i rent brain rcg1 n (cere bell urn , fr ntal lobe and 
cipital l be) f marm . t e. po ed t McHg. Th re wa a clear regi nal difference in the 
number and profil e f pr tc in affec ted b; MeHg leadin g to the differenti al functional 
chang in th thre brain region . Ba ed on the number of differ ntiall y ex pre ed protein 
identified in th r g10n , w h V\ ed the r lative vulnerabl e sites in response to Mell g 
timuli in the following order: er bellum ( 1 02) > ccipital lobe (89) > frontal lobe (62). 
Moreo er, MeHg affect d protein as ociated with the most diver e cellular functions and 
number of biological pathway in the cerebellum and occipital lobe. Th se results support 
previous observation that cerebellum and occipital lobe were the primary target of MeHg 
(Eto, 1997). alcium signaling and ion transport espec iall y ynaptic transmission were 
identified as the main affected pathway and function in the cerebellum of MeHg expo ed 
marmoset. Corresponding to the biological functi on alterati on , MeHg wa found mainl y to 
target organelle distributed in plasma membranes e pecially in synaptic membrane in 
cerebellum . One of the most important finding of our tudy is the identifi cati on of DLG4 
and MIR-19A/MIR-19B as the key targets leading to multiple effect of MeHg in the 
cerebellum. In the frontal and occipital lobes of the cerebrum of MeHg treated marmo et 
APOE was identifi ed as a key affected protein that serve as a hub linking mul ti-function . 
This direct cause-effect relationship provide e cell ent mechani tic upport for the previou ~ 
reported correlation between the APO 4 genotype and pati ent with chroni c mercury toxicity 
(Wojcik et al. , 2006), and further support the proposed usc of APOE a a potentia l clinical 
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bi n1arker [! r n1 r ur 
upp rting ur h p th 
icit ( odfr et aL 200 ). In a ditional to the evidence 
that MeHg i a ociated ith P , we al o id ntifi d interaction of 
M Hg ith an u neur degenerati e di ea he pr teomic re ult of both the in vitr 
and in tudie sh wed tha t M Hg induced hange 111 pr teins ass ciated with 
neur degen rati e di ea uch a Parkin n 's di ea e, Huntington 's di ea e and 
lzh imer ' ugge ting that M Hg can be a ri k fac tor in the development of pathogen is of 
van u n urodegenerati ve conditi n . 
Th ultimate g a l of mechani ti c tud y i t id entify the molecular, biochemical or 
ph iological change that can ex pl ain the functi onal or behav ioral changes ob erved. In thi s 
study, we demon trat d the foll owing mechani ms: i ) Mel lg impaired energy generation in 
marmoset brain by affecting key prote in invo l ed in carbohydrate deri ved metaboli m and 
lipid metaboli sm in all three region of marmo et brain ; i i) ignificant alterati ons of synaptic 
tran mi ion, carbohydrate derived m tabolic process and neuronal morphology in the 
cerebellum may explain the motor dy function sign presented in MeHg-do ed mam1o et: iii ) 
MeHg caused brain edema by altering the key protein AQP4 as well a its associated water 
transport pathway. 
In sun1mary, our results suggest that MeHg can be a risk factor for multiple neurological 
disorders (PD, HD, AD, ASL) . The present results (Chap Ill and IV) speci ally foc u ed on the 
compari sion of biological pathway and molecul ar changes of MeHg and MPP+ in the 
context of PD pathogenes i , which not only provided the ev idence in the a sociat ion of 
MeHg with PD but also gave the additiona l hints for other dopaminergic r lated di order . 
such as I ID , schi zophrenia and drug addiction . furthermore, the re ult of Chap ter V and VI 
demonstrated a compreh nsive overview of the molec ul ar change and targets across the 
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c r b llum, L, and L r gion m M Hg e p d marm et. The identified molecular 
target uld p t ntiall bee m g d andida tc :D r de el ping biomarker in diagn or 
ph rmarc 1 gi al target :D r tr atment f Mellg int icati n . Particularly, the e tudie are 
1mp rtant in providing th ba i .G r the d ve l pm nt of pre ntive and treatment trategie to 
mi tigate the e adver e effl ct m clini c per pecti v e ampled candidates in previous 
chapter , 4 and P ar c r protein in linking and maintaining functi ons of synaptic 
tran mi n and lipid metaboli m in the phy ical conditi n . ignifi cant changes of these two 
protein c uld be pr mi ing marker. or a the candidate targe t in predi ction/ treatm ent for 
MeHg p i 10nmg. M reover, the "omi c " appr ach wa pr ved as a re li able and powerful 
method to identi fy k y targe t prot in . and provided a n ve l way to 1uc idate the r gional-
specific biological fun cti on and pathway a oc iated with MeHg n urotox ic ity. Therefore, 
L -M S/MS i approperate t chnique and t st methodo logy to evaluate the effects of MeHg 
exposure on human nervous y tern. Finally, results of thi s stud y provide the indirect 
guidance to policy deci sion-making in the deve lopment of regulation fo r MeHg emi ss ions 
and exposure advisori es to protect the health of sen itive populati ons. Hg is a global i ue 
encountered in various countries including Canada. In terms of potential tox ic effects of Hg 
in the ai r, food, wild life and human health, there is still far too little to know the e act toxic 
mechanisms of MeHg parti cular on humans, the top chefs in the food chain. The present data 
provides the dose effects of MeH g that could be reffe red for safety evalua tion, and for further 
fac ilitate our understanding of the pathogenesi changes of MeHg toxicity from laboratory 
anim als to people. Particulary, the primate mode l used in th is study provided the more direct 
proofs for predi cti ons of I lg on human healath effec ts. OveralL this study contribute to a 
better understanding of magnitude in the uncertain mechani tic questions of MeHg 
neurotox ic ity in humans. 
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ontribution to knowledge and limitation 
ntribution : 
• T the c n iderati n of MeHg a a contribut r ri k fac tor for PD and other 
neur 1 g i al di rder . and identi fy ing on the p ible linkag between MeHg 
e p ure and n ur deg nerati v di ea e . 
• To the identifi ati n f the electi ve effec t of MeHg on plasma membran pr t ms, 
particularl y n prot in f ; napti membrane in cerebe llum. 
• To pro ide furth er in ight into the development of k y prote ins as biomarker for 
prediction and treatment fo r MeHg int x icati on . The bi omarker co uld be useful for 
future human ri k a e ment and other epidemi ology studi es. 
• To promote the evidence-bas d p licy making in translati on to nv ir nm enta l-heath 
management and po licy proce into protecti on of human from environmental and 
man-made exposure of MeHg. 
Limitations: 
o The question po ed in the Chapter III and IV is whether MeH g expo ure and PD 
share similar etiopathology . In the normal biological conditi on. compensatory 
processes occur first before damage manifestati ons ( lark on et aL 2007). hort te rm 
and high concentration of MeHg exposure can produce acute toxic effect wherea 
long term low dose e posure may induce com pen a tory respon e \\ hich cause 
different net tox ic effects. In thi s tudy, the ce ll culture dos ing experiments were 
de igned to have a do ing period of 24h-72h and the marmoset ex perim nt \\ a a lso 
de igned to study the hort te rm acute effects. Therefore, our result , ma) not 
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n ce aril b refl ecti e f the 1 ng term 1 do e ituation e perienced by the fi sh 
n urn r . 
o Ther are limita ti n in th u e fbi informati c t identify pathway a ci ated with 
chang d pr t in . We identifi ed the indi idual pathwa in each of bra in regi n , but 
till la k f v i den e and knovv l dge t under tand the ca cade ef-[1 ct /pa ttern and 
r lati n hip between all th affec ted pa thwa . urth r s tudi e are n eded to confirm 
the do e-re p n e effec t vvith a more e tab!i hed method. 
o Th predict d fun cti on and pathway need to be further verifi ed by additi onal 
multipl e do e . longer term anima l d ing e periment . 
Future research 
1) The creemng re ults of th pre ent proteomic work prov ide the important bi ological 
pathway and proteins in linking MeHg-affected multi -functi ons. The prec ise functi ons of 
key proteins and regul ated factor identified including DLG4 and MIR-19A/B in cerebe llum 
and APOE in occipital lobe will need to be further clari fied . 
2) This study identified the connection of MeHg-neurodegenerati ve di sease thro ugh 
pathway enrichment analys is. The detailed underlying mechanisms of interacti on of MeH g 
with these neurodegenerati ve conditions particul arl y in HD, AD and ALS need to be further 
investi gated . 
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Appendix 1: E tabli hing the erebellar Granule Neuron and A trocyte 
Primary ulture Model for Methylmercury Toxicity tudy 
Background 
r wth factor (F ' , F and B F) have be n hoVvn t alter tatu n gap junction 
intra ellular ( J ) communi ation betw en a trocytcs and neur n. There i little rc earch to 
in e tigat the role f J functi n on mercury neuron to icity. erebel lum is known as a 
target regi n for mercury to , icit . The objective of this study is to develop primary 
erebellar trocyte ( ) and ' erebellar ranule Neurons ( N) -mono and co-cultures 
m del for furth r tudy of th groVv1.h factor F F2 ( Fi br blast rowth Factor 2) on ap 
Junction Channel onne in4.., ( x4 ) communication in respond to Methylmercury (McHg) . 
Until now, w have ucce fully e tabli hed th model f mou e r bellar Astrocytes, 
Cerebellar ranule Neuron co-culture (Fig.4) and mono culture (Fig.5 ), which were 
e timated by ingle IF (immunofluorescence) and double IF staining a say for MAP-2 (for 
neurons) and GF P proteins (for astrocytes). erebellar A and GN mono and co-cultures 
were expo ed to MeHg (0-20!-lM) for 24h or 48h. The results of the cell viability assay 
demonstrate that MeHg induced a time and dose dependent decrease of the cerebellar A and 
GGN in both mono and co-cultures (Fig.6 ). The mono-cultures are more sensitiv to the 
lower doses of MeHg than the co-culture. These results indicate that cer be liar A and CGN 
cultures are appropriate cell models to study MeHg toxicity. The primary cell viability a ay 
provides the range of concentration to be used to further study the effects of FGF -2 on the 
regulation of Cx43 in the cerebell ar AS and CGN co-culture. 
The protocol of c -culture AS and CGN modeL results of IF staining and cell viability a sa; 
in AS and GN cultures are present as fo llows. The animal experimental de ign and 
methodology were approved by th e U nive rs ity of Ottawa Animal Care and U e committee 
(June, 20 1 2). 
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Protocol of Co-culture Astrocytes and Cerebella Granule Neuron 
Astrocytes preparation was based on Marek eta!. paper 
(Marek et al., 2008) with modification. Cerebellar Granule 
Neuron (CON) culture protocol was referred from Hae Young 
Lee etal. video article (Lee et al., 2009). Below is the 
procedure of preparation co-culture of CGN and AS. 
Primary astrocyte cultures were collected from the cerebella 
of post-natal day 4-6 mice. 
1) Remove meninges and mince cerebellar ti ssues, 
incubate in rocking water bath/ or MACSmix™ Tube Rotator 
at 3 7°C for 30 minutes in 1 OmL HBBS + 300jlg/mL Dnase I 
and 0.25% trypsin (I0011L) 
2) Triturate digested cells with 0.25% FBS, wash and 
spin (300 x g for 1 Omin) 
3) Re-suspend pellet in HBBS and pass through 70~tm 
nylon mesh screen. wash and spin 
4) Re-suspend dislodged cells in 1 OmL of MACS 
separation buffer. pass suspension through a 40!-lm sc reener 
into a 15mL tube 
5) Spin (300 x g for 5min at 4°C). wash with buffer and 
re-suspend at 1 x 107 cells / 1 OOuL buffer 
6) Add 1 OuL of Anti-ACSA-2 Micro Bead per 1 0011L 
buffer. incubate for 30min at 4°C with gentle mixing every 
5min 
7) Wash once with separation buffer: re-suspend m 
500j1L buffer I 1 X 1 08 cells 
8) Prepare MS columns by adding 5mL of buffer, wash 
with buffer 3mL x 3 





Cerebellum dissection Smgle cell 





Elut1on on MS 
magnet1c column . 
Ant1-GLAST 
Microbead Kit 
Figure 1. Diagram of primary cerebellar astrocytes isolation 
and purification 
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9) Place column in fresh 15ml tube and add cells, use 
plunger to flush with 5mL buffer 
1 0) Spin 15ml tube and dilute astrocytes enriched 
suspension with MEM medium to obtain the desired density 
(l x l05/w in a 12-well plate. ~ 100,000 cells/mL, depending on 
the time required to reach confluence) 
11) Place AS enriched cultures into C02 incubator for 2 
weeks. medium was changed twice per week 
12) When glial cells reached confluence and form a 
uniform monolayer on the cover slips, add FUDR so lution 
( ex.12.5 1-11 FUDR per petri dish) 
2-weeks old purified AS ( +) were pre-seeded 1-2 days before 
CGN and progenitor cells collection. 
13) After collection of CGN, count cell density with a 
hemacytometer and trypan blue and add SFM to reach the 
desired cell density (100,000 to 350,000 cells/mL). For 12 
well plates. plate 2.5-3.5 x l 05 cells/well 
14) For cerebellar CGN and AS co-culture, seed CGN (5 -
6 folds density as AS) on top of pre-plated monolayer of 
astrocytes (2 weeks old) with SFM/MEM+medium. 
15) Add cytosine arabinoside to a final concentration of 
51-!M in SFM/MEM+ medium to reduce the proliferation of 
glial cells 
16) If culture remained beyond 7 days, add 500~1 
SFM/MEM+ once per week of incubation thereafter to 
compensate for evaporation, resume incubation. 
J;>< 















Suspension plated on 
POL coated plate . 













Figure3. Diagram of AS and CGN co-culture plating in a ratio 
of l :6 for 7 days following MeHg exposure 
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Li t of chemical and reagent : 
HB , n alcium, n Magne ium, n Phenol Red (In itrogen, 14175-095) 
Minimum ential Medium (M M) (In itr gen. 110 50 0) 
ur ba al -Medium (lnvitr gen. 12 49-015) 
Penicillin- tr pt mycin/ P luti n (lnvitr gen. 15140-122) 
B-27 erum re upplement (50. ) (lnvitr gen. 17504-044) 
Tr pin- ~ DT Jution (Invitrogen. R-001-100) 
H at-Inactivated F (Invitrogen, 1 ~4 4028) 
lutaM X (lnvitrog n, 050061) 
MA mi TM Tube Rotator (Miltenyi Biot , 130-090-753) 
MA B A tock olution (Miltenyi Bi tee. 130-091 -376) 
Anti-AC -2 MicroBead, Mou e (Milten i Biotec, 1 30-097-6 78) 
orning 15m1 graduated plastic tube PET (Fisher Scientific, 05-538-51 A) 
Cell Strainer (Fi her cientific. 40~-tm 22-363-547: 70~-tm 22-363-548) 
Characterized FBS SOOml (Fisher Scientific, H3039603Hl) 
lOOmM sodium pyruvate solution (Sigma-Aldrich, 8636-1 OOml) 
Cytosine ~-D-arabinofuranoside (Sigma-Aldrich, C 1 768-1 OOmg) 
45o/o (w/v) D-glucose (Sigma-Aldrich, G8769-l OOml) 
MITO + Serum extender ( orning, 355006) 
165 
Prepare culture media and lution: 
erum-free medium ( FM) and 10% FB medium 
4 ml of ur ba al -Medium 
500 !J.l 1 OO x lutaM 
500 !J.l 1 OO x P ni illin- tr pt mycm 
6.25 !J.l 2 M K 1 (final ... 50 !J.M). 
plit in 2 aliqu t f9 ml and 4 ml. T pr pare 10°/o FB medium, add lml fheat-
inacti ated to the 9 ml aliqu t. T prepare FM, add 800 !J.I of th e erum-free 
uppl m nt -27 t the 40 ml aliqu t. Filt r teriliz d and tore at 4° for a rna imum of 2 
w ek . 
MEM+ (MEM/1 0% FBS medium 1 OOml) * an be t red at 3 7°( ~ r 1 week 
87 .6ml nditi ned M ~ M ( vlinimal e enti a! media with Earl salt and without L-
glutamine) + lml P (100 ) 
1.33 ml 45 o/o (w/v) D-gluco e 
lml 1 OOmM sodium pyruvate oluti n 
MITO (5ml H2 in 1 vial of MIT + erum E tender) 
Filtered using a 0.22!J.M nylon mesh bottle filter 
lOml FB 
SFM + MEM( +) solution 
66ml SFM 
33ml conditioned MEM+ 
FUDR solution *Prepare lml aliquots and store up to 1 year at -20°( 
203 m! MEM (with Earl e's salts, without L-glutamine and phenol red) 
1 OOmg 5-fluoro-2' -deoxyuridine 
198mg uridine 
Filter using a 0.2!J.M nylon mesh bottle filter 
Cytosine arabinoside * tore up to 6 months at - 20oC. 
To make 2mM ytosine arabinos ide, di sso lve 2mg c tosi nc-l-f3-D-arabino-furano ide in 5ml 
water. 
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Figure4. Immunofl uorescence of Cerebellum Astrocytes (AS) and Cerebellar ranule 
Neurons (CGN) co-culture for 10 day . Astrocytes are tained with GFAP, repr ented in 
green (A), and neurons are stained with MAP-2, repre ented in red (B). Nucleus stained with 
DAPI represented in blue (C). D is a merged image of AS and CGN in co-culture, E i a 
phase contract image of AS+ GN co-culture (A-E, object ive lens 40 x), and F is AS and 




FigureS. Immunofluorescence of mono cerebellar a trocytes and mono cerebellar granule 
neurons of postnatal day 4-6 mice. Immunocytochemi try again t MAP-2 with DAPI (A) and 
without DAPI (B) staining in GN enriched cultures (1 Ox). Merged FAP and D Pl 
staining (C), and GF AP ingle taining (D) in i olated cerebellum astrocytes ( 1 Ox). Boxe 
indicated the expression of mono CGN and a trocytes under 40 x obj ctive len . 
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MeHg (~M ) 
Figure6. Cell viability of cerebellar granule neurons and astrocytes in mono and co-cu lture 
fo llowing a 24h exposure (A) and 48h expos ure (B) to various concentrations of MeH g. 
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Appendi II: upplementary data 
hapter V: 
Table 1. 25 6 id ntified pr tein 
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D-3-pho phoglyce rate dehyd r gena e 
Eukar oti c translat i n initiati on fac tor 2 ub unit 2 
CD81 anti gen 
Glutamate deh drogena e 
F-bo only protein 2 
Tubulin beta chain 
Guanine nucleotide-binding protein G( q) ubunit 
alpha 
Cytopla mic FMR !-interactin g protein 2 
Creatine kinase 8 -type 
Tran itional endopl asmi c reti culum A TPa e 
Tubulin alpha- ! A chain 
T-complex protein 1 subunit gamma 
arcoplasmic/endopla mi c reti culum ca lcium 
ATPase 2 
Ras- re lated protein Rab-3 A 
Spectrin alpha chain , non-e rythrocyti c I 
26S protease regulatory ubunit 6A 
V-type protonATPa e ubunitH 
Dynamin- 1 
Synaptosomal-a soc iated protein 25 
Ra -related protein Rab- 1 I A;Ra -related protein 
Rab- 11 B 
ontactin-as oc iated protein I 
Mitochondrial inn r membrane protein 
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Protein DR 4 
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-ra; repatr cro -c mplementing pro tein 5 
Pia ma m mbrane ca lcium -tran port ing A TPa c I 
eptin-9 
ur nal c II ad h ion molecule 
Microtu bule-a ocia ted pro te in RP/[:8 fa mil y 
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RmB -lik I 
Amphiphy in 
V-type proton AT Pa ·e ubunit D 
Ru vB-like 2 
Protein ip nap homolog 2 
ynaptotagmin - I 
Tal in -2 
Non-POU domain-containing octamer-b in ding 
protein 
Cal cium/ca lmodulin -dependent protei n kinase ty pe 
II subunit alpha 
60S ribo omal protei n L26 
Sodium- and chloride-dependent GA BA transporter 
I 
Small glutamin e-ri ch tetratr icopeptide repeat-
containing protein alpha 
Homer protein homolog 3 
Ankyrin-2 
Eukaryoti c translati on initiati on factor 3 ubun it A 
E3 ubiquitin -pro tein l iga HUWE I 
Clathrin li ght chain B 
Pl asma membrane ca lcium-tra nsporti ng A TPa e 2 
Protein bassoo n 
Ves icular glutamate transporter I 
Acti va ted RNA polymerase II transcri ptional 
coacti va tor p 15 
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Lo\\ -density lipoprotein receptor-related prote in 1 
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Sodium/ca lcium exchanger I 
Neurocan core protein 
C2 domain-containing protein 5 
RNA-binding protein 14 
Limbic system-assoc iated membrane protein 
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Inos itol-tri sphosphate 3-ki nase A 
GMP synthase [glutamine-hydro lyzing] 
OmX-1 ike protein 2 
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Associated Genes Found 
ANK2, CNTNAPI, GNAQ. KCNJ 10, SCN2A 
CRY AB, GSKJA, LGII. NRCAM, RAB II A 
EIF2S2, LICAM. MFN2. PSMCJ, SLC8AI 
ARF5. DLG4. DNM I. GNAQ. GNAS. GNB5. PLCB I, 
RAB II A, RABJA. SRGAP2 
ANKI. ANK2, ATP2A2, ATP2BL ATP282, ATP6VIO, 
ATP6V I H. CAMK2A. DLG4, HBB. KCNJ 10, RABJA. 
SCN2A, SHANK I. SLCI7A7. SLC6AI, SLC8AI, 
LC8A2 . SNAP25. SYTL VPS4A 
ANK2. ATP2A2. ATP2B2. CAMK2A, SLC8A I 
ANK2, ATP2A2. ATP2B2. DLG4. IMMT, SLC8A I 
ANKL CAPI, DLG-t NAPB. PAKI, PLCBI. PPIA. 
RABJA. SNAP25. SRCIN I, SUB I. SYT I 
AMPH . ATP2B2. BSN. CAMK2A. C NTNAPI , DLG_., 
ITPKA, KCNJIO , LGII , NAPB, NCAN, PLCBJ , 
RABIIA, RABJA, SHANKt , SLCI7A7, SLC6AI , 
SNAP25, SYP. SYTJ 
ANKL ANK2. CAPL CNTNAPI, DLG4. LICAM. LGII, 
NCAN, NRCAM. PAKI. RABIIA. RABJA. SPTANI. 
SPTBN2. SRGAP2 
ANKI. ANK2. CAPI. CNTNAPI. DLG4, LICAM. LGII, 
NCAN, NRCAM. PAKI, SPTANI. SPTBN2. SRGAP2 
AMPH. DLG4. PLCBI. SHANKI. SLC17A7. SLC6AI 
ARF5. A TP2B2, ATP6V I H, CAP I. DLG4, DNM I, GBAS, 
GLUD I, GMPS. GNAQ. GNAS. GNB5. GSKJA, PHGDH, 




ARFS, A TP2S2, A TP6V I H, CAP l, DLG4, DNM I, GS AS, 
G0 :0009 150 20 19.4 1.93£-31 GMPS. GNAQ. GNAS, GNS S, GS K3A, PLCS I, PSMC3, 
metabo lic process RAS I I A, RAS 3A, RUVS L2, SRGA P2, VCP, VPS4A 
G0:0009 152 purine ribonucleotide 5 15.2 3.78£-05 CA P!, GSAS, GM PS, GNAS. GS K3A biosynthetic process 
purine ribonucleotide 
ARFS, A TP6V I H. DLG4. DN M I, GNAQ, GNAS, GN BS, 
G0 :0009 154 15 20 .5 2.02£-11 PLCS I, PSMC3. RAS II A RAS3A, RUVS L2, SRGAP2, 
catabo lic process VCP. VPS4A 
nucleotide catabolic 
ARFS, A TP6V I H. DLG4. DNM I, GNAQ, GNAS, GN BS, 
G0 :0009 166 16 20 .3 1.41 E-15 GS K3A, PLCS I, PSMC3, RAS II A, RAS3A, RUVBL2, process SRGAP2. VCP. VPS4A 
purine ribonucleos ide ARFS, ATP6V I H. DLG4, DNM I, GSAS, GNAQ, GNAS, 
G0:0009205 triphosphate metabo lic 16 18 .8 2.94£-12 GNSS. PLCB I, PSMC3, RAS II A, RAB3A, RUVBL2, 
process SRGAP2, VCP, VPS4A 
G0:0009790 embryo deve lo pment 10 18.9 9 .62£-120 
ATP282, EJF2S2, GNAQ, GNAS, LICAM, MFN2, 
PHGDH. PLCB I. PSMC3, SLC8A I 
G0:0015711 organic ani on transport 7 21.9 8.43£-11 
HBS. KCNJIO. RAS3A, SLCI7A7. SLC6Al, SNAP25, 
SYTI 
AMPH, ANK I, ARFS, A TP6V I H, CAP I, CL TB, CYFIP2, 
G0:0016192 vesic le-medi ated 23 15.1 1.29E-1 00 
DLG4. DNM L LRP I, NAPS, PAK I, PLCB I, PPIA, 
transport RASIIA. RAB3A. SNAP25. SPTSN2. SRCINI, SUB I, 
SYP. SYT I, VPS4A 
G0:0016570 histone modificat ion 5 29.4 2 .7 1 E-1 0 HUWE I, PAK I, RSM 14, RUVSL I. RUVBL2 
AMPH. ATP2S2, BSN. CAMK2A, CNTNAPI, DLG4, 
G0:0019226 transmission of nerve 22 15.9 9.30£-56 ITPKA, KCNJ 10, LGII, NAPS, NCAN, NRCAM. PLCB I, impulse RASIIA RAB3A. SCN2A. SHANKl, SLCI7A ., 
SLC6A I. SNAP25, SYP, SYTI 
ARFS. ATP2S2, ATP6VIH, CAP!, CD81. DLG4, DNMJ, 
G0:0019637 organophosphate 25 15.9 2.74E-99 GSAS, GLUD I. GMPS, GNAQ. GNAS, GNBS, GSK3A 
metabolic process lTPKA, PHGOH, PIP4K28, PLCB I, PSMC3, RABIJA, 
RAS3A. RUVBL2. SRGAP2, YCP, VPS4A 
G0:0023061 signal release 9 15.5 3.05£-09 CAMK2A. GLUDI, GNAS, NAPS. RAB3A. SLC17A., SLC6AL SNAP25, SYTI 
G0:0030097 hemopoiesis 6 15. 8 1.35£-35 ADD2, ANKJ, GNAS, LICAM, TPD52, XRCCS 
G0:0031329 regulation of cel lular 8 17.0 6.21 E-26 DLG4. GNAQ, GNAS, GSK3A, PLCB I, RBMI4, 
catabolic process SRGAP2. VCP 
G0:0032940 secretion by ce ll 17 16.5 1.17£-54 AN K I, CAMK2A, CAP!. DLG4, GLUDI, GNAS. NAPB, 
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PAKI, PLCBI, PPIA, RAB3A, SLCI7A7, SLC6AI. 
SNAP25, SRCIN I, SUB I, SYTl 
G0:0032970 
regulation of actin 7 17.9 1.98E-05 ADD2. ANK2, LRPI, PAKI, SHANK!, SPTANI, SPTBN2 
filament-based process 
AMPH. ANK2. ATP2B2, BSN. CAMK2A, CNTNAPI, 
G0:0035637 multicellular 24 16.7 5.39E-68 
DLG4, ITPKA, KCNJ I 0, LGI I, NAPB, NCAN, NRCAM, 
organismal signaling PLCBI, RABIIA, RAB3A, SCN2A, SHANK!, SLC17A ., 
SLC6A I, SLC8A I, SNAP25, SYP, SYT I 
G0:0040008 regulation of growth 8 17.4 2.08E-29 
CRYAB. GSK3A. LGII, NRCAM, PLCBI, RABIIA, 
RUVBLI, RUVBL2 
G0:0042060 wound healing 12 15.4 5.67E-39 
A TP2A2. A TP2B I, ATP2B2, CAP I, GNAQ, GNAS, HBB, 
LICAM, MFN2. PAKI. PPIA, SLC8A2 
G0:0042391 regulation of membrane 9 19.6 1.21 E-08 
ANK2, ATP2A2. CNTNAPI, DLG4, GNAQ, KCNJIO, 
potential SCN2A, SHANK!, SLCI7A 
G0:0043009 chordate embryonic 7 20.0 3 . 13E-35 
EIF2S2, GNAS, LICAM, MFN2, PHGDH, PSMC3 , 
development SLC8AI 
G0:0043547 positive regulation of 5 27.8 1.02E-02 DLG4. GNAQ. GNAS, PLCB I, SRGAP2 GTPase activity 
regulation of system 
ANK2, ATP2A2. ATP2B2, CAMK2A, DLG4. GSK3A, 
G0:0044057 15 19.7 1.42E-16 ITPKA, KCNJIO, LGII, NAPB, RABIIA, RAB3A. process SLC6A I. SLC8A I. SYP 
G0:0044708 s ingle-organism 8 16.3 6 .08E-I 0 
AMPH. DLG4. KCNJ I 0, PLCB I, SHANK I, SLC 17 A 
behavior SLC6A I, SPTBN2 
negative regulation of 
G0:0045936 phosphate metabolic 5 15 .6 1.69E-12 DUSPJ. GNAQ. GSKJA, LRP l, SRCIN I 
process 
G0:0046128 purine ribonucleoside 
ARFS. A TP6V l H. DLG4. DNM l. GBAS, GMPS, GNAQ, 
metabolic process 17 18 .3 6 .3 0E-18 GNAS, GNBS, PLCB I. PSMC3. RAB II A, RAB3A, RUVBL2, SRGAP2, VCP, VPS4A 
G0:0046130 purine ribonucleos ide 
ARFS. ATP6VIH. DLG4. DNMI. GNAQ, GNAS, GNBS, 
catabolic process 15 20.5 1.16E-IO PLCB I. PSMCJ , RAB ll A. RABJA. RUVBL2, SRGAP2, VCP. VPS4A 
ANK I. ATP2B2. CAMK2A. CAP I, DLG4, GLUD I, 
G0:0046903 secretion 19 17.1 6 .39E-99 GNAS. NAPB, PAKI, PLCBl. PPIA, RAB3A, SLCI7A 
SLC6A I. SNAP25, SRCIN I, SUB l, SYT I. TPD52 
G0:0048468 cell devel opment 28 15.2 1.12E-102 ANKI. ANK2, ATP2B2. CAPL CNTNAPL CRYAB. DLG4. GNAQ, GSK3A. KCNJIO, LICAM, LGII, 
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MAPRE3, NCAN, NRCAM, PAKI, PHGDH, PLCBl, 
RAB I I A, RAB3A, SHANK I, SLC8A I, SPTAN l, 
SPTBN2, SRCIN I, SRGAP2, SUB I, XRCCS 
cell morphogenesis ANKI, ANK2, ATP282, CAP!, CNTNAPI, DLG4, 
G0:0048667 involved in neuron 18 17.0 7.02E-22 LICAM, LGII , NCAN, NRCAM, PAKI, RABIIA, 
differentiation RAB3A, SHANK I, SPTAN I, SPTBN2, SRCIN I, SRGAP2 
neuron projection ANKI, ANK2, CAP!, CNTNAPL DLG4, LICAM, LGII, G0:0048812 17 15.7 4.29E-24 NCAN, NRCAM, PAKI, RABIIA, RAB3A, SHANKl, 
morphogenesis SPTAN I, SPTBN2, SRCIN l, SRGAP2 
ANKI. ANK2, ATP6VID, CAP!, CNTNAPl, DLG4, 
G0:0048858 cell projection 19 16.4 1.29E-45 LICAM, LGII. MAPREJ, NCAN, NRCAM, PAKI, 
morphogenesis RAB II A, RABJA , SHANK I, SPTAN I, SPTBN2, 
SRCIN L SRGAP2 
G0:0050801 ion homeostasis II 15.9 I .0 I E-25 
ANK2, ATP2A2, ATP2B2. ATP6V I 0, ATP6V I H, CKB, 
DLG4, IMMT, KCNJ 10, PDK2, SLC8AI 
G0:0051 046 regulation of secretion II 21.6 7.08E-17 
CAMK2A, GLUD L GNAS, NAPB, PLCB I, PPIA, 
RABJA, SLC6A I, SNAP25. SRCIN L SYT I 
ANK2, ATP282 , CAMK2A, CRYAB, DLG4, GLUDI , 
G0:0051 049 regulation of transport 21 15 .3 1.09E-I 03 
GNAQ. GNAS. GSKJA, LRP I, NAPB, PLCB I, PPIA, 
RAB II A. RABJA. SHANK I, SLC6A I, SLC8A I, SNAP25 , 
SRCIN I. SYT I 
G0:0051276 chromosome 6 15 .0 
organization 3 .22E-83 
HUWEI. PAKI. RBMI4 , RUVBLI, RUVBL2, XRCC5 
G0:0051640 organelle localization 9 17.6 6 .67E-05 AMPH, DLG4. MFN2, NAPB, RABIIA, RAB3A, SNAP25, SYP. SYTI 
G0:0055082 cellular chemical 10 ANIC , ATP2A2, ATP282, ATP6V I D. ATP6V I H. CKB, 15.9 3.14E-22 homeostasis DLG4, IMMT, L I CAM. SLC8A I 
G0:0071345 cellular response to 6 18 .2 2 .63E-21 CAMK2A, CAP I, GSK3A. LICAM, PLCBI, TUBAIA 
cytokine stimllllus 
cellular response to 
G0:0071375 peptide hormone 6 15.4 3A5E-09 ATP6VID, ATP6VIH. GNAS. GSK3A, PAKL PDK2 
stimulus 
regulation of purine 
G0:1900542 nucleotide metabolic 7 23.3 2.31E-14 CAPL DLG4, GNAQ, GNAS. GSKJA PLCBL SRGAP2 
process 
GO: 1901068 guanosine-containing 11 21.6 2.68E-09 ARF5, DLG4, DNMl, GMPS. GNAQ, GNAS, GNB5, 
compound metabolic PLCB I, RAB I I A, RABJA, SRGAP2 
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process 
ARF5, ATP28 2, ATP6VIH, CAP!. DLG4, DNMI , 
GO: 1901135 carbohydrate derivative 22 15 .7 2 .26E-I 08 
FBX02, GBAS, GMPS. GNAQ, GNAS, GNB5 , GSK3A, 
metabolic process NCAN. PLCB I. PSMCJ. RAB II A, RAB J A. RUVBL2 , 
SRGAP2, VCP, VPS4A 
carbohydrate derivative 
ARF5. ATP6VIH . DLG4. DNMI . FBX02. GNAQ, GNAS. 
G0:1901136 18 22.0 8 .97E-2 1 GNB5. GSKJ A. NCAN . PLCB I, PSMCJ, RAB II A, 
catabolic process RABJ A. RUVBL2. SRGAP2. VCP, VPS4A 
G0:1901137 carbohydrate derivative 8 15 . 1 1.05 E-48 
CAP I. GBA S. GMPS. GNAS, GSK3A, NCAN , PLCB I. 
biosynthetic process VCP 
organon itrogen ARF5, ATP6Vl H, BLVRB, DLG4, DNM I, GLUDI , 
GO: 1901565 compound catabolic 18 15 .8 5.35E-65 GNAQ, GNAS, GN85, NCAN, PLCB I, PSMC3, RAB II A, 
process RABJ A. RUVBL2. SRGAP2, VCP, VPS4A 
G0:2000145 regulation of cell 7 15.9 3. 03 E-22 
LRP I. PAK I. PLC BI , RBM I4, SLC8AI , SRCINI , 























SYP. SPTAN I. ATP2B I. DLG4 . ATP2B2. SCN2A. ATP2A2. LRP I. SLC8A I. 
SYTI. CNTNAPI. CAMK2A . SNAP25. C2CD5. HOMERJ . CLTB. SHANKI , 
CD81 . GBAS. NDRG4 . AMPH . GNAS. SRCIN I. KCNJ I 0, SRGAP2. GNAQ. 
SPTBN2. L I CAM. PAK I. DUSPJ . SLC6A I. ANK2 . ANK I. NRC AM 
SYP. DLG4. BSN. SHANK I. SYT I. SLC 17 A 
SNAP25 . SYP. Ll CAM . HOMERJ . DLG4. SRCIN I. SHANK I. ANK2. SYT I. 
SRGAP2. ANK I. CAMK2A 
6 P-value corrected using the Benjamini and Hochberg method 
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A 
DLG4 (Disks large homolog 4) : P78352 
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SLC17 A7 (Vesicular glutamate transporter 1 ): Q9P2U7 
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igure l.Repre entative M /M spectra from (A) DLG4 (P78352) and (8) SLC17A7 
(Q9P2U7) in marmo et cerebellum 
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Cell adhesion molecules (CAMs) 
Chagas disease (American trypanosomiasis) 
Vascular smooth muscle contraction 





l ATP2A2, ATP2B2, 
l ATP2B 1, CAMK2A, 
i GNAS, GNAQ, ITPKA, 
i PLCBl , SLC8A2 and 
i SLC8Al 
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Figure 2. KEGG pathway enrichment analysis of differentially expres ed proteins tn 
MeHg-treated mannoset cerebellum using WebGestalt 
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FigureS3 . Calcium signaling pathway was classified by KEGG pathway mapping system 
from uploaded 102 differentially expressed proteins. Proteins with red labels were the 




APEO (Apolipoprotein E): P02649 
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DYNC1LI2 (Cytoplasmic dynein llight intermediate chain 2) : 043237 
B~ Ions rD-tA+-V F-+-1-+-P+A~GI-W-t-D 1~-f-E V-l 
Y~ Ions 1-V -I-V -t-E N D-t- -lGtA-t P +- +- F t-V-tA1 
B Ions f-D -+-A-t- F -t- +-P-t-A-+-G W D---!- I,J --1-E ---1--V -----1 








80 Score= 1 ~5 03 
Expectvalue = 0 00 4 9~13 
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Figure l .Repre entative MS/MS pectra from (A) PO (P02649) in marmoset occipital 
lobe and (B) DYN 1 LI2 (04323 7) in frontal lobe 
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